query	target	qheader	theader	fident	alnlen	mismatch	qstart	qend	tstart	tend	evalue	bits
DESULFOASV1_1484_hypothetical_protein	2pun-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	2pun-assembly1.cif.gz_B Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	0.128	367	303	11	359	12	378	8.480E-08	240
DESULFOASV1_1484_hypothetical_protein	2olc-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2olc-assembly1.cif.gz_A Crystal structure of 5-methylthioribose kinase in complex with ADP-2Ho	0.124	364	310	4	358	8	371	7.689E-08	237
DESULFOASV1_1484_hypothetical_protein	2pup-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2pup-assembly1.cif.gz_A Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	0.127	367	309	5	359	5	371	1.254E-07	233
DESULFOASV1_1484_hypothetical_protein	2pul-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	2pul-assembly1.cif.gz_B Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	0.122	364	312	4	359	6	369	1.254E-07	232
DESULFOASV1_1484_hypothetical_protein	2pul-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2pul-assembly1.cif.gz_A Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	0.137	368	300	11	359	14	381	8.480E-08	232
DESULFOASV1_1484_hypothetical_protein	2pu8-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2pu8-assembly1.cif.gz_A Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	0.137	356	287	26	359	18	373	1.083E-07	231
DESULFOASV1_1484_hypothetical_protein	2pui-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	2pui-assembly1.cif.gz_B Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	0.118	358	312	4	358	5	362	8.075E-08	229
DESULFOASV1_1484_hypothetical_protein	2pun-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2pun-assembly1.cif.gz_A Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	0.133	375	307	5	359	6	380	2.255E-07	228
DESULFOASV1_1484_hypothetical_protein	2olc-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	2olc-assembly1.cif.gz_B Crystal structure of 5-methylthioribose kinase in complex with ADP-2Ho	0.123	376	314	1	359	1	376	5.712E-07	219
DESULFOASV1_1484_hypothetical_protein	2pu8-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	2pu8-assembly1.cif.gz_B Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	0.125	360	311	4	359	6	365	1.766E-07	217
DESULFOASV1_1484_hypothetical_protein	2pup-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	2pup-assembly1.cif.gz_B Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	0.137	367	306	4	359	4	370	4.473E-07	214
DESULFOASV1_1484_hypothetical_protein	4few-assembly8.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	4few-assembly8.cif.gz_D Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP2	0.145	287	209	25	311	20	265	4.056E-07	210
DESULFOASV1_1484_hypothetical_protein	3att-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3att-assembly1.cif.gz_A Crystal structure of Rv3168 with ATP	0.182	347	277	9	348	6	352	4.260E-07	210
DESULFOASV1_1484_hypothetical_protein	4fex-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4fex-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor tyrphostin AG1478	0.141	289	207	23	311	16	257	1.759E-06	209
DESULFOASV1_1484_hypothetical_protein	4r77-assembly3.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4r77-assembly3.cif.gz_A Crystal structure of choline kinase LicA from Streptococcus pneumoniae	0.129	337	240	9	345	3	279	4.260E-07	209
DESULFOASV1_1484_hypothetical_protein	4fev-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4fev-assembly1.cif.gz_A Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP1	0.127	292	211	20	311	17	259	1.027E-06	208
DESULFOASV1_1484_hypothetical_protein	4n57-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4n57-assembly1.cif.gz_A Crystal structure of aminoglycoside phosphotransferase APH(2'')-IVa ADP complex	0.116	342	258	5	346	4	296	1.855E-07	207
DESULFOASV1_1484_hypothetical_protein	3n4v-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3n4v-assembly2.cif.gz_B apo APH(2")-IVa form III	0.114	337	261	1	337	1	296	2.487E-07	206
DESULFOASV1_1484_hypothetical_protein	4feu-assembly4.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	4feu-assembly4.cif.gz_D Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	0.148	265	195	47	311	9	238	1.940E-06	205
DESULFOASV1_1484_hypothetical_protein	4few-assembly7.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4few-assembly7.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP2	0.145	289	205	23	311	12	252	4.680E-06	204
DESULFOASV1_1484_hypothetical_protein	2ppq-assembly1.cif.gz_A-2	DESULFOASV1_1484_hypothetical_protein	2ppq-assembly1.cif.gz_A-2 Crystal structure of the homoserine kinase from Agrobacterium tumefaciens	0.133	358	267	3	360	2	310	9.783E-07	203
DESULFOASV1_1484_hypothetical_protein	4gkh-assembly17.cif.gz_I	DESULFOASV1_1484_hypothetical_protein	4gkh-assembly17.cif.gz_I Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NA-PP1	0.135	311	221	1	311	9	265	8.448E-07	202
DESULFOASV1_1484_hypothetical_protein	8bi5-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8bi5-assembly1.cif.gz_A Crystal structure of human Choline Kinase A in complex with UNC0737	0.107	356	305	3	358	1	342	4.260E-07	202
DESULFOASV1_1484_hypothetical_protein	4gkh-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4gkh-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NA-PP1	0.135	289	211	23	311	23	267	1.940E-06	200
DESULFOASV1_1484_hypothetical_protein	2pui-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2pui-assembly1.cif.gz_A Structures of 5-methylthioribose kinase reveal substrate specificity and unusual mode of nucleotide binding	0.128	352	293	23	359	17	368	4.056E-07	200
DESULFOASV1_1484_hypothetical_protein	4fev-assembly9.cif.gz_F	DESULFOASV1_1484_hypothetical_protein	4fev-assembly9.cif.gz_F Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP1	0.138	267	197	45	311	19	248	2.870E-06	198
DESULFOASV1_1484_hypothetical_protein	4ej7-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4ej7-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, ATP-bound	0.146	292	209	20	311	19	264	1.759E-06	198
DESULFOASV1_1484_hypothetical_protein	2q83-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	2q83-assembly2.cif.gz_B Crystal structure of ytaA (2635576) from Bacillus subtilis at 2.50 A resolution	0.135	352	279	6	357	9	331	6.323E-08	198
DESULFOASV1_1484_hypothetical_protein	4fev-assembly7.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4fev-assembly7.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP1	0.148	267	195	45	311	21	250	1.596E-06	197
DESULFOASV1_1484_hypothetical_protein	4feu-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	4feu-assembly3.cif.gz_C Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	0.122	288	226	24	311	1	258	2.360E-06	197
DESULFOASV1_1484_hypothetical_protein	1nd4-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	1nd4-assembly1.cif.gz_B Crystal structure of aminoglycoside-3'-phosphotransferase-IIa	0.154	301	206	11	311	5	248	3.678E-07	195
DESULFOASV1_1484_hypothetical_protein	4gki-assembly6.cif.gz_F	DESULFOASV1_1484_hypothetical_protein	4gki-assembly6.cif.gz_F Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NM-PP1	0.145	267	196	45	311	28	257	1.940E-06	195
DESULFOASV1_1484_hypothetical_protein	4fex-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	4fex-assembly3.cif.gz_C Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor tyrphostin AG1478	0.133	292	210	20	311	18	260	1.848E-06	194
DESULFOASV1_1484_hypothetical_protein	4few-assembly9.cif.gz_F	DESULFOASV1_1484_hypothetical_protein	4few-assembly9.cif.gz_F Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor pyrazolopyrimidine PP2	0.140	292	211	20	311	20	265	1.079E-06	194
DESULFOASV1_1484_hypothetical_protein	2q83-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2q83-assembly1.cif.gz_A Crystal structure of ytaA (2635576) from Bacillus subtilis at 2.50 A resolution	0.146	339	269	6	344	9	324	1.525E-07	193
DESULFOASV1_1484_hypothetical_protein	4gkh-assembly18.cif.gz_K	DESULFOASV1_1484_hypothetical_protein	4gkh-assembly18.cif.gz_K Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NA-PP1	0.141	267	199	45	311	36	268	1.027E-06	189
DESULFOASV1_1484_hypothetical_protein	4r78-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4r78-assembly1.cif.gz_A Crystal structure of LicA in complex with AMP	0.130	354	244	5	358	2	283	1.447E-06	187
DESULFOASV1_1484_hypothetical_protein	6sul-assembly2.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	6sul-assembly2.cif.gz_D Amicoumacin kinase AmiN in complex with AMP-PNP, Mg2+ and Ami	0.126	336	267	20	355	28	333	8.448E-07	185
DESULFOASV1_1484_hypothetical_protein	4gkh-assembly10.cif.gz_J	DESULFOASV1_1484_hypothetical_protein	4gkh-assembly10.cif.gz_J Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor 1-NA-PP1	0.141	311	214	1	311	14	263	1.075E-05	183
DESULFOASV1_1484_hypothetical_protein	4feu-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4feu-assembly2.cif.gz_B Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	0.155	274	208	22	295	16	262	1.519E-06	182
DESULFOASV1_1484_hypothetical_protein	8agy-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8agy-assembly1.cif.gz_A The Corramycin phosphotransferase in complex with Corramycin	0.130	350	280	9	358	3	325	2.360E-06	181
DESULFOASV1_1484_hypothetical_protein	3i0o-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3i0o-assembly1.cif.gz_A Crystal Structure of Spectinomycin Phosphotransferase, APH(9)-Ia, in complex with ADP and Spectinomcyin	0.118	356	283	3	358	2	323	5.180E-07	180
DESULFOASV1_1484_hypothetical_protein	8ahd-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8ahd-assembly1.cif.gz_A The apo structure of the Corramycin phosphotransferase	0.140	350	271	9	358	2	317	1.848E-06	180
DESULFOASV1_1484_hypothetical_protein	2ckq-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	2ckq-assembly1.cif.gz_B Crystal structure of Human Choline Kinase alpha 2 in complex with Phosphocholine	0.104	348	293	11	358	8	335	2.038E-06	180
DESULFOASV1_1484_hypothetical_protein	4feu-assembly6.cif.gz_F	DESULFOASV1_1484_hypothetical_protein	4feu-assembly6.cif.gz_F Crystal structure of the aminoglycoside phosphotransferase APH(3')-Ia, with substrate kanamycin and small molecule inhibitor anthrapyrazolone SP600125	0.154	274	205	22	295	2	244	4.456E-06	179
DESULFOASV1_1484_hypothetical_protein	4r77-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4r77-assembly2.cif.gz_B Crystal structure of choline kinase LicA from Streptococcus pneumoniae	0.135	350	237	9	358	3	277	3.490E-06	179
DESULFOASV1_1484_hypothetical_protein	7nb2-assembly1.cif.gz_AAA	DESULFOASV1_1484_hypothetical_protein	7nb2-assembly1.cif.gz_AAA Crystal structure of human choline alpha in complex with an inhibitor	0.118	337	270	22	358	28	334	1.940E-06	178
DESULFOASV1_1484_hypothetical_protein	3f2r-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3f2r-assembly1.cif.gz_A Crystal structure of human choline kinase alpha in complex with hemicholinium-3	0.111	339	273	20	358	30	337	4.914E-06	175
DESULFOASV1_1484_hypothetical_protein	2qg7-assembly2.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	2qg7-assembly2.cif.gz_D Plasmodium vivax ethanolamine kinase Pv091845	0.146	354	273	5	358	34	354	4.056E-07	175
DESULFOASV1_1484_hypothetical_protein	2qg7-assembly1.cif.gz_E	DESULFOASV1_1484_hypothetical_protein	2qg7-assembly1.cif.gz_E Plasmodium vivax ethanolamine kinase Pv091845	0.141	338	254	21	358	60	356	8.871E-07	173
DESULFOASV1_1484_hypothetical_protein	3zm9-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3zm9-assembly2.cif.gz_B The mechanism of allosteric coupling in choline kinase a1 revealed by a rationally designed inhibitor	0.112	349	294	10	358	2	333	8.015E-06	172
DESULFOASV1_1484_hypothetical_protein	3ham-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3ham-assembly1.cif.gz_A Structure of the gentamicin-APH(2")-IIa complex	0.118	346	256	1	346	1	291	1.848E-06	170
DESULFOASV1_1484_hypothetical_protein	2qg7-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	2qg7-assembly2.cif.gz_B Plasmodium vivax ethanolamine kinase Pv091845	0.146	339	250	20	358	57	350	6.615E-07	169
DESULFOASV1_1484_hypothetical_protein	4pdy-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4pdy-assembly1.cif.gz_A Crystal structure of aminoglycoside phosphotransferase from Alicyclobacillus acidocaldarius subsp. acidocaldarius DSM 446	0.114	312	260	47	358	32	325	1.759E-06	167
DESULFOASV1_1484_hypothetical_protein	3w0m-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3w0m-assembly1.cif.gz_A Crystal structure of a thermostable mutant of aminoglycoside phosphotransferase APH(4)-Ia, apo form	0.131	349	244	10	358	2	283	1.079E-06	166
DESULFOASV1_1484_hypothetical_protein	3w0q-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3w0q-assembly1.cif.gz_A Crystal structure of a thermostable mutant of aminoglycoside phosphotransferase APH(4)-Ia (N203A), ternary complex with AMP-PNP and hygromycin B	0.107	339	258	7	345	2	291	1.129E-05	166
DESULFOASV1_1484_hypothetical_protein	2cko-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2cko-assembly1.cif.gz_A Crystal structure of Human Choline Kinase alpha 2	0.117	339	272	20	358	23	331	7.268E-06	165
DESULFOASV1_1484_hypothetical_protein	2qg7-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2qg7-assembly1.cif.gz_A Plasmodium vivax ethanolamine kinase Pv091845	0.155	354	271	5	358	34	355	2.038E-06	165
DESULFOASV1_1484_hypothetical_protein	3hav-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3hav-assembly2.cif.gz_B Structure of the streptomycin-ATP-APH(2")-IIa ternary complex	0.124	349	259	1	349	1	297	1.373E-05	164
DESULFOASV1_1484_hypothetical_protein	8ahd-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	8ahd-assembly2.cif.gz_B The apo structure of the Corramycin phosphotransferase	0.145	350	268	9	358	3	316	5.976E-06	164
DESULFOASV1_1484_hypothetical_protein	3w0r-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3w0r-assembly1.cif.gz_A Crystal structure of a thermostable mutant of aminoglycoside phosphotransferase APH(4)-Ia (N202A), ternary complex with AMP-PNP and hygromycin B	0.121	351	249	8	358	2	285	6.591E-06	161
DESULFOASV1_1484_hypothetical_protein	5eqe-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5eqe-assembly1.cif.gz_A Crystal structure of choline kinase alpha-1 bound by [4-[(4-methyl-1,4-diazepan-1-yl)methyl]phenyl]methanamine (compound 11)	0.115	333	271	26	358	34	340	7.632E-06	161
DESULFOASV1_1484_hypothetical_protein	4dca-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4dca-assembly1.cif.gz_A Crystal structure of aminoglycoside phosphotransferase APH(2'')-Ib, ADP-bound	0.107	354	261	5	358	1	293	6.921E-06	159
DESULFOASV1_1484_hypothetical_protein	4da5-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4da5-assembly1.cif.gz_A Choline Kinase alpha acts through a double-displacement kinetic mechanism involving enzyme isomerisation, as determined through enzyme and inhibitor kinetics and structural biology	0.119	339	272	20	358	30	339	3.665E-06	157
DESULFOASV1_1484_hypothetical_protein	5iqc-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	5iqc-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Gentamicin C1	0.127	331	250	7	337	5	291	2.602E-06	154
DESULFOASV1_1484_hypothetical_protein	7a06-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7a06-assembly1.cif.gz_A Structure of human CKa1 in complex with compound o	0.114	350	295	9	358	8	341	8.417E-06	154
DESULFOASV1_1484_hypothetical_protein	3w0p-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3w0p-assembly1.cif.gz_A Crystal structure of a thermostable mutant of aminoglycoside phosphotransferase APH(4)-Ia (D198A), ternary complex with ADP and hygromycin B	0.111	351	252	8	358	2	285	5.976E-06	153
DESULFOASV1_1484_hypothetical_protein	5iqe-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	5iqe-assembly3.cif.gz_C Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Neomycin B	0.122	354	251	7	360	5	291	8.838E-06	151
DESULFOASV1_1484_hypothetical_protein	3hav-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3hav-assembly1.cif.gz_A Structure of the streptomycin-ATP-APH(2")-IIa ternary complex	0.107	347	258	1	347	1	290	8.417E-06	151
DESULFOASV1_1484_hypothetical_protein	3g15-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3g15-assembly1.cif.gz_A Crystal structure of human choline kinase alpha in complex with hemicholinium-3 and ADP	0.107	356	304	3	358	1	341	9.282E-06	151
DESULFOASV1_1484_hypothetical_protein	5eqe-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5eqe-assembly1.cif.gz_B Crystal structure of choline kinase alpha-1 bound by [4-[(4-methyl-1,4-diazepan-1-yl)methyl]phenyl]methanamine (compound 11)	0.118	349	290	10	358	2	331	3.477E-05	150
DESULFOASV1_1484_hypothetical_protein	5fut-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5fut-assembly1.cif.gz_A Human choline kinase a1 in complex with compound 4-(dimethylamino)-1-{4-[4-(4-{[4-(pyrrolidin- 1-yl)pyridinium-1-yl]methyl}phenyl)butyl]benzyl}pyridinium (compound BR25)	0.122	339	273	20	358	31	342	6.591E-06	150
DESULFOASV1_1484_hypothetical_protein	1l8t-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1l8t-assembly1.cif.gz_A Crystal Structure Of 3',5"-Aminoglycoside Phosphotransferase Type IIIa ADP Kanamycin A Complex	0.119	309	223	3	311	3	256	5.670E-05	149
DESULFOASV1_1484_hypothetical_protein	5uxb-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5uxb-assembly1.cif.gz_A Crystal structure of macrolide 2'-phosphotransferase MphH from Brachybacterium faecium, apoenzyme	0.139	321	248	10	330	2	290	1.075E-05	148
DESULFOASV1_1484_hypothetical_protein	2ckq-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2ckq-assembly1.cif.gz_A Crystal structure of Human Choline Kinase alpha 2 in complex with Phosphocholine	0.119	337	270	22	358	26	333	1.753E-05	147
DESULFOASV1_1484_hypothetical_protein	2i7q-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2i7q-assembly1.cif.gz_A Crystal structure of Human Choline Kinase A	0.117	314	260	45	358	38	332	1.245E-05	146
DESULFOASV1_1484_hypothetical_protein	4da5-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4da5-assembly1.cif.gz_B Choline Kinase alpha acts through a double-displacement kinetic mechanism involving enzyme isomerisation, as determined through enzyme and inhibitor kinetics and structural biology	0.126	313	257	46	358	23	317	1.129E-05	144
DESULFOASV1_1484_hypothetical_protein	5uxb-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5uxb-assembly2.cif.gz_B Crystal structure of macrolide 2'-phosphotransferase MphH from Brachybacterium faecium, apoenzyme	0.139	324	254	7	330	2	297	2.592E-05	143
DESULFOASV1_1484_hypothetical_protein	3tyk-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3tyk-assembly1.cif.gz_A Crystal structure of aminoglycoside phosphotransferase APH(4)-Ia	0.112	354	254	5	358	1	287	1.753E-05	142
DESULFOASV1_1484_hypothetical_protein	3i0q-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3i0q-assembly1.cif.gz_A Crystal Structure of the AMP-bound complex of Spectinomycin Phosphotransferase, APH(9)-Ia	0.111	311	252	48	358	28	311	1.075E-05	142
DESULFOASV1_1484_hypothetical_protein	5iqc-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5iqc-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Gentamicin C1	0.128	331	245	7	337	13	294	1.753E-05	140
DESULFOASV1_1484_hypothetical_protein	3f2r-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3f2r-assembly1.cif.gz_B Crystal structure of human choline kinase alpha in complex with hemicholinium-3	0.116	301	241	58	358	20	293	7.241E-05	138
DESULFOASV1_1484_hypothetical_protein	5iqd-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5iqd-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Ribostamycin	0.144	333	245	5	337	7	293	1.753E-05	135
DESULFOASV1_1484_hypothetical_protein	6cgd-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6cgd-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Amikacin	0.138	331	243	7	337	9	291	2.132E-05	134
DESULFOASV1_1484_hypothetical_protein	3my0-assembly15.cif.gz_O	DESULFOASV1_1484_hypothetical_protein	3my0-assembly15.cif.gz_O Crystal structure of the ACVRL1 (ALK1) kinase domain bound to LDN-193189	0.118	346	260	14	359	2	297	1.590E-05	133
DESULFOASV1_1484_hypothetical_protein	6xag-assembly1.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	6xag-assembly1.cif.gz_C Apo BRAF dimer bound to 14-3-3	0.113	340	223	19	358	7	258	2.469E-05	132
DESULFOASV1_1484_hypothetical_protein	5iqi-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5iqi-assembly2.cif.gz_B Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) Y237F mutant in complex with GMPPNP and Magnesium	0.139	331	241	7	337	9	289	4.026E-05	132
DESULFOASV1_1484_hypothetical_protein	5iqe-assembly4.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	5iqe-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia (CTD of AAC(6')-Ie/APH(2'')-Ia) in complex with GMPPNP, Magnesium, and Neomycin B	0.131	350	242	7	356	9	288	8.806E-05	131
DESULFOASV1_1484_hypothetical_protein	4fk3-assembly3.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4fk3-assembly3.cif.gz_B B-Raf Kinase V600E Oncogenic Mutant in Complex with PLX3203	0.125	340	212	19	358	8	250	6.895E-05	129
DESULFOASV1_1484_hypothetical_protein	4qny-assembly3.cif.gz_A-2	DESULFOASV1_1484_hypothetical_protein	4qny-assembly3.cif.gz_A-2 Crystal structure of MapK from Leishmania donovani, LDBPK_331470	0.094	354	293	5	358	3	326	4.228E-05	124
DESULFOASV1_1484_hypothetical_protein	7s3l-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7s3l-assembly1.cif.gz_A Structure of Bacillus subtilis CcrZ (previously called YtmP)	0.127	299	200	47	345	22	251	2.583E-04	123
DESULFOASV1_1484_hypothetical_protein	3oz6-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3oz6-assembly1.cif.gz_B Crystal structure of MapK from Cryptosporidium Parvum, cgd2_1960	0.086	339	266	20	358	9	300	2.030E-05	122
DESULFOASV1_1484_hypothetical_protein	6u2h-assembly1.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	6u2h-assembly1.cif.gz_D BRAF dimer bound to 14-3-3	0.123	340	225	19	358	8	264	5.399E-05	121
DESULFOASV1_1484_hypothetical_protein	5ng2-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5ng2-assembly1.cif.gz_B Structure of RIP2K(D146N) with bound Staurosporine	0.103	337	231	22	358	13	270	2.124E-04	119
DESULFOASV1_1484_hypothetical_protein	6t6d-assembly4.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	6t6d-assembly4.cif.gz_D Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2149	0.112	338	245	21	358	6	282	1.240E-04	119
DESULFOASV1_1484_hypothetical_protein	4qny-assembly3.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4qny-assembly3.cif.gz_B Crystal structure of MapK from Leishmania donovani, LDBPK_331470	0.102	354	295	5	358	3	332	1.020E-04	119
DESULFOASV1_1484_hypothetical_protein	4yht-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4yht-assembly2.cif.gz_B bRaf complexed with an inhibitor	0.116	340	217	19	358	7	252	1.181E-04	118
DESULFOASV1_1484_hypothetical_protein	3v8w-assembly3.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3v8w-assembly3.cif.gz_B Crystal Structure of Interleukin-2 Inducible T-cell Kinase Itk Catalytic Domain with Thienopyrazolylindole Inhibitor 469	0.124	337	199	22	358	8	235	2.991E-04	117
DESULFOASV1_1484_hypothetical_protein	4yht-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4yht-assembly1.cif.gz_A bRaf complexed with an inhibitor	0.116	340	216	19	358	7	251	1.240E-04	117
DESULFOASV1_1484_hypothetical_protein	2bkk-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2bkk-assembly1.cif.gz_A Crystal structure of Aminoglycoside Phosphotransferase APH(3')-IIIa in complex with the inhibitor AR_3a	0.130	303	204	9	311	9	243	1.067E-03	116
DESULFOASV1_1484_hypothetical_protein	5ng2-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5ng2-assembly1.cif.gz_A Structure of RIP2K(D146N) with bound Staurosporine	0.111	337	225	22	358	13	266	2.848E-04	116
DESULFOASV1_1484_hypothetical_protein	6opi-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6opi-assembly1.cif.gz_A phosphorylated ERK2 with SCH-CPD336	0.120	338	240	22	359	15	288	3.153E-05	116
DESULFOASV1_1484_hypothetical_protein	6i99-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6i99-assembly2.cif.gz_B Bone Marrow Tyrosine Kinase in Chromosome X in complex with a newly designed covalent inhibitor JS24	0.125	339	219	20	358	6	256	2.712E-04	115
DESULFOASV1_1484_hypothetical_protein	5jsm-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5jsm-assembly1.cif.gz_A BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-3-VEM	0.107	340	221	19	358	11	258	2.712E-04	114
DESULFOASV1_1484_hypothetical_protein	7b8w-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	7b8w-assembly3.cif.gz_C Structure of LIMK1 Kinase domain with allosteric inhibitor TH-470	0.122	337	229	20	356	9	270	1.746E-04	114
DESULFOASV1_1484_hypothetical_protein	3s95-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3s95-assembly2.cif.gz_B Crystal structure of the human LIMK1 kinase domain in complex with staurosporine	0.125	337	215	22	358	11	257	4.011E-04	114
DESULFOASV1_1484_hypothetical_protein	7n9g-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	7n9g-assembly2.cif.gz_B Crystal structure of the Abl 1b Kinase domain in complex with Dasatinib and Imatinib	0.104	357	229	2	358	3	259	6.566E-05	113
DESULFOASV1_1484_hypothetical_protein	6u2h-assembly1.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	6u2h-assembly1.cif.gz_C BRAF dimer bound to 14-3-3	0.117	340	219	19	358	8	256	2.712E-04	113
DESULFOASV1_1484_hypothetical_protein	6jmf-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6jmf-assembly1.cif.gz_A Crystal structure of human tyrosine-protein kinase Fes/Fps in complex with compound 4	0.126	339	222	20	358	111	365	9.247E-05	113
DESULFOASV1_1484_hypothetical_protein	6c1c-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6c1c-assembly2.cif.gz_B FGFR1 kinase complex with inhibitor SN37116	0.119	339	214	20	358	15	258	1.020E-04	112
DESULFOASV1_1484_hypothetical_protein	3kul-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3kul-assembly1.cif.gz_A Kinase domain of human ephrin type-A receptor 8 (EPHA8)	0.116	339	222	20	358	8	259	2.230E-04	112
DESULFOASV1_1484_hypothetical_protein	5s7u-assembly1.cif.gz_B-2	DESULFOASV1_1484_hypothetical_protein	5s7u-assembly1.cif.gz_B-2 XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010938a	0.106	338	242	21	358	4	275	9.247E-05	112
DESULFOASV1_1484_hypothetical_protein	5s7g-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5s7g-assembly2.cif.gz_B XChem group deposition -- Crystal Structure of human ACVR1 in complex with XS035844b	0.103	338	247	21	358	2	277	1.436E-04	112
DESULFOASV1_1484_hypothetical_protein	4zk5-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4zk5-assembly1.cif.gz_A MAP4K4 in complex with inhibitor GNE-495	0.122	340	241	19	358	7	281	1.368E-04	112
DESULFOASV1_1484_hypothetical_protein	4l68-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4l68-assembly1.cif.gz_A Structure of the psedudokinase domain of BIR2, an immune regulator of the RLK/Pelle family	0.132	350	248	9	358	2	288	1.020E-04	112
DESULFOASV1_1484_hypothetical_protein	3piz-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3piz-assembly1.cif.gz_A Crystal structure of BTK kinase domain complexed with (5-Amino-1-o-tolyl-1H-pyrazol-4-yl)-[3-(1-methanesulfonyl-piperidin-4-yl)-phenyl]-methanone	0.142	337	194	22	358	11	237	1.125E-04	111
DESULFOASV1_1484_hypothetical_protein	3zew-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3zew-assembly1.cif.gz_A Crystal structure of EphB4 in complex with staurosporine	0.111	331	235	20	350	6	270	7.955E-04	111
DESULFOASV1_1484_hypothetical_protein	6srh-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6srh-assembly1.cif.gz_A Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2117	0.110	338	246	21	358	8	284	1.834E-04	111
DESULFOASV1_1484_hypothetical_protein	6cgg-assembly4.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	6cgg-assembly4.cif.gz_D Aminoglycoside Phosphotransferase (2'')-Ia in complex with GMPPNP, Magnesium, and Arbekacin	0.141	325	236	32	356	12	287	1.302E-04	111
DESULFOASV1_1484_hypothetical_protein	7rj8-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7rj8-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 ISOFORM 1 COMPLEXED WITH LIGAND (2R)-2-AMINO-N-[3-(DIFLUOROM ETHOXY)-4-(1,3-OXAZOL-5-YL)PHENYL]-4-METHYLPENTANAMIDE	0.107	336	244	23	358	6	279	7.604E-05	111
DESULFOASV1_1484_hypothetical_protein	5jrq-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5jrq-assembly1.cif.gz_A BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-6-VEM	0.123	339	213	20	358	10	253	4.896E-05	110
DESULFOASV1_1484_hypothetical_protein	4j95-assembly5.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4j95-assembly5.cif.gz_A Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.	0.118	339	228	20	358	14	272	3.141E-04	110
DESULFOASV1_1484_hypothetical_protein	1gjo-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1gjo-assembly1.cif.gz_A The FGFr2 tyrosine kinase domain	0.096	339	234	20	358	14	273	2.124E-04	110
DESULFOASV1_1484_hypothetical_protein	8sam-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8sam-assembly1.cif.gz_A Crystal structure of class III lanthipeptide synthetase LP-GS-ThurKC in complex with ATP	0.132	345	231	6	350	207	473	2.592E-05	110
DESULFOASV1_1484_hypothetical_protein	4aw5-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4aw5-assembly1.cif.gz_A Complex of the EphB4 kinase domain with an oxindole inhibitor	0.119	339	211	20	358	8	247	7.576E-04	109
DESULFOASV1_1484_hypothetical_protein	4jvg-assembly4.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	4jvg-assembly4.cif.gz_D B-Raf Kinase in Complex with Birb796	0.117	340	217	19	358	8	254	1.181E-04	109
DESULFOASV1_1484_hypothetical_protein	6in0-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6in0-assembly1.cif.gz_A Crystal structure of EphA3 in complex with 18-Crown-6	0.123	334	229	20	353	8	269	1.926E-04	109
DESULFOASV1_1484_hypothetical_protein	5ng3-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5ng3-assembly2.cif.gz_B Structure of inactive kinase RIP2K(K47R)	0.114	338	230	22	359	9	269	2.583E-04	109
DESULFOASV1_1484_hypothetical_protein	7aqb-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7aqb-assembly1.cif.gz_A Crystal structure of human mitogen activated protein kinase 6 (MAPK6)	0.129	312	236	47	358	19	290	4.896E-05	109
DESULFOASV1_1484_hypothetical_protein	5nki-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5nki-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 4b	0.104	331	222	20	350	9	257	8.773E-04	108
DESULFOASV1_1484_hypothetical_protein	4yfi-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4yfi-assembly1.cif.gz_A TNNI3K complexed with inhibitor 1	0.118	339	211	20	358	22	261	1.584E-04	108
DESULFOASV1_1484_hypothetical_protein	6yll-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6yll-assembly1.cif.gz_A Biochemical, Cellular and Structural Characterization of Novel ERK3 Inhibitors	0.122	337	248	22	358	6	288	1.302E-04	108
DESULFOASV1_1484_hypothetical_protein	3qgy-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3qgy-assembly1.cif.gz_A Crystal structure of ITK inhibitor complex	0.126	339	203	20	358	8	240	1.235E-03	107
DESULFOASV1_1484_hypothetical_protein	6uuo-assembly2.cif.gz_B-2	DESULFOASV1_1484_hypothetical_protein	6uuo-assembly2.cif.gz_B-2 Crystal structure of BRAF kinase domain bound to the PROTAC P4B	0.108	340	211	19	358	8	245	7.576E-04	107
DESULFOASV1_1484_hypothetical_protein	4mnf-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4mnf-assembly1.cif.gz_B Crystal structure of BRAF-V600E bound to GDC0879	0.117	340	215	19	358	7	251	4.878E-04	107
DESULFOASV1_1484_hypothetical_protein	3mj2-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3mj2-assembly1.cif.gz_A X-ray crystal structure of ITK complexed with inhibitor BMS-509744	0.122	339	220	20	358	6	256	3.637E-04	107
DESULFOASV1_1484_hypothetical_protein	3sxr-assembly3.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3sxr-assembly3.cif.gz_A Crystal structure of BMX non-receptor tyrosine kinase complex with dasatinib	0.121	337	216	22	358	9	255	1.016E-03	107
DESULFOASV1_1484_hypothetical_protein	3kul-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3kul-assembly2.cif.gz_B Kinase domain of human ephrin type-A receptor 8 (EPHA8)	0.117	339	227	20	358	8	265	1.834E-04	107
DESULFOASV1_1484_hypothetical_protein	5mjb-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5mjb-assembly1.cif.gz_A Kinase domain of human EphB1, G703C mutant, covalently bound to a quinazoline-based inhibitor	0.124	340	232	20	359	11	276	1.297E-03	107
DESULFOASV1_1484_hypothetical_protein	7xdw-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	7xdw-assembly2.cif.gz_B Crystal structure of a receptor like kinase from Arabidopsis	0.109	355	240	4	358	3	272	8.773E-04	107
DESULFOASV1_1484_hypothetical_protein	5cf4-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5cf4-assembly2.cif.gz_B CRYSTAL STRUCTURE OF JANUS KINASE 2 IN COMPLEX WITH N,N-DICYCLOPROPYL-10-ETHYL-7-[(3-METHOXYPROPYL)AMINO] -3-METHYL-3,5,8,10-TETRAAZATRICYCLO[7.3.0.0,6] DODECA-1(9),2(6),4,7,11-PENTAENE-11-CARBOXAMIDE	0.089	339	250	20	358	10	284	7.576E-04	107
DESULFOASV1_1484_hypothetical_protein	3g15-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3g15-assembly1.cif.gz_B Crystal structure of human choline kinase alpha in complex with hemicholinium-3 and ADP	0.130	299	236	60	358	22	293	5.932E-04	107
DESULFOASV1_1484_hypothetical_protein	4h3q-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4h3q-assembly1.cif.gz_A Crystal structure of human ERK2 complexed with a MAPK docking peptide	0.105	337	259	22	358	16	305	1.302E-04	107
DESULFOASV1_1484_hypothetical_protein	3cd3-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3cd3-assembly1.cif.gz_A Crystal structure of phosphorylated human feline sarcoma viral oncogene homologue (v-FES) in complex with staurosporine and a consensus peptide	0.118	339	221	20	358	96	346	1.436E-04	107
DESULFOASV1_1484_hypothetical_protein	8sap-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8sap-assembly1.cif.gz_A Crystal structure of class III lanthipeptide synthetase ThurKC	0.140	345	229	6	350	180	446	2.030E-05	107
DESULFOASV1_1484_hypothetical_protein	5jrq-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5jrq-assembly1.cif.gz_B BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-6-VEM	0.123	341	203	18	358	8	240	3.637E-04	106
DESULFOASV1_1484_hypothetical_protein	3psd-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3psd-assembly1.cif.gz_A Non-oxime pyrazole based inhibitors of B-Raf kinase	0.112	340	218	19	358	8	253	3.637E-04	106
DESULFOASV1_1484_hypothetical_protein	7shv-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	7shv-assembly1.cif.gz_B Crystal structure of BRAF kinase domain bound to GDC0879	0.107	340	221	19	358	7	255	8.354E-04	106
DESULFOASV1_1484_hypothetical_protein	6ep9-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6ep9-assembly1.cif.gz_A Crystal structure of BTK kinase domain complexed with N-[2-methyl-3-[4-methyl-6-[4-(4-methylpiperazine-1-carbonyl)anilino]-5-oxo-pyrazin-2-yl]phenyl]-4-(1-piperidyl)benzamide	0.140	337	215	22	358	6	256	8.806E-05	106
DESULFOASV1_1484_hypothetical_protein	8gmc-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8gmc-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH 5-[(4-aminopiperidin-1-yl)methyl]-N-{3-[5-(propan-2-yl)-1,3,4-thiadiazol-2-yl]phenyl}pyrrolo[2,1-f][1,2,4]triazin-4-amine	0.093	337	245	22	358	4	274	1.834E-04	106
DESULFOASV1_1484_hypothetical_protein	8gmd-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8gmd-assembly1.cif.gz_A CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH (5P)-3-({(8R)-5-[(4-aminopiperidin-1-yl)methyl]pyrrolo[2,1-f][1,2,4]triazin-4-yl}amino)-5-[2-(propan-2-yl)-2H-tetrazol-5-yl]phenol	0.102	320	229	39	358	21	276	8.806E-05	106
DESULFOASV1_1484_hypothetical_protein	4xv1-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4xv1-assembly1.cif.gz_B B-Raf Kinase V600E oncogenic mutant in complex with PLX7904	0.111	340	209	19	358	7	242	8.773E-04	105
DESULFOASV1_1484_hypothetical_protein	5jt2-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	5jt2-assembly2.cif.gz_C BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-BISAMIDE	0.115	340	207	19	358	12	246	2.583E-04	105
DESULFOASV1_1484_hypothetical_protein	5ita-assembly3.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5ita-assembly3.cif.gz_B Crystal Structure of BRAF Kinase Domain Bound to AZ-VEM	0.109	340	211	19	358	8	245	2.583E-04	105
DESULFOASV1_1484_hypothetical_protein	6xfp-assembly1.cif.gz_A-2	DESULFOASV1_1484_hypothetical_protein	6xfp-assembly1.cif.gz_A-2 Crystal Structure of BRAF kinase domain bound to Belvarafenib	0.101	340	233	19	358	7	266	4.011E-04	105
DESULFOASV1_1484_hypothetical_protein	3zep-assembly4.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	3zep-assembly4.cif.gz_D Crystal Structure of JAK3 Kinase Domain in Complex with a Pyrrolopyrazine-2-phenyl Ether Inhibitor	0.123	339	230	20	358	8	270	1.657E-03	105
DESULFOASV1_1484_hypothetical_protein	5s7b-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5s7b-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM000329d	0.107	338	245	21	358	7	281	3.637E-04	105
DESULFOASV1_1484_hypothetical_protein	5s7o-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5s7o-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM007391c	0.106	338	246	21	358	8	283	2.583E-04	105
DESULFOASV1_1484_hypothetical_protein	5hez-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5hez-assembly2.cif.gz_B JAK2 kinase (JH1 domain) mutant P1057A in complex with TG101209	0.088	339	251	20	358	7	282	4.645E-04	105
DESULFOASV1_1484_hypothetical_protein	3my0-assembly8.cif.gz_H	DESULFOASV1_1484_hypothetical_protein	3my0-assembly8.cif.gz_H Crystal structure of the ACVRL1 (ALK1) kinase domain bound to LDN-193189	0.129	349	252	10	358	2	291	8.806E-05	105
DESULFOASV1_1484_hypothetical_protein	5ikw-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5ikw-assembly1.cif.gz_A Crystal Structure of BMP-2-inducible kinase in complex with an Indazole inhibitor	0.095	337	247	22	358	1	274	5.379E-04	105
DESULFOASV1_1484_hypothetical_protein	4l68-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4l68-assembly2.cif.gz_B Structure of the psedudokinase domain of BIR2, an immune regulator of the RLK/Pelle family	0.129	317	215	42	358	53	300	2.342E-04	105
DESULFOASV1_1484_hypothetical_protein	6b5j-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	6b5j-assembly3.cif.gz_C TNNI3K complexed with a 4,6-diaminopyrimidine	0.115	339	213	20	358	12	253	2.124E-04	104
DESULFOASV1_1484_hypothetical_protein	5jsm-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	5jsm-assembly2.cif.gz_C BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-3-VEM	0.119	340	214	19	358	11	254	2.991E-04	104
DESULFOASV1_1484_hypothetical_protein	4g2f-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4g2f-assembly1.cif.gz_A Human EphA3 kinase domain in complex with compound 7	0.107	326	218	20	345	12	256	4.878E-04	104
DESULFOASV1_1484_hypothetical_protein	5mja-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5mja-assembly2.cif.gz_B Kinase domain of human EphB1 bound to a quinazoline-based inhibitor	0.122	341	234	20	360	10	276	5.122E-04	104
DESULFOASV1_1484_hypothetical_protein	5s7k-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5s7k-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010936a	0.115	338	242	21	358	7	281	7.985E-05	104
DESULFOASV1_1484_hypothetical_protein	3mdy-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	3mdy-assembly2.cif.gz_C Crystal structure of the cytoplasmic domain of the bone morphogenetic protein receptor type-1B (BMPR1B) in complex with FKBP12 and LDN-193189	0.097	354	279	5	358	2	311	2.583E-04	104
DESULFOASV1_1484_hypothetical_protein	2jko-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2jko-assembly1.cif.gz_A Focal Adhesion Kinase catalytic domain in complex with bis-anilino pyrimidine inhibitor	0.129	339	208	20	358	7	246	7.576E-04	103
DESULFOASV1_1484_hypothetical_protein	6fnl-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6fnl-assembly1.cif.gz_A Crystal Structure of Ephrin B4 (EphB4) Receptor Protein Kinase	0.123	331	223	20	350	8	262	3.298E-04	103
DESULFOASV1_1484_hypothetical_protein	6q7f-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6q7f-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATDL18	0.101	331	223	20	350	8	256	1.235E-03	103
DESULFOASV1_1484_hypothetical_protein	7du8-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	7du8-assembly1.cif.gz_B Crystal structure of human Proto-oncogene tyrosine-protein kinase receptor Ret in complex with Selpercatinib	0.128	350	235	9	358	3	272	1.368E-04	103
DESULFOASV1_1484_hypothetical_protein	6aah-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6aah-assembly1.cif.gz_B Crystal structure of JAK1 in complex with peficitinib	0.115	339	240	20	358	10	281	2.712E-04	103
DESULFOASV1_1484_hypothetical_protein	3f5p-assembly17.cif.gz_M-2	DESULFOASV1_1484_hypothetical_protein	3f5p-assembly17.cif.gz_M-2 Complex Structure of Insulin-like Growth Factor Receptor and 3-Cyanoquinoline Inhibitor	0.110	340	246	20	359	19	295	2.459E-04	103
DESULFOASV1_1484_hypothetical_protein	4kio-assembly4.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	4kio-assembly4.cif.gz_D Kinase domain mutant of human Itk in complex with a covalently-binding inhibitor	0.121	337	200	22	358	8	236	1.120E-03	102
DESULFOASV1_1484_hypothetical_protein	7kpl-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7kpl-assembly1.cif.gz_A Crystal structure of hEphB1 in apo form	0.126	323	213	20	342	8	252	2.333E-03	102
DESULFOASV1_1484_hypothetical_protein	6b5j-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6b5j-assembly1.cif.gz_A TNNI3K complexed with a 4,6-diaminopyrimidine	0.117	339	210	20	358	18	256	3.637E-04	102
DESULFOASV1_1484_hypothetical_protein	8f7p-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	8f7p-assembly1.cif.gz_B BRAF kinase in complex with LXH254 (naporafenib)	0.096	340	226	19	358	8	258	7.955E-04	102
DESULFOASV1_1484_hypothetical_protein	2x9f-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2x9f-assembly1.cif.gz_A ephB4 kinase domain inhibitor complex	0.124	331	226	20	350	7	265	1.235E-03	102
DESULFOASV1_1484_hypothetical_protein	4xg3-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4xg3-assembly2.cif.gz_B Crystal structure of an inhibitor-bound Syk	0.089	339	230	20	358	7	260	7.214E-04	102
DESULFOASV1_1484_hypothetical_protein	6xag-assembly1.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	6xag-assembly1.cif.gz_D Apo BRAF dimer bound to 14-3-3	0.120	340	221	19	358	8	259	2.848E-04	102
DESULFOASV1_1484_hypothetical_protein	5ttv-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5ttv-assembly1.cif.gz_A Jak3 with covalent inhibitor 6	0.110	339	238	20	358	8	275	1.067E-03	102
DESULFOASV1_1484_hypothetical_protein	3lxl-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3lxl-assembly1.cif.gz_A Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6	0.110	339	240	20	358	8	278	6.870E-04	102
DESULFOASV1_1484_hypothetical_protein	2qok-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2qok-assembly1.cif.gz_A Human EphA3 kinase and juxtamembrane region, Y596F:Y602F:S768A triple mutant	0.108	339	227	20	358	17	271	4.645E-04	102
DESULFOASV1_1484_hypothetical_protein	2wtk-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	2wtk-assembly2.cif.gz_C Structure of the heterotrimeric LKB1-STRADalpha-MO25alpha complex	0.126	342	228	19	360	1	262	1.071E-04	102
DESULFOASV1_1484_hypothetical_protein	3cbl-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3cbl-assembly1.cif.gz_A Crystal structure of human feline sarcoma viral oncogene homologue (v-FES) in complex with staurosporine and a consensus peptide	0.131	339	221	20	358	95	349	1.926E-04	102
DESULFOASV1_1484_hypothetical_protein	3v5l-assembly6.cif.gz_B-3	DESULFOASV1_1484_hypothetical_protein	3v5l-assembly6.cif.gz_B-3 Crystal Structure of Interleukin-2 Inducible T-cell Kinase Itk Catalytic Domain with Thienopyrazolylindole Inhibitor 542	0.134	337	196	22	358	8	234	7.576E-04	101
DESULFOASV1_1484_hypothetical_protein	3zew-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3zew-assembly2.cif.gz_B Crystal structure of EphB4 in complex with staurosporine	0.114	329	217	20	348	6	251	8.773E-04	101
DESULFOASV1_1484_hypothetical_protein	6v34-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6v34-assembly1.cif.gz_A Crystal structure of BRAF V600E oncogenic mutant in complex with TAK-580	0.121	340	211	19	358	7	247	4.212E-04	101
DESULFOASV1_1484_hypothetical_protein	3pxk-assembly3.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3pxk-assembly3.cif.gz_B FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH Pyrrolo[2,3-d]thiazole	0.130	339	208	20	358	8	247	1.067E-03	101
DESULFOASV1_1484_hypothetical_protein	5ia1-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5ia1-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with MLN8054	0.117	331	223	20	350	8	261	1.297E-03	101
DESULFOASV1_1484_hypothetical_protein	6c1o-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6c1o-assembly2.cif.gz_B FGFR1 kinase domain complexed with FIIN-1	0.106	339	214	20	358	14	253	7.214E-04	101
DESULFOASV1_1484_hypothetical_protein	5lmb-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5lmb-assembly2.cif.gz_B HUMAN SPLEEN TYROSINE KINASE KINASE DOMAIN IN COMPLEX WITH AZANAPHTHYRIDINE INHIBITOR	0.099	339	227	20	358	6	258	1.740E-03	101
DESULFOASV1_1484_hypothetical_protein	5u94-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5u94-assembly1.cif.gz_A Crystal structure of the Mycobacterium tuberculosis PASTA kinase PknB in complex with the potential theraputic kinase inhibitor GSK690693.	0.107	338	222	21	358	9	258	4.645E-04	101
DESULFOASV1_1484_hypothetical_protein	6c19-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6c19-assembly2.cif.gz_B FGFR1 kinase complex with inhibitor SN36985	0.103	339	217	20	358	14	256	5.379E-04	101
DESULFOASV1_1484_hypothetical_protein	6aua-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6aua-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE IN COMPLEX WITH INHIBITOR CGI2625	0.130	337	218	22	358	8	258	1.926E-04	101
DESULFOASV1_1484_hypothetical_protein	8bof-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8bof-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 12	0.103	331	222	20	350	8	255	1.362E-03	101
DESULFOASV1_1484_hypothetical_protein	7xdx-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	7xdx-assembly2.cif.gz_B Crystal structure of a receptor like kinase from Arabidopsis	0.113	325	225	34	358	18	272	1.067E-03	101
DESULFOASV1_1484_hypothetical_protein	2gsf-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2gsf-assembly1.cif.gz_A The Human Epha3 Receptor Tyrosine Kinase and Juxtamembrane Region	0.114	334	229	20	353	18	277	5.122E-04	101
DESULFOASV1_1484_hypothetical_protein	6hzu-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6hzu-assembly2.cif.gz_B HUMAN JAK1 IN COMPLEX WITH LASW1393	0.125	339	236	20	358	10	280	4.423E-04	101
DESULFOASV1_1484_hypothetical_protein	4oh4-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4oh4-assembly2.cif.gz_B Crystal structure of BRI1 in complex with BKI1	0.136	314	225	28	341	32	292	1.297E-03	101
DESULFOASV1_1484_hypothetical_protein	3qgw-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3qgw-assembly2.cif.gz_B Crystal Structure of ITK kinase bound to an inhibitor	0.120	337	203	22	358	5	236	8.773E-04	100
DESULFOASV1_1484_hypothetical_protein	3v5l-assembly5.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3v5l-assembly5.cif.gz_A Crystal Structure of Interleukin-2 Inducible T-cell Kinase Itk Catalytic Domain with Thienopyrazolylindole Inhibitor 542	0.131	337	198	22	358	8	236	1.177E-03	100
DESULFOASV1_1484_hypothetical_protein	6xlo-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6xlo-assembly1.cif.gz_B Crystal structure of bRaf in complex with inhibitor	0.119	340	210	19	358	6	244	1.431E-03	100
DESULFOASV1_1484_hypothetical_protein	4y8d-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4y8d-assembly2.cif.gz_B Crystal structure of Cyclin-G associated kinase (GAK) complexed with selective 12i inhibitor	0.113	317	219	21	337	14	261	2.222E-03	100
DESULFOASV1_1484_hypothetical_protein	6s75-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	6s75-assembly3.cif.gz_C Crystal structure of Nek7 bound to compound 51	0.100	339	219	20	358	12	255	1.827E-03	100
DESULFOASV1_1484_hypothetical_protein	4bb4-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4bb4-assembly1.cif.gz_A ephB4 kinase domain inhibitor complex	0.130	331	223	20	350	9	265	1.235E-03	100
DESULFOASV1_1484_hypothetical_protein	5mja-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5mja-assembly1.cif.gz_A Kinase domain of human EphB1 bound to a quinazoline-based inhibitor	0.119	326	229	20	345	10	270	7.214E-04	100
DESULFOASV1_1484_hypothetical_protein	4qps-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	4qps-assembly2.cif.gz_C Crystal structure of Jak3 complexed to N-[3-(6-Phenylamino-pyrazin-2-yl)-3H-benzoimidazol-5-yl]-acrylamide	0.120	339	230	20	358	8	269	1.016E-03	100
DESULFOASV1_1484_hypothetical_protein	5i9v-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5i9v-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with AGS	0.114	331	233	20	350	8	271	1.827E-03	100
DESULFOASV1_1484_hypothetical_protein	5ng3-assembly1.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	5ng3-assembly1.cif.gz_D Structure of inactive kinase RIP2K(K47R)	0.106	338	236	22	359	9	273	5.649E-04	100
DESULFOASV1_1484_hypothetical_protein	1w0x-assembly1.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	1w0x-assembly1.cif.gz_C Crystal structure of human CDK2 in complex with the inhibitor olomoucine.	0.101	338	239	22	359	3	269	3.820E-04	100
DESULFOASV1_1484_hypothetical_protein	3eyh-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3eyh-assembly1.cif.gz_A Crystal structures of JAK1 and JAK2 inhibitor complexes	0.116	322	234	37	358	17	282	2.459E-04	100
DESULFOASV1_1484_hypothetical_protein	4fk6-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4fk6-assembly1.cif.gz_A JAK1 kinase (JH1 domain) in complex with compound 72	0.114	339	239	20	358	12	282	3.637E-04	100
DESULFOASV1_1484_hypothetical_protein	3pj3-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3pj3-assembly1.cif.gz_A Crystal structure of BTK kinase domain complexed with 2-Methyl-5-[(E)-(3-phenyl-acryloyl)amino]-N-(2-phenyl-3H-imidazo[4,5-b]pyridin-6-yl)-benzamide	0.141	337	190	22	358	11	232	3.637E-04	99
DESULFOASV1_1484_hypothetical_protein	3v5l-assembly6.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	3v5l-assembly6.cif.gz_C Crystal Structure of Interleukin-2 Inducible T-cell Kinase Itk Catalytic Domain with Thienopyrazolylindole Inhibitor 542	0.123	337	203	22	358	8	240	8.354E-04	99
DESULFOASV1_1484_hypothetical_protein	4l7s-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4l7s-assembly1.cif.gz_A Kinase domain mutant of human Itk in complex with an aminobenzothiazole inhibitor	0.129	339	204	20	358	8	242	1.657E-03	99
DESULFOASV1_1484_hypothetical_protein	7n4r-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7n4r-assembly1.cif.gz_A Bruton's tyrosine kinase in complex with compound 21	0.136	337	208	22	358	9	250	1.584E-04	99
DESULFOASV1_1484_hypothetical_protein	4yff-assembly1.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	4yff-assembly1.cif.gz_D TNNI3K complexed with inhibitor 2	0.101	339	215	20	358	11	250	7.214E-04	99
DESULFOASV1_1484_hypothetical_protein	8f7o-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	8f7o-assembly1.cif.gz_B BRAF kinase in complex with TAK580 (tovorafenib)	0.112	340	220	19	358	7	255	1.120E-03	99
DESULFOASV1_1484_hypothetical_protein	6bke-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6bke-assembly1.cif.gz_A BTK complex with compound 10	0.131	337	217	22	358	7	257	2.459E-04	99
DESULFOASV1_1484_hypothetical_protein	3umw-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3umw-assembly1.cif.gz_A Crystal structure of Pim1 kinase in complex with inhibitor (Z)-2-[(1H-indazol-3-yl)methylene]-6-methoxy-7-(piperazin-1-ylmethyl)benzofuran-3(2H)-one	0.122	339	219	21	359	2	251	7.576E-04	99
DESULFOASV1_1484_hypothetical_protein	4xg6-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4xg6-assembly1.cif.gz_A Crystal structure of an inhibitor-bound Syk	0.106	327	236	20	346	7	271	1.297E-03	99
DESULFOASV1_1484_hypothetical_protein	5ng3-assembly4.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	5ng3-assembly4.cif.gz_C Structure of inactive kinase RIP2K(K47R)	0.106	338	230	22	359	9	266	6.870E-04	99
DESULFOASV1_1484_hypothetical_protein	4p5q-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4p5q-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with quinoxaline derivatives	0.115	340	224	20	359	12	265	5.932E-04	99
DESULFOASV1_1484_hypothetical_protein	3zep-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3zep-assembly1.cif.gz_A Crystal Structure of JAK3 Kinase Domain in Complex with a Pyrrolopyrazine-2-phenyl Ether Inhibitor	0.120	339	233	20	358	8	273	3.286E-03	99
DESULFOASV1_1484_hypothetical_protein	6i82-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6i82-assembly1.cif.gz_A Crystal structure of partially phosphorylated RET V804M tyrosine kinase domain complexed with PDD00018412	0.118	339	221	20	358	24	274	2.712E-04	99
DESULFOASV1_1484_hypothetical_protein	2qoc-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2qoc-assembly1.cif.gz_A Human EphA3 kinase domain, phosphorylated, AMP-PNP bound structure	0.119	339	218	20	358	8	255	3.820E-04	99
DESULFOASV1_1484_hypothetical_protein	5lpw-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5lpw-assembly1.cif.gz_A Crystal structure of the apo-BRI1 kinase domain (865-1160)	0.134	355	236	4	358	6	279	9.213E-04	99
DESULFOASV1_1484_hypothetical_protein	4xv3-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4xv3-assembly1.cif.gz_A B-Raf Kinase V600E oncogenic mutant in complex with PLX7922	0.103	340	209	19	358	8	241	1.235E-03	98
DESULFOASV1_1484_hypothetical_protein	4xv2-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4xv2-assembly1.cif.gz_A B-Raf Kinase V600E oncogenic mutant in complex with Dabrafenib	0.110	340	208	19	358	7	241	6.542E-04	98
DESULFOASV1_1484_hypothetical_protein	4p2k-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4p2k-assembly1.cif.gz_A Structure of Ephrin type-A receptor 2	0.100	336	216	23	358	14	254	4.212E-04	98
DESULFOASV1_1484_hypothetical_protein	5csx-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5csx-assembly1.cif.gz_A CRYSTAL STRUCTURE OF B-RAF IN COMPLEX WITH BI 882370	0.127	340	216	19	358	8	255	4.645E-04	98
DESULFOASV1_1484_hypothetical_protein	6b2q-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	6b2q-assembly2.cif.gz_C Dual Inhibition of the Essential Protein Kinases A and B in Mycobacterium tuberculosis	0.118	337	206	22	358	15	249	1.827E-03	98
DESULFOASV1_1484_hypothetical_protein	5l6p-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5l6p-assembly1.cif.gz_A EphB3 kinase domain covalently bound to an irreversible inhibitor (compound 6)	0.107	338	231	21	358	2	261	1.919E-03	98
DESULFOASV1_1484_hypothetical_protein	6gla-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6gla-assembly2.cif.gz_B Crystal structure of JAK3 in complex with Compound 11 (FM481)	0.106	339	240	20	358	9	278	1.067E-03	98
DESULFOASV1_1484_hypothetical_protein	3b2t-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3b2t-assembly1.cif.gz_A Structure of phosphotransferase	0.092	339	214	20	358	17	253	6.229E-04	98
DESULFOASV1_1484_hypothetical_protein	6i83-assembly1.cif.gz_A-2	DESULFOASV1_1484_hypothetical_protein	6i83-assembly1.cif.gz_A-2 Crystal structure of phosphorylated RET V804M tyrosine kinase domain complexed with PDD00018366	0.110	339	231	20	358	24	284	9.674E-04	98
DESULFOASV1_1484_hypothetical_protein	4cqe-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4cqe-assembly1.cif.gz_A B-Raf Kinase V600E mutant in complex with a diarylthiazole B-Raf Inhibitor	0.108	340	211	19	358	7	244	9.674E-04	97
DESULFOASV1_1484_hypothetical_protein	3sxr-assembly3.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3sxr-assembly3.cif.gz_B Crystal structure of BMX non-receptor tyrosine kinase complex with dasatinib	0.111	312	209	47	358	18	253	1.235E-03	97
DESULFOASV1_1484_hypothetical_protein	2hen-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	2hen-assembly2.cif.gz_B Crystal Structure of the EphB2 Receptor Kinase domain in complex with ADP	0.121	341	221	20	360	8	259	2.702E-03	97
DESULFOASV1_1484_hypothetical_protein	6fnj-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6fnj-assembly2.cif.gz_B Crystal Structure of Ephrin B4 (EphB4) Receptor Protein Kinase with an isomer of NVP-BHG712	0.140	326	207	20	345	8	249	1.120E-03	97
DESULFOASV1_1484_hypothetical_protein	4z16-assembly4.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	4z16-assembly4.cif.gz_D Crystal Structure of the Jak3 Kinase Domain Covalently Bound to N-(3-(((5-chloro-2-((2-methoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)methyl)phenyl)acrylamide	0.113	339	228	20	358	8	265	3.624E-03	97
DESULFOASV1_1484_hypothetical_protein	4c61-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4c61-assembly1.cif.gz_A Inhibitors of Jak2 Kinase domain	0.077	315	233	44	358	15	267	6.517E-03	97
DESULFOASV1_1484_hypothetical_protein	3tv6-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3tv6-assembly2.cif.gz_B Human B-Raf Kinase Domain in Complex with a Methoxypyrazolopyridinyl Benzamide Inhibitor	0.118	340	228	19	358	8	267	7.955E-04	97
DESULFOASV1_1484_hypothetical_protein	5cxh-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5cxh-assembly1.cif.gz_A SYK catalytic domain complexed with a potent orally bioavailable thiazole inhibitor	0.109	326	237	20	345	7	273	1.431E-03	97
DESULFOASV1_1484_hypothetical_protein	5l3a-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5l3a-assembly1.cif.gz_A Fragment-based discovery of 6-arylindazole JAK inhibitors	0.089	340	236	20	359	8	267	2.450E-03	97
DESULFOASV1_1484_hypothetical_protein	3eid-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3eid-assembly1.cif.gz_A CDK2/CyclinA complexed with a pyrazolopyridazine inhibitor	0.098	339	246	20	358	3	276	4.628E-03	97
DESULFOASV1_1484_hypothetical_protein	7ctx-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7ctx-assembly1.cif.gz_A Crystal structure of Arabidopsis thaliana SOBIR1 kinase domain(residues 388-401 deleted) in complex with AMP-PNP and magnesium	0.130	324	232	35	358	25	292	3.298E-04	97
DESULFOASV1_1484_hypothetical_protein	8sam-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	8sam-assembly2.cif.gz_B Crystal structure of class III lanthipeptide synthetase LP-GS-ThurKC in complex with ATP	0.125	345	233	6	350	206	472	3.477E-05	97
DESULFOASV1_1484_hypothetical_protein	5jt2-assembly2.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	5jt2-assembly2.cif.gz_D BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-BISAMIDE	0.116	339	194	20	358	11	230	1.177E-03	96
DESULFOASV1_1484_hypothetical_protein	6dfl-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6dfl-assembly1.cif.gz_A WaaP in complex with acyl carrier protein	0.117	290	182	12	301	18	224	6.517E-03	96
DESULFOASV1_1484_hypothetical_protein	3oct-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3oct-assembly1.cif.gz_A Crystal structure of bruton's tyrosine kinase mutant V555R in complex with dasatinib	0.120	358	209	1	358	1	239	2.712E-04	96
DESULFOASV1_1484_hypothetical_protein	5jt2-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5jt2-assembly1.cif.gz_A BRAFV600E Kinase Domain In Complex with Chemically Linked Vemurafenib Inhibitor VEM-BISAMIDE	0.138	340	207	19	358	12	252	2.022E-04	96
DESULFOASV1_1484_hypothetical_protein	4yff-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	4yff-assembly2.cif.gz_C TNNI3K complexed with inhibitor 2	0.100	339	217	20	358	11	252	1.120E-03	96
DESULFOASV1_1484_hypothetical_protein	6o8i-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6o8i-assembly1.cif.gz_A BTK In Complex With Inhibitor	0.135	337	209	22	358	11	253	4.011E-04	96
DESULFOASV1_1484_hypothetical_protein	7qq6-assembly2.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	7qq6-assembly2.cif.gz_D GCN2 (EIF2ALPHA KINASE 4, E2AK4) IN COMPLEX WITH COMPOUND 1 (dovitinib)	0.102	324	204	22	345	6	233	2.838E-03	96
DESULFOASV1_1484_hypothetical_protein	6fni-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6fni-assembly1.cif.gz_A Crystal Structure of Ephrin B4 (EphB4) Receptor Protein Kinase with NVP-BHG712	0.124	331	221	20	350	8	260	1.740E-03	96
DESULFOASV1_1484_hypothetical_protein	3fzo-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3fzo-assembly1.cif.gz_A Crystal Structure of PYK2-Apo, Proline-rich Tyrosine Kinase	0.132	339	213	20	358	5	250	1.578E-03	96
DESULFOASV1_1484_hypothetical_protein	4yff-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4yff-assembly2.cif.gz_B TNNI3K complexed with inhibitor 2	0.120	339	210	20	358	18	257	5.122E-04	96
DESULFOASV1_1484_hypothetical_protein	7juz-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7juz-assembly1.cif.gz_A Crystal Structure of KSR1:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor Selumetinib	0.125	338	224	21	358	13	269	9.711E-05	96
DESULFOASV1_1484_hypothetical_protein	6m0u-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6m0u-assembly1.cif.gz_A Structure of AhSYMRK kinase domain mutant - K625E	0.108	318	210	41	358	26	261	6.542E-04	96
DESULFOASV1_1484_hypothetical_protein	6q7g-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6q7g-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATHA01	0.120	326	209	20	345	12	249	2.450E-03	96
DESULFOASV1_1484_hypothetical_protein	2vx0-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2vx0-assembly1.cif.gz_A ephB4 kinase domain inhibitor complex	0.124	331	233	20	350	7	273	5.932E-04	96
DESULFOASV1_1484_hypothetical_protein	5nk6-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5nk6-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2d	0.106	331	237	20	350	8	273	1.431E-03	96
DESULFOASV1_1484_hypothetical_protein	3lpb-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3lpb-assembly2.cif.gz_B Crystal structure of Jak2 complexed with a potent 2,8-diaryl-quinoxaline inhibitor	0.073	339	248	20	358	10	277	3.805E-03	96
DESULFOASV1_1484_hypothetical_protein	4cxa-assembly1.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	4cxa-assembly1.cif.gz_C Crystal structure of the human CDK12-cyclin K complex bound to AMPPNP	0.119	340	263	20	359	9	307	1.297E-03	96
DESULFOASV1_1484_hypothetical_protein	4uak-assembly1.cif.gz_A-2	DESULFOASV1_1484_hypothetical_protein	4uak-assembly1.cif.gz_A-2 MRCK beta in complex with ADP	0.123	340	231	20	359	77	340	4.423E-04	96
DESULFOASV1_1484_hypothetical_protein	3zfm-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3zfm-assembly1.cif.gz_A Crystal structure of EphB2	0.119	308	206	42	349	14	248	2.015E-03	95
DESULFOASV1_1484_hypothetical_protein	6yvy-assembly4.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	6yvy-assembly4.cif.gz_D FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide	0.133	339	206	20	358	7	245	2.450E-03	95
DESULFOASV1_1484_hypothetical_protein	7mgk-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	7mgk-assembly3.cif.gz_C TNNI3K complexed with 1-(3,5-dichloro-4-((6-(methylamino)pyrimidin-4-yl)oxy)phenyl)-3-(3-(trifluoromethyl)phenyl)urea	0.118	339	207	20	358	18	253	3.129E-03	95
DESULFOASV1_1484_hypothetical_protein	7shv-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7shv-assembly1.cif.gz_A Crystal structure of BRAF kinase domain bound to GDC0879	0.109	340	220	19	358	7	254	8.773E-04	95
DESULFOASV1_1484_hypothetical_protein	4yfi-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4yfi-assembly1.cif.gz_B TNNI3K complexed with inhibitor 1	0.114	339	213	20	358	12	252	5.932E-04	95
DESULFOASV1_1484_hypothetical_protein	4yff-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4yff-assembly1.cif.gz_A TNNI3K complexed with inhibitor 2	0.126	339	209	20	358	18	257	5.122E-04	95
DESULFOASV1_1484_hypothetical_protein	8boi-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8boi-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 9	0.108	331	222	20	350	9	258	2.116E-03	95
DESULFOASV1_1484_hypothetical_protein	5w86-assembly4.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	5w86-assembly4.cif.gz_D CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN WITH A 4,6-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 7)	0.120	339	231	20	358	8	270	5.910E-03	95
DESULFOASV1_1484_hypothetical_protein	4gk4-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4gk4-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with ligand 90	0.117	339	216	20	358	12	257	8.354E-04	95
DESULFOASV1_1484_hypothetical_protein	2xa4-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2xa4-assembly1.cif.gz_A Inhibitors of Jak2 Kinase domain	0.081	339	244	20	358	6	271	7.187E-03	95
DESULFOASV1_1484_hypothetical_protein	5s7v-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5s7v-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010942a	0.118	338	239	21	358	7	278	1.508E-04	95
DESULFOASV1_1484_hypothetical_protein	4czt-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4czt-assembly2.cif.gz_B Crystal structure of the kinase domain of CIPK23	0.113	341	229	19	359	8	266	6.542E-04	95
DESULFOASV1_1484_hypothetical_protein	2ivu-assembly1.cif.gz_A-2	DESULFOASV1_1484_hypothetical_protein	2ivu-assembly1.cif.gz_A-2 Crystal structure of phosphorylated RET tyrosine kinase domain complexed with the inhibitor ZD6474	0.115	339	229	20	358	23	282	5.932E-04	95
DESULFOASV1_1484_hypothetical_protein	7yaw-assembly4.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	7yaw-assembly4.cif.gz_C Crystal structure of ZAK in complex with compound YH-180	0.104	339	234	20	358	8	269	1.020E-04	95
DESULFOASV1_1484_hypothetical_protein	7jij-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7jij-assembly1.cif.gz_A ATP-bound AMP-activated protein kinase	0.127	314	229	19	332	4	266	3.820E-04	95
DESULFOASV1_1484_hypothetical_protein	6d3l-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6d3l-assembly1.cif.gz_A Crystal structure of unphosphorylated human PKR	0.125	320	206	22	341	9	244	7.187E-03	94
DESULFOASV1_1484_hypothetical_protein	5ct7-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5ct7-assembly2.cif.gz_B BRAF in Complex with RAF265	0.103	340	215	19	358	7	247	1.657E-03	94
DESULFOASV1_1484_hypothetical_protein	8f7p-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8f7p-assembly1.cif.gz_A BRAF kinase in complex with LXH254 (naporafenib)	0.112	340	214	19	358	7	248	4.423E-04	94
DESULFOASV1_1484_hypothetical_protein	6di3-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6di3-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BTK IN COMPLEX WITH FRAGMENT LIGAND	0.121	337	210	22	358	9	248	2.459E-04	94
DESULFOASV1_1484_hypothetical_protein	3tud-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3tud-assembly1.cif.gz_A Crystal structure of SYK kinase domain with N-(4-methyl-3-(8-methyl-7-oxo-2-(phenylamino)-7,8-dihydropyrido[2,3-d]pyrimidin-6-yl)phenyl)-3-(trifluoromethyl)benzamide	0.084	339	219	20	358	7	246	3.451E-03	94
DESULFOASV1_1484_hypothetical_protein	1mqb-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1mqb-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (ephA2) Receptor Protein Kinase	0.107	339	213	20	358	8	247	2.222E-03	94
DESULFOASV1_1484_hypothetical_protein	5fd2-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5fd2-assembly1.cif.gz_A B-Raf wild-type kinase domain in complex with a purinylpyridinylamino-based inhibitor	0.125	340	219	19	358	8	258	4.423E-04	94
DESULFOASV1_1484_hypothetical_protein	3ppj-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3ppj-assembly2.cif.gz_B Human B-Raf Kinase in Complex with a Furopyridine Inhibitor	0.122	340	217	19	358	8	255	3.464E-04	94
DESULFOASV1_1484_hypothetical_protein	6w07-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6w07-assembly1.cif.gz_A Bruton's tyrosine kinase in complex with compound 1	0.155	337	210	22	358	9	257	6.895E-05	94
DESULFOASV1_1484_hypothetical_protein	2xvd-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2xvd-assembly1.cif.gz_A ephB4 kinase domain inhibitor complex	0.132	331	227	20	350	8	270	1.657E-03	94
DESULFOASV1_1484_hypothetical_protein	2qoi-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2qoi-assembly1.cif.gz_A Human EphA3 kinase and juxtamembrane region, Y596F:Y602F double mutant	0.109	339	211	20	358	17	254	2.838E-03	94
DESULFOASV1_1484_hypothetical_protein	4xuf-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4xuf-assembly2.cif.gz_B Crystal structure of the FLT3 kinase domain bound to the inhibitor quizartinib (AC220)	0.113	339	232	20	358	10	271	4.423E-04	94
DESULFOASV1_1484_hypothetical_protein	6fng-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6fng-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with an isomer of NVP-BHG712	0.113	331	223	20	350	14	265	2.015E-03	94
DESULFOASV1_1484_hypothetical_protein	6guk-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6guk-assembly1.cif.gz_A CDK2 in complex with CGP74514A	0.111	337	229	22	358	3	261	1.120E-03	94
DESULFOASV1_1484_hypothetical_protein	2r3k-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2r3k-assembly1.cif.gz_A Crystal Structure of Cyclin-Dependent Kinase 2 with inhibitor	0.100	332	233	26	357	4	263	5.649E-04	94
DESULFOASV1_1484_hypothetical_protein	1ckp-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1ckp-assembly1.cif.gz_A HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR PURVALANOL B	0.104	337	233	20	356	3	263	8.773E-04	94
DESULFOASV1_1484_hypothetical_protein	7eef-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7eef-assembly1.cif.gz_A Crystal structure of EphA7 mutant G656E	0.127	351	232	8	358	5	271	1.740E-03	94
DESULFOASV1_1484_hypothetical_protein	7c3n-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7c3n-assembly1.cif.gz_A Crystal structure of JAK3 in complex with Delgocitinib	0.116	339	242	20	358	8	282	1.502E-03	94
DESULFOASV1_1484_hypothetical_protein	8gmc-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	8gmc-assembly2.cif.gz_B CRYSTAL STRUCTURE OF AP2 ASSOCIATED KINASE 1 COMPLEXED WITH 5-[(4-aminopiperidin-1-yl)methyl]-N-{3-[5-(propan-2-yl)-1,3,4-thiadiazol-2-yl]phenyl}pyrrolo[2,1-f][1,2,4]triazin-4-amine	0.098	337	231	22	358	19	275	5.649E-04	94
DESULFOASV1_1484_hypothetical_protein	5p9l-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5p9l-assembly1.cif.gz_A BTK1 IN COMPLEX WITH CC 292	0.134	337	204	22	358	10	246	5.122E-04	93
DESULFOASV1_1484_hypothetical_protein	7lty-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7lty-assembly1.cif.gz_A Bruton's tyrosine kinase in complex with compound 23	0.133	337	207	22	358	9	248	2.991E-04	93
DESULFOASV1_1484_hypothetical_protein	1k2p-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1k2p-assembly1.cif.gz_A Crystal structure of Bruton's tyrosine kinase domain	0.131	336	216	23	358	6	255	4.011E-04	93
DESULFOASV1_1484_hypothetical_protein	7mgj-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	7mgj-assembly3.cif.gz_C TNNI3K complexed with N-methyl-4-(4-(3-(3-(trifluoromethyl) phenyl) ureido) phenoxy)picolinamide	0.120	339	208	20	358	18	254	3.805E-03	93
DESULFOASV1_1484_hypothetical_protein	6s75-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6s75-assembly2.cif.gz_B Crystal structure of Nek7 bound to compound 51	0.114	339	217	20	358	14	259	1.362E-03	93
DESULFOASV1_1484_hypothetical_protein	6hew-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6hew-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative AT069	0.112	331	225	20	350	8	261	3.451E-03	93
DESULFOASV1_1484_hypothetical_protein	2vx1-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2vx1-assembly1.cif.gz_A ephB4 kinase domain inhibitor complex	0.127	327	231	20	346	7	272	9.213E-04	93
DESULFOASV1_1484_hypothetical_protein	7uyv-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7uyv-assembly1.cif.gz_A Crystal structure of JAK3 kinase domain in complex with compound 25	0.109	339	236	20	358	8	273	5.359E-03	93
DESULFOASV1_1484_hypothetical_protein	6q48-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6q48-assembly1.cif.gz_A CDK2 in complex with FragLite7	0.114	335	233	22	356	3	266	6.542E-04	93
DESULFOASV1_1484_hypothetical_protein	2y7j-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	2y7j-assembly1.cif.gz_B Structure of human phosphorylase kinase, gamma 2	0.103	347	244	14	360	9	281	1.919E-03	93
DESULFOASV1_1484_hypothetical_protein	4fkq-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4fkq-assembly1.cif.gz_A Crystal structure of the cdk2 in complex with oxindole inhibitor	0.106	337	236	20	356	3	267	8.354E-04	93
DESULFOASV1_1484_hypothetical_protein	5s7w-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5s7w-assembly1.cif.gz_A XChem group deposition -- Crystal Structure of human ACVR1 in complex with HM000007h	0.123	338	239	21	358	7	280	2.022E-04	93
DESULFOASV1_1484_hypothetical_protein	3zfx-assembly7.cif.gz_G	DESULFOASV1_1484_hypothetical_protein	3zfx-assembly7.cif.gz_G Crystal structure of EphB1	0.111	331	218	20	350	8	253	2.838E-03	92
DESULFOASV1_1484_hypothetical_protein	7kpm-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7kpm-assembly1.cif.gz_A Crystal structure of hEphB1 bound with ADP	0.127	323	212	20	342	8	251	1.827E-03	92
DESULFOASV1_1484_hypothetical_protein	2hel-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2hel-assembly1.cif.gz_A Crystal structure of a mutant EphA4 kinase domain (Y742A)	0.118	337	209	21	357	9	246	1.740E-03	92
DESULFOASV1_1484_hypothetical_protein	6gcx-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6gcx-assembly1.cif.gz_A Focal Adhesion Kinase catalytic domain in complex with irreversible inhibitor	0.138	339	206	20	358	9	248	5.122E-04	92
DESULFOASV1_1484_hypothetical_protein	7mgj-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	7mgj-assembly2.cif.gz_B TNNI3K complexed with N-methyl-4-(4-(3-(3-(trifluoromethyl) phenyl) ureido) phenoxy)picolinamide	0.127	339	205	20	358	18	253	5.103E-03	92
DESULFOASV1_1484_hypothetical_protein	3t9t-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3t9t-assembly1.cif.gz_A Crystal structure of BTK mutant (F435T,K596R) complexed with Imidazo[1,5-a]quinoxaline	0.127	337	218	22	358	7	257	1.502E-03	92
DESULFOASV1_1484_hypothetical_protein	4ehe-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4ehe-assembly1.cif.gz_A B-Raf Kinase Domain in Complex with an Aminothienopyrimidine-based Inhibitor	0.112	340	221	19	358	8	257	2.573E-03	92
DESULFOASV1_1484_hypothetical_protein	6zc0-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6zc0-assembly1.cif.gz_A SYK Kinase domain in complex with azabenzimidazole inhibitor 2b	0.103	326	231	20	345	7	264	2.333E-03	92
DESULFOASV1_1484_hypothetical_protein	6s73-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6s73-assembly2.cif.gz_B Crystal structure of Nek7 SRS mutant bound to compound 51	0.125	340	216	19	358	13	260	9.213E-04	92
DESULFOASV1_1484_hypothetical_protein	4ewh-assembly1.cif.gz_B-2	DESULFOASV1_1484_hypothetical_protein	4ewh-assembly1.cif.gz_B-2 Co-crystal structure of ACK1 with inhibitor	0.085	333	237	26	358	10	269	7.187E-03	92
DESULFOASV1_1484_hypothetical_protein	4rt7-assembly1.cif.gz_A-2	DESULFOASV1_1484_hypothetical_protein	4rt7-assembly1.cif.gz_A-2 Crystal Structure of FLT3 with a small molecule inhibitor	0.123	339	225	20	358	11	267	6.542E-04	92
DESULFOASV1_1484_hypothetical_protein	4o38-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4o38-assembly1.cif.gz_B Crystal structure of the human cyclin G associated kinase (GAK)	0.108	296	222	39	334	23	272	4.860E-03	92
DESULFOASV1_1484_hypothetical_protein	6jgm-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6jgm-assembly1.cif.gz_A Crystal structure of CDK2 IN complex with Inhibitor NU-6140	0.102	337	233	20	356	3	263	1.578E-03	92
DESULFOASV1_1484_hypothetical_protein	4fkv-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4fkv-assembly1.cif.gz_A Crystal structure of the cdk2 in complex with oxindole inhibitor	0.108	332	235	26	357	4	267	8.354E-04	92
DESULFOASV1_1484_hypothetical_protein	1h08-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1h08-assembly1.cif.gz_A CDK2 in complex with a disubstituted 2, 4-bis anilino pyrimidine CDK4 inhibitor	0.106	337	236	20	356	3	267	9.213E-04	92
DESULFOASV1_1484_hypothetical_protein	5ng3-assembly3.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5ng3-assembly3.cif.gz_A Structure of inactive kinase RIP2K(K47R)	0.104	338	240	22	359	10	278	1.431E-03	92
DESULFOASV1_1484_hypothetical_protein	3rvg-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3rvg-assembly1.cif.gz_A Crystals structure of Jak2 with a 1-amino-5H-pyrido[4,3-b]indol-4-carboxamide inhibitor	0.093	339	245	20	358	8	278	2.980E-03	92
DESULFOASV1_1484_hypothetical_protein	6tpf-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6tpf-assembly1.cif.gz_A Fragment-based discovery of pyrazolopyridones as JAK1 inhibitors with excellent subtype selectivity	0.118	339	241	20	358	11	284	5.628E-03	92
DESULFOASV1_1484_hypothetical_protein	7ju6-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	7ju6-assembly1.cif.gz_B Structure of RET protein tyrosine kinase in complex with selpercatinib	0.109	339	232	20	358	24	284	1.297E-03	92
DESULFOASV1_1484_hypothetical_protein	4c57-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4c57-assembly2.cif.gz_B Structure of GAK kinase in complex with a nanobody	0.099	322	241	37	358	20	287	1.740E-03	92
DESULFOASV1_1484_hypothetical_protein	6xlo-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6xlo-assembly1.cif.gz_A Crystal structure of bRaf in complex with inhibitor	0.127	340	214	19	358	7	252	1.235E-03	91
DESULFOASV1_1484_hypothetical_protein	8x2a-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8x2a-assembly1.cif.gz_A The Crystal Structure of BMX from Biortus.	0.129	339	215	20	358	7	254	1.663E-04	91
DESULFOASV1_1484_hypothetical_protein	5vam-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5vam-assembly2.cif.gz_B BRAF in Complex with RAF709	0.116	340	217	19	358	7	253	1.746E-04	91
DESULFOASV1_1484_hypothetical_protein	7avy-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7avy-assembly1.cif.gz_A MerTK kinase domain in complex with quinazoline-based inhbitor	0.096	337	240	5	341	1	266	5.932E-04	91
DESULFOASV1_1484_hypothetical_protein	2vtq-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2vtq-assembly1.cif.gz_A Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design.	0.104	340	233	20	359	3	263	1.297E-03	91
DESULFOASV1_1484_hypothetical_protein	6q7d-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6q7d-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATDL13	0.120	326	209	20	345	13	251	3.451E-03	91
DESULFOASV1_1484_hypothetical_protein	2vv9-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2vv9-assembly1.cif.gz_A CDK2 in complex with an imidazole piperazine	0.099	337	234	20	356	3	263	1.740E-03	91
DESULFOASV1_1484_hypothetical_protein	4lyn-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4lyn-assembly1.cif.gz_A Crystal structure of cyclin-dependent kinase 2 (cdk2-wt) complex with (2s)-n-(5-(((5-tert-butyl-1,3-oxazol-2-yl)methyl)sulfanyl)-1,3-thiazol-2-yl)-2-phenylpropanamide	0.105	332	240	26	357	4	272	1.235E-03	91
DESULFOASV1_1484_hypothetical_protein	3hng-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3hng-assembly1.cif.gz_A Crystal structure of VEGFR1 in complex with N-(4-Chlorophenyl)-2-((pyridin-4-ylmethyl)amino)benzamide	0.122	339	229	20	358	23	284	2.333E-03	91
DESULFOASV1_1484_hypothetical_protein	3rpv-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3rpv-assembly1.cif.gz_A CDK2 in complex with inhibitor RC-2-88	0.107	335	246	22	356	3	278	1.502E-03	91
DESULFOASV1_1484_hypothetical_protein	7s6v-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7s6v-assembly1.cif.gz_A Leishmania infantum Glycogen Synthase Kinase 3 beta bound to CGP60474	0.117	329	284	4	332	3	325	3.637E-04	91
DESULFOASV1_1484_hypothetical_protein	3tub-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3tub-assembly1.cif.gz_A Crystal structure of SYK kinase domain with 1-(5-(6,7-dimethoxyquinolin-4-yloxy)pyridin-2-yl)-3-((1R,2S)-2-phenylcyclopropyl)urea	0.084	339	218	20	358	8	246	7.547E-03	90
DESULFOASV1_1484_hypothetical_protein	2vwv-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2vwv-assembly1.cif.gz_A ephB4 kinase domain inhibitor complex	0.130	339	204	20	358	9	244	4.011E-04	90
DESULFOASV1_1484_hypothetical_protein	5hid-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5hid-assembly1.cif.gz_A BRAF Kinase domain b3aC loop deletion mutant in complex with AZ628	0.113	340	215	19	358	7	249	5.932E-04	90
DESULFOASV1_1484_hypothetical_protein	3zfx-assembly4.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	3zfx-assembly4.cif.gz_D Crystal structure of EphB1	0.116	330	225	20	349	8	263	8.740E-03	90
DESULFOASV1_1484_hypothetical_protein	8flh-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8flh-assembly1.cif.gz_A Bruton's tyrosine kinase in complex with an orthosteric inhibitor	0.141	337	214	22	358	10	259	3.298E-04	90
DESULFOASV1_1484_hypothetical_protein	3zfx-assembly8.cif.gz_H	DESULFOASV1_1484_hypothetical_protein	3zfx-assembly8.cif.gz_H Crystal structure of EphB1	0.116	331	228	20	350	8	266	2.573E-03	90
DESULFOASV1_1484_hypothetical_protein	6cd6-assembly4.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	6cd6-assembly4.cif.gz_D Crystal Structure of the Human CAMKK1A in complex with GSK650394	0.144	340	223	19	358	4	265	3.141E-04	90
DESULFOASV1_1484_hypothetical_protein	5njz-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5njz-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 1g	0.111	331	225	20	350	9	262	5.932E-04	90
DESULFOASV1_1484_hypothetical_protein	4bgh-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4bgh-assembly1.cif.gz_A Crystal Structure of CDK2 in complex with pan-CDK Inhibitor	0.101	338	231	20	357	3	260	1.431E-03	90
DESULFOASV1_1484_hypothetical_protein	6fer-assembly6.cif.gz_F	DESULFOASV1_1484_hypothetical_protein	6fer-assembly6.cif.gz_F Crystal Structure of human DDR2 kinase in complex with 2-[4,5-difluoro-2-oxo-1'-(1H-pyrazolo[3,4-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-N-(2,2,2-trifluoroethyl)acetamide	0.106	339	235	20	358	10	273	2.333E-03	90
DESULFOASV1_1484_hypothetical_protein	2qof-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2qof-assembly1.cif.gz_A Human EphA3 kinase and juxtamembrane region, Y596F mutant	0.106	339	212	20	358	19	256	5.628E-03	90
DESULFOASV1_1484_hypothetical_protein	5k4j-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5k4j-assembly1.cif.gz_A Crystal Structure of CDK2 in complex with compound 22	0.109	337	233	20	356	4	266	1.502E-03	90
DESULFOASV1_1484_hypothetical_protein	2qoq-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2qoq-assembly1.cif.gz_A Human EphA3 kinase and juxtamembrane region, base, AMP-PNP bound structure	0.117	339	212	20	358	24	264	1.120E-03	90
DESULFOASV1_1484_hypothetical_protein	4fk6-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4fk6-assembly2.cif.gz_B JAK1 kinase (JH1 domain) in complex with compound 72	0.109	339	241	20	358	11	281	1.016E-03	90
DESULFOASV1_1484_hypothetical_protein	5hes-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5hes-assembly1.cif.gz_A Human leucine zipper- and sterile alpha motif-containing kinase (ZAK, MLT, HCCS-4, MRK, AZK, MLTK) in complex with vemurafenib	0.108	339	228	20	358	10	266	2.583E-04	90
DESULFOASV1_1484_hypothetical_protein	1yvj-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1yvj-assembly1.cif.gz_A Crystal structure of the Jak3 kinase domain in complex with a staurosporine analogue	0.121	339	241	20	358	8	282	3.996E-03	90
DESULFOASV1_1484_hypothetical_protein	6vnf-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6vnf-assembly1.cif.gz_B JAK2 JH1 in complex with MA9-086	0.087	339	251	20	358	8	283	1.827E-03	90
DESULFOASV1_1484_hypothetical_protein	4h39-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4h39-assembly1.cif.gz_A Crystal Structure of JNK3 in Complex with JIP1 Peptide	0.097	337	253	22	358	19	299	2.342E-04	90
DESULFOASV1_1484_hypothetical_protein	7k7q-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	7k7q-assembly1.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH COMPOUND-12 AKA:6-[(cyclopropanecarbonyl)amino]-4-({3-[6-(dimethylcarbamoyl)pyridazin-3-yl]-2-methoxyphenyl}amino)-N-methylpyridazine-3-carboxamide	0.089	333	218	26	358	10	249	7.547E-03	89
DESULFOASV1_1484_hypothetical_protein	4r5y-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4r5y-assembly2.cif.gz_B The complex structure of Braf V600E kinase domain with a novel Braf inhibitor	0.103	340	216	19	358	7	248	3.996E-03	89
DESULFOASV1_1484_hypothetical_protein	8c7x-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	8c7x-assembly1.cif.gz_B Crystal structure of BRAF in complex with a hybrid compound 6	0.132	340	214	19	358	8	254	4.212E-04	89
DESULFOASV1_1484_hypothetical_protein	4g9r-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4g9r-assembly1.cif.gz_A B-Raf V600E Kinase Domain Bound to a Type II Dihydroquinazoline Inhibitor	0.116	340	218	19	358	8	255	8.354E-04	89
DESULFOASV1_1484_hypothetical_protein	3ii5-assembly3.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3ii5-assembly3.cif.gz_A The Complex of wild-type B-RAF with Pyrazolo pyrimidine inhibitor	0.119	340	218	19	358	8	256	2.712E-04	89
DESULFOASV1_1484_hypothetical_protein	5p9h-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5p9h-assembly1.cif.gz_A BTK1 COCRYSTALLIZED WITH RN983	0.152	337	212	22	358	7	257	4.878E-04	89
DESULFOASV1_1484_hypothetical_protein	7pi4-assembly1.cif.gz_DDD	DESULFOASV1_1484_hypothetical_protein	7pi4-assembly1.cif.gz_DDD FAK Protac GSK215 in complex with FAK and pVHL:ElonginC:ElonginB	0.130	339	214	20	358	7	253	9.213E-04	89
DESULFOASV1_1484_hypothetical_protein	8ff0-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8ff0-assembly1.cif.gz_A Structure of BTK kinase domain with the second-generation inhibitor tirabrutinib	0.142	337	215	22	358	7	257	7.214E-04	89
DESULFOASV1_1484_hypothetical_protein	4y95-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4y95-assembly2.cif.gz_B Crystal structure of the kinase domain of Bruton's tyrosine kinase with mutations in the activation loop	0.138	337	216	22	358	8	258	2.022E-04	89
DESULFOASV1_1484_hypothetical_protein	4p5z-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4p5z-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with quinoxaline derivatives	0.118	331	221	20	350	12	263	2.333E-03	89
DESULFOASV1_1484_hypothetical_protein	3zfx-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3zfx-assembly1.cif.gz_A Crystal structure of EphB1	0.111	339	217	20	358	8	252	5.103E-03	89
DESULFOASV1_1484_hypothetical_protein	4trl-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4trl-assembly1.cif.gz_A Structure of Ephrin type-A receptor 2	0.106	339	224	20	358	14	265	1.740E-03	89
DESULFOASV1_1484_hypothetical_protein	1gij-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1gij-assembly1.cif.gz_A HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR	0.105	338	228	20	357	3	258	1.740E-03	89
DESULFOASV1_1484_hypothetical_protein	5ia5-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5ia5-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with golvatinib (E7050)	0.121	339	225	20	358	8	264	3.451E-03	89
DESULFOASV1_1484_hypothetical_protein	5ia3-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5ia3-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with PD173955	0.115	326	212	20	345	11	251	3.451E-03	89
DESULFOASV1_1484_hypothetical_protein	1ke8-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1ke8-assembly1.cif.gz_A CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE	0.108	340	239	20	359	3	271	1.502E-03	89
DESULFOASV1_1484_hypothetical_protein	5hvj-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5hvj-assembly1.cif.gz_A Crystal structure of LIMK1 D460N mutant in complex with AMP-PNP	0.111	337	236	20	356	10	276	1.120E-03	89
DESULFOASV1_1484_hypothetical_protein	6guh-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6guh-assembly1.cif.gz_A CDK2 in complex with AZD5438	0.103	335	236	22	356	5	268	5.122E-04	89
DESULFOASV1_1484_hypothetical_protein	3fy2-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3fy2-assembly1.cif.gz_A Human EphA3 Kinase and Juxtamembrane Region Bound to Substrate KQWDNYEFIW	0.120	339	218	20	358	14	262	1.235E-03	89
DESULFOASV1_1484_hypothetical_protein	5nkc-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5nkc-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2h	0.115	326	221	20	345	12	262	2.702E-03	89
DESULFOASV1_1484_hypothetical_protein	3pjc-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3pjc-assembly1.cif.gz_A Crystal structure of JAK3 complexed with a potent ATP site inhibitor showing high selectivity within the Janus kinase family	0.118	339	238	20	358	7	277	1.362E-03	89
DESULFOASV1_1484_hypothetical_protein	3fxx-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3fxx-assembly1.cif.gz_A Human EphA3 Kinase and Juxtamembrane Region Bound to Substrate KQWDNYE[pTyr]IW	0.125	339	218	20	358	15	264	1.016E-03	89
DESULFOASV1_1484_hypothetical_protein	4q5j-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4q5j-assembly2.cif.gz_B Crystal structure of SeMet derivative BRI1 in complex with BKI1	0.122	331	225	28	358	33	289	2.450E-03	89
DESULFOASV1_1484_hypothetical_protein	4eop-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	4eop-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 Q131E - human cyclin A3 complex with the inhibitor RO3306	0.106	337	249	20	356	4	283	1.362E-03	89
DESULFOASV1_1484_hypothetical_protein	4kao-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4kao-assembly1.cif.gz_A FOCAL ADHESION KINASE CATALYTIC DOMAIN IN COMPLEX WITH 1-(5-tert-Butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-(4-pyridin-3- yl-phenyl)-urea	0.137	339	203	20	358	7	242	1.827E-03	88
DESULFOASV1_1484_hypothetical_protein	2xyu-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2xyu-assembly1.cif.gz_A Crystal structure of EphA4 kinase domain in complex with VUF 12058	0.122	326	219	20	345	9	258	2.333E-03	88
DESULFOASV1_1484_hypothetical_protein	4yfi-assembly2.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	4yfi-assembly2.cif.gz_D TNNI3K complexed with inhibitor 1	0.121	339	210	20	358	12	251	1.578E-03	88
DESULFOASV1_1484_hypothetical_protein	8fln-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8fln-assembly1.cif.gz_A Crystal structure of BTK C481S kinase domain in complex with pirtobrutinib	0.128	337	218	22	358	7	257	4.423E-04	88
DESULFOASV1_1484_hypothetical_protein	3zfx-assembly9.cif.gz_I	DESULFOASV1_1484_hypothetical_protein	3zfx-assembly9.cif.gz_I Crystal structure of EphB1	0.117	329	224	20	348	8	262	3.286E-03	88
DESULFOASV1_1484_hypothetical_protein	1oit-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1oit-assembly1.cif.gz_A Imidazopyridines: a potent and selective class of Cyclin-dependent Kinase inhibitors identified through Structure-based hybridisation	0.099	335	231	22	356	1	257	1.919E-03	88
DESULFOASV1_1484_hypothetical_protein	8c7x-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8c7x-assembly1.cif.gz_A Crystal structure of BRAF in complex with a hybrid compound 6	0.126	340	226	19	358	7	266	1.235E-03	88
DESULFOASV1_1484_hypothetical_protein	2vth-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2vth-assembly1.cif.gz_A Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design	0.109	335	229	20	354	3	260	1.362E-03	88
DESULFOASV1_1484_hypothetical_protein	7uxi-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7uxi-assembly1.cif.gz_A Structure of CDK2 in complex with FP19711, a Helicon Polypeptide	0.111	330	228	25	354	5	262	3.451E-03	88
DESULFOASV1_1484_hypothetical_protein	7uyv-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	7uyv-assembly3.cif.gz_C Crystal structure of JAK3 kinase domain in complex with compound 25	0.119	339	234	20	358	10	276	2.116E-03	88
DESULFOASV1_1484_hypothetical_protein	3lfn-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3lfn-assembly1.cif.gz_A Crystal structure of CDK2 with SAR57, an aminoindazole type inhibitor	0.103	337	239	20	356	3	269	1.235E-03	88
DESULFOASV1_1484_hypothetical_protein	5nkd-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5nkd-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2i	0.097	339	225	20	358	13	262	2.333E-03	88
DESULFOASV1_1484_hypothetical_protein	2r3q-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2r3q-assembly1.cif.gz_A Crystal Structure of Cyclin-Dependent Kinase 2 with inhibitor	0.101	337	241	20	356	3	271	1.578E-03	88
DESULFOASV1_1484_hypothetical_protein	6glb-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6glb-assembly2.cif.gz_B Crystal structure of JAK3 in complex with Compound 20 (FM484)	0.121	339	238	20	358	9	280	2.116E-03	88
DESULFOASV1_1484_hypothetical_protein	5nk4-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5nk4-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2c	0.102	331	240	20	350	12	279	2.222E-03	88
DESULFOASV1_1484_hypothetical_protein	3r8z-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3r8z-assembly1.cif.gz_A CDK2 in complex with inhibitor RC-1-136	0.114	335	240	22	356	3	274	1.297E-03	88
DESULFOASV1_1484_hypothetical_protein	5k5n-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5k5n-assembly2.cif.gz_B Crystal structure of GSK-3beta complexed with PF-04802367, a highly selective brain-penetrant kinase inhibitor	0.096	338	249	21	358	16	291	1.297E-03	88
DESULFOASV1_1484_hypothetical_protein	6n0q-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6n0q-assembly1.cif.gz_A BRAF in complex with N-(4-methyl-3-(1-methyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-5-yl)phenyl)-3-(trifluoromethyl)benzamide.	0.126	337	209	22	358	11	250	7.576E-04	87
DESULFOASV1_1484_hypothetical_protein	4fc0-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4fc0-assembly1.cif.gz_B Crystal Structure of Human Kinase Domain of B-raf with a DFG-out Inhibitor	0.115	340	220	19	358	8	257	1.502E-03	87
DESULFOASV1_1484_hypothetical_protein	3cc6-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3cc6-assembly1.cif.gz_A Crystal structure of kinase domain of protein tyrosine kinase 2 beta (PTK2B)	0.123	339	216	20	358	10	256	6.844E-03	87
DESULFOASV1_1484_hypothetical_protein	5w86-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5w86-assembly2.cif.gz_B CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN WITH A 4,6-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 7)	0.100	339	234	20	358	6	266	6.206E-03	87
DESULFOASV1_1484_hypothetical_protein	4mne-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4mne-assembly1.cif.gz_B Crystal structure of the BRAF:MEK1 complex	0.107	340	228	19	358	7	262	3.451E-03	87
DESULFOASV1_1484_hypothetical_protein	1zyd-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1zyd-assembly1.cif.gz_A Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type Complexed with ATP.	0.100	343	227	18	360	5	257	4.197E-03	87
DESULFOASV1_1484_hypothetical_protein	5w86-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	5w86-assembly3.cif.gz_C CRYSTAL STRUCTURE OF JAK3 KINASE DOMAIN WITH A 4,6-DIAMINONICOTINAMIDE INHIBITOR (COMPOUND NUMBER 7)	0.117	339	232	20	358	8	271	1.231E-02	87
DESULFOASV1_1484_hypothetical_protein	1wcc-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1wcc-assembly1.cif.gz_A screening for fragment binding by X-ray crystallography	0.105	337	236	20	356	3	267	5.359E-03	87
DESULFOASV1_1484_hypothetical_protein	6z36-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6z36-assembly1.cif.gz_A Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2118	0.121	338	242	21	358	7	282	4.011E-04	87
DESULFOASV1_1484_hypothetical_protein	7atu-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	7atu-assembly2.cif.gz_B The LIMK1 Kinase Domain Bound To LIJTF500025	0.120	333	215	26	358	11	255	1.177E-03	87
DESULFOASV1_1484_hypothetical_protein	4obo-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4obo-assembly2.cif.gz_B MAP4K4 in complex with inhibitor (compound 22), 6-(3-CHLOROPHENYL)QUINAZOLIN-4-AMINE	0.115	341	245	18	358	11	288	1.016E-03	87
DESULFOASV1_1484_hypothetical_protein	4u43-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4u43-assembly1.cif.gz_B MAP4K4 in complex with inhibitor (compound 6)	0.130	358	258	1	358	1	297	8.354E-04	87
DESULFOASV1_1484_hypothetical_protein	8fp1-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8fp1-assembly1.cif.gz_A PKCeta kinase domain in complex with compound 2	0.126	315	238	20	334	6	278	1.657E-03	87
DESULFOASV1_1484_hypothetical_protein	6ae3-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	6ae3-assembly2.cif.gz_C Crystal structure of GSK3beta complexed with Morin	0.096	338	246	21	358	17	289	1.297E-03	87
DESULFOASV1_1484_hypothetical_protein	3v6r-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3v6r-assembly1.cif.gz_A Discovery of potent and selective covalent inhibitors of JNK	0.093	337	265	22	358	19	311	8.354E-04	87
DESULFOASV1_1484_hypothetical_protein	4mf1-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4mf1-assembly1.cif.gz_B ITK kinase domain in complex with benzothiazole inhibitor 12b (1S,2S)-2-{4-[(DIMETHYLAMINO)METHYL]PHENYL}-N-[6-(1H-PYRAZOL-4-YL)-1,3-BENZOTHIAZOL-2-YL]CYCLOPROPANECARBOXAMIDE	0.122	337	203	22	358	8	239	3.286E-03	86
DESULFOASV1_1484_hypothetical_protein	6nsl-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6nsl-assembly2.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound-6c AKA 6-((1-(4-CYANOPHENY L)-2-OXO-1,2-DIHYDRO-3-PYRIDINYL)AMINO)-N-CYCLOPROPYL-8-(M ETHYLAMINO)IMIDAZO[1,2-B]PYRIDAZINE-3-CARBOXAMIDE	0.087	340	219	20	359	8	248	5.103E-03	86
DESULFOASV1_1484_hypothetical_protein	6nzf-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6nzf-assembly1.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_5 AKA 4-[(2-CARBAMOYLPHEN YL)AMINO]-6-[(5-FLUOROPYRIDIN-2-YL)AMINO]-N-METHYLPYRIDINE -3-CARBOXAMIDE	0.084	334	218	26	359	10	248	5.103E-03	86
DESULFOASV1_1484_hypothetical_protein	3zfx-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	3zfx-assembly3.cif.gz_C Crystal structure of EphB1	0.099	331	219	20	350	5	248	4.197E-03	86
DESULFOASV1_1484_hypothetical_protein	7n4q-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7n4q-assembly1.cif.gz_A Bruton's tyrosine kinase in complex with compound 45	0.144	337	208	22	358	10	253	5.379E-04	86
DESULFOASV1_1484_hypothetical_protein	5bq0-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5bq0-assembly1.cif.gz_A Crystal structure of bruton agammaglobulinemia tyrosine kinase complexed with BMS-824171 AKA 6-[(3R)-3-(4-tert-bu tylbenzamido)piperidin-1-yl]-2-{[4-(morpholine-4-carbonyl) phenyl]amino}pyridine-3-carboxamide	0.133	337	212	22	358	13	257	4.423E-04	86
DESULFOASV1_1484_hypothetical_protein	8bk0-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8bk0-assembly1.cif.gz_A Crystal structure of human Ephrin type-A receptor 2 (EPHA2) Kinase domain in complex with LDN-211904	0.091	339	220	20	358	8	250	2.573E-03	86
DESULFOASV1_1484_hypothetical_protein	6hex-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6hex-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATMM006	0.109	331	222	20	350	8	257	5.103E-03	86
DESULFOASV1_1484_hypothetical_protein	7uyv-assembly4.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	7uyv-assembly4.cif.gz_D Crystal structure of JAK3 kinase domain in complex with compound 25	0.116	339	229	20	358	8	267	4.860E-03	86
DESULFOASV1_1484_hypothetical_protein	8ex2-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8ex2-assembly1.cif.gz_A Crystal structure of JAK2 JH2 (pseudokinase domain) in complex with HTSA3	0.084	339	239	20	358	9	270	3.129E-03	86
DESULFOASV1_1484_hypothetical_protein	7jxh-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	7jxh-assembly1.cif.gz_B HER2 in complex with JBJ-08-178-01	0.111	335	230	20	354	13	272	1.827E-03	86
DESULFOASV1_1484_hypothetical_protein	4czu-assembly1.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	4czu-assembly1.cif.gz_C Crystal structure of the kinase domain of CIPK23 T190D mutant	0.124	341	226	19	359	3	261	1.016E-03	86
DESULFOASV1_1484_hypothetical_protein	5i9u-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5i9u-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase	0.108	326	220	20	345	12	259	1.578E-03	86
DESULFOASV1_1484_hypothetical_protein	2qon-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2qon-assembly1.cif.gz_A Human EphA3 kinase and juxtamembrane region, Y596F:Y602F:Y742A triple mutant	0.121	339	213	20	358	16	258	1.919E-03	86
DESULFOASV1_1484_hypothetical_protein	1xjd-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1xjd-assembly1.cif.gz_A Crystal Structure of PKC-theta complexed with Staurosporine at 2A resolution	0.135	335	236	20	354	3	276	8.773E-04	86
DESULFOASV1_1484_hypothetical_protein	8g8x-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	8g8x-assembly1.cif.gz_B X-ray co-crystal structure of compound 27 in with complex JAK2	0.089	339	245	20	358	7	276	7.187E-03	86
DESULFOASV1_1484_hypothetical_protein	5nk7-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5nk7-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2a	0.102	339	225	20	358	9	259	2.450E-03	86
DESULFOASV1_1484_hypothetical_protein	1oir-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1oir-assembly1.cif.gz_A Imidazopyridines: a potent and selective class of Cyclin-dependent Kinase inhibitors identified through Structure-based hybridisation	0.107	335	241	22	356	3	273	2.450E-03	86
DESULFOASV1_1484_hypothetical_protein	3eid-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	3eid-assembly2.cif.gz_C CDK2/CyclinA complexed with a pyrazolopyridazine inhibitor	0.105	340	249	20	359	3	281	2.838E-03	86
DESULFOASV1_1484_hypothetical_protein	5lwm-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5lwm-assembly1.cif.gz_A Crystal structure of JAK3 in complex with Compound 4 (FM381)	0.113	339	243	20	358	8	282	2.333E-03	86
DESULFOASV1_1484_hypothetical_protein	8b54-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	8b54-assembly2.cif.gz_C CDK2/cyclin A2 in complex with pyrazolo[4,3-d]pyrimidine inhibitor LGR6768	0.103	339	252	20	358	3	284	2.573E-03	86
DESULFOASV1_1484_hypothetical_protein	6yl6-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6yl6-assembly1.cif.gz_A Cdk2(F80C)	0.105	341	255	19	359	7	292	2.222E-03	86
DESULFOASV1_1484_hypothetical_protein	5m06-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5m06-assembly1.cif.gz_A Crystal structure of Mycobacterium tuberculosis PknI kinase domain	0.129	339	205	20	358	6	241	1.919E-03	85
DESULFOASV1_1484_hypothetical_protein	6nzf-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6nzf-assembly1.cif.gz_A CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_5 AKA 4-[(2-CARBAMOYLPHEN YL)AMINO]-6-[(5-FLUOROPYRIDIN-2-YL)AMINO]-N-METHYLPYRIDINE -3-CARBOXAMIDE	0.088	332	203	26	357	10	233	5.359E-03	85
DESULFOASV1_1484_hypothetical_protein	5m06-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5m06-assembly1.cif.gz_B Crystal structure of Mycobacterium tuberculosis PknI kinase domain	0.138	316	191	43	358	23	244	5.379E-04	85
DESULFOASV1_1484_hypothetical_protein	5c9c-assembly3.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5c9c-assembly3.cif.gz_B CRYSTAL STRUCTURE OF BRAF(V600E) IN COMPLEX WITH LY3009120 COMPND	0.132	340	207	19	358	7	245	8.354E-04	85
DESULFOASV1_1484_hypothetical_protein	2vww-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2vww-assembly1.cif.gz_A ephB4 kinase domain inhibitor complex	0.130	329	214	20	348	6	252	2.980E-03	85
DESULFOASV1_1484_hypothetical_protein	4i4e-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4i4e-assembly1.cif.gz_A Structure of Focal Adhesion Kinase catalytic domain in complex with hinge binding pyrazolobenzothiazine compound.	0.130	339	205	20	358	8	244	5.628E-03	85
DESULFOASV1_1484_hypothetical_protein	2ijm-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2ijm-assembly1.cif.gz_A Crystal Structure of Focal Adhesion Kinase Domain with 2 molecules in the Asymmetric Unit Complexed with ADP and ATP	0.149	339	204	20	358	8	248	4.628E-03	85
DESULFOASV1_1484_hypothetical_protein	2y6m-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2y6m-assembly1.cif.gz_A Crystal structure of EphA4 kinase domain	0.112	326	220	20	345	12	260	4.197E-03	85
DESULFOASV1_1484_hypothetical_protein	4p4c-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4p4c-assembly1.cif.gz_A Human EphA3 Kinase domain in complex with quinoxaline derivatives	0.110	339	221	20	358	8	256	3.805E-03	85
DESULFOASV1_1484_hypothetical_protein	1jpa-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	1jpa-assembly2.cif.gz_B Crystal Structure of unphosphorylated EphB2 receptor tyrosine kinase and juxtamembrane region	0.121	339	212	21	359	28	269	6.844E-03	85
DESULFOASV1_1484_hypothetical_protein	7jxh-assembly7.cif.gz_G	DESULFOASV1_1484_hypothetical_protein	7jxh-assembly7.cif.gz_G HER2 in complex with JBJ-08-178-01	0.108	334	230	20	353	14	272	2.116E-03	85
DESULFOASV1_1484_hypothetical_protein	2qod-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2qod-assembly1.cif.gz_A Human EphA3 kinase and juxtamembrane region, Y602F mutant	0.115	339	210	20	358	17	254	2.838E-03	85
DESULFOASV1_1484_hypothetical_protein	5ano-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5ano-assembly1.cif.gz_A Crystal structure of CDK2 processed with the CrystalDirect automated mounting and cryo-cooling technology	0.098	337	233	20	356	3	261	2.116E-03	85
DESULFOASV1_1484_hypothetical_protein	4bzd-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4bzd-assembly1.cif.gz_A Structure of CDK2 in complex with a benzimidazopyrimidine	0.110	337	230	20	356	3	261	2.980E-03	85
DESULFOASV1_1484_hypothetical_protein	5ani-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5ani-assembly1.cif.gz_A Crystal structure of CDK2 in complex with 6-chloro-7H-purine processed with the CrystalDirect automated mounting and cryo-cooling technology	0.111	339	232	20	358	2	263	1.177E-03	85
DESULFOASV1_1484_hypothetical_protein	2y7j-assembly1.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	2y7j-assembly1.cif.gz_D Structure of human phosphorylase kinase, gamma 2	0.110	345	240	14	358	9	279	5.628E-03	85
DESULFOASV1_1484_hypothetical_protein	2r2p-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2r2p-assembly1.cif.gz_A Kinase domain of human ephrin type-A receptor 5 (EphA5)	0.114	339	227	20	358	13	269	3.451E-03	85
DESULFOASV1_1484_hypothetical_protein	6q4k-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6q4k-assembly1.cif.gz_A CDK2 in complex with FragLite38	0.104	335	244	22	356	4	276	3.451E-03	85
DESULFOASV1_1484_hypothetical_protein	4krc-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4krc-assembly1.cif.gz_A Crystal Structure of Pho85-Pcl10-ATP-gamma-S Complex	0.105	338	254	20	357	5	289	7.547E-03	85
DESULFOASV1_1484_hypothetical_protein	2j0j-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2j0j-assembly1.cif.gz_A Crystal structure of a fragment of focal adhesion kinase containing the FERM and kinase domains.	0.134	339	212	20	358	356	601	1.740E-03	85
DESULFOASV1_1484_hypothetical_protein	5val-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5val-assembly1.cif.gz_A BRAF in Complex with N-(3-(tert-butyl)phenyl)-4-methyl-3-(6-morpholinopyrimidin-4-yl)benzamide	0.123	337	208	22	358	11	248	1.502E-03	84
DESULFOASV1_1484_hypothetical_protein	5val-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5val-assembly2.cif.gz_B BRAF in Complex with N-(3-(tert-butyl)phenyl)-4-methyl-3-(6-morpholinopyrimidin-4-yl)benzamide	0.117	340	211	19	358	8	247	1.177E-03	84
DESULFOASV1_1484_hypothetical_protein	3zfx-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3zfx-assembly2.cif.gz_B Crystal structure of EphB1	0.115	331	218	20	350	8	254	6.206E-03	84
DESULFOASV1_1484_hypothetical_protein	3zfy-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3zfy-assembly2.cif.gz_B Crystal structure of EphB3	0.105	340	216	19	358	1	242	1.919E-03	84
DESULFOASV1_1484_hypothetical_protein	5vdk-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5vdk-assembly1.cif.gz_A Crystal structure of human WEE2 kinase domain in complex with MK1775	0.108	337	219	22	358	8	254	2.116E-03	84
DESULFOASV1_1484_hypothetical_protein	3zfy-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3zfy-assembly1.cif.gz_A Crystal structure of EphB3	0.108	338	219	21	358	2	247	1.502E-03	84
DESULFOASV1_1484_hypothetical_protein	3zon-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3zon-assembly1.cif.gz_A Human TYK2 pseudokinase domain bound to a kinase inhibitor	0.087	339	224	20	358	12	257	7.547E-03	84
DESULFOASV1_1484_hypothetical_protein	1zyc-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1zyc-assembly1.cif.gz_A Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type in Apo Form.	0.101	341	223	20	360	7	255	5.628E-03	84
DESULFOASV1_1484_hypothetical_protein	1uwh-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	1uwh-assembly1.cif.gz_B The complex of wild type B-RAF and BAY439006.	0.111	340	220	19	358	8	255	1.740E-03	84
DESULFOASV1_1484_hypothetical_protein	6hm7-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6hm7-assembly1.cif.gz_A CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE (SYK) IN COMPLEX WITH A 2-(PHENOXYMETHYL)PYRIDINE INHIBITOR	0.083	326	234	20	345	7	262	3.996E-03	84
DESULFOASV1_1484_hypothetical_protein	5ia4-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5ia4-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with foretinib (XL880)	0.125	339	223	20	358	8	263	1.827E-03	84
DESULFOASV1_1484_hypothetical_protein	6fnm-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6fnm-assembly1.cif.gz_A Crystal Structure of Ephrin B4 (EphB4) Receptor Protein Kinase with Dasatinib	0.116	331	232	20	350	7	269	1.362E-03	84
DESULFOASV1_1484_hypothetical_protein	6fer-assembly7.cif.gz_G	DESULFOASV1_1484_hypothetical_protein	6fer-assembly7.cif.gz_G Crystal Structure of human DDR2 kinase in complex with 2-[4,5-difluoro-2-oxo-1'-(1H-pyrazolo[3,4-b]pyridine-5-carbonyl)spiro[indole-3,4'-piperidine]-1-yl]-N-(2,2,2-trifluoroethyl)acetamide	0.105	336	233	23	358	11	271	5.103E-03	84
DESULFOASV1_1484_hypothetical_protein	2qoo-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2qoo-assembly1.cif.gz_A Human EphA3 kinase and juxtamembrane region, Y596F:Y602F:Y742F triple mutant	0.118	339	219	20	358	17	265	2.980E-03	84
DESULFOASV1_1484_hypothetical_protein	1r78-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1r78-assembly1.cif.gz_A CDK2 complex with a 4-alkynyl oxindole inhibitor	0.097	337	229	20	356	3	257	4.197E-03	84
DESULFOASV1_1484_hypothetical_protein	4l00-assembly3.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4l00-assembly3.cif.gz_B Crystal structure of the apo Jak1 pseudokinase domain	0.099	339	230	20	358	18	273	5.910E-03	84
DESULFOASV1_1484_hypothetical_protein	1ke9-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1ke9-assembly1.cif.gz_A CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[4-({[AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE	0.096	339	242	22	360	3	271	1.120E-03	84
DESULFOASV1_1484_hypothetical_protein	4eev-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4eev-assembly1.cif.gz_A Crystal structure of c-Met in complex with LY2801653	0.097	340	239	4	343	9	274	3.996E-03	84
DESULFOASV1_1484_hypothetical_protein	5nkb-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5nkb-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 4a	0.108	331	237	20	350	8	274	3.996E-03	84
DESULFOASV1_1484_hypothetical_protein	3fup-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3fup-assembly1.cif.gz_A Crystal structures of JAK1 and JAK2 inhibitor complexes	0.089	339	247	20	358	6	277	7.547E-03	84
DESULFOASV1_1484_hypothetical_protein	5oo3-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5oo3-assembly1.cif.gz_A Cdk2(F80C, C177A) with covalent ligand at F80C	0.106	339	242	20	358	2	273	2.222E-03	84
DESULFOASV1_1484_hypothetical_protein	1buh-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1buh-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE HUMAN CDK2 KINASE COMPLEX WITH CELL CYCLE-REGULATORY PROTEIN CKSHS1	0.111	339	247	22	360	3	281	1.177E-03	84
DESULFOASV1_1484_hypothetical_protein	3f5x-assembly1.cif.gz_A-3	DESULFOASV1_1484_hypothetical_protein	3f5x-assembly1.cif.gz_A-3 CDK-2-Cyclin complex with indazole inhibitor 9 bound at its active site	0.097	339	250	20	358	3	280	2.015E-03	84
DESULFOASV1_1484_hypothetical_protein	8bzp-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8bzp-assembly1.cif.gz_A JNK3 (Mitogen-activated protein kinase 10) in Complex with Compound 23 bearing a C(sp3)F2Br moiety	0.089	337	265	22	358	18	309	1.431E-03	84
DESULFOASV1_1484_hypothetical_protein	7s6u-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7s6u-assembly1.cif.gz_A Leishmania infantum Glycogen Synthase Kinase 3 beta bound to AZD5438	0.116	329	290	4	332	3	331	1.657E-03	84
DESULFOASV1_1484_hypothetical_protein	3tku-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3tku-assembly1.cif.gz_A MRCK beta in complex with fasudil	0.125	341	235	20	360	74	343	1.016E-03	84
DESULFOASV1_1484_hypothetical_protein	6v2u-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6v2u-assembly2.cif.gz_B Crystal structure of the insect cell-expressed WT-BRAF kinase in complex with Dabrafenib	0.134	340	205	19	358	7	244	7.955E-04	83
DESULFOASV1_1484_hypothetical_protein	5xka-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5xka-assembly1.cif.gz_B Crystal structure of M.tuberculosis PknI kinase domain	0.115	232	133	20	251	5	155	3.451E-03	83
DESULFOASV1_1484_hypothetical_protein	3fzs-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3fzs-assembly1.cif.gz_A Crystal Structure of PYK2 complexed with BIRB796	0.129	339	207	20	358	5	243	2.333E-03	83
DESULFOASV1_1484_hypothetical_protein	4ksq-assembly3.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4ksq-assembly3.cif.gz_B Crystal Structure of Human B-raf bound to a DFG-out Inhibitor 5B	0.125	340	212	19	358	7	249	1.827E-03	83
DESULFOASV1_1484_hypothetical_protein	6nzr-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6nzr-assembly1.cif.gz_A CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_12 AKA 4-[(2-methanesulfonylphenyl)amino]-N-(H3)methyl-6-[(pyridin-2- yl)amino]pyridazine-3-carboxamide	0.089	334	226	26	359	12	260	1.063E-02	83
DESULFOASV1_1484_hypothetical_protein	3tv4-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3tv4-assembly1.cif.gz_A Human B-Raf Kinase Domain in Complex with an Bromopyridine Benzamide Inhibitor	0.135	340	214	19	358	8	255	1.431E-03	83
DESULFOASV1_1484_hypothetical_protein	6het-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6het-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative AT055	0.119	326	208	20	345	8	244	4.197E-03	83
DESULFOASV1_1484_hypothetical_protein	3eqr-assembly3.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3eqr-assembly3.cif.gz_B Crystal Structure of Ack1 with compound T74	0.098	339	232	20	358	9	266	9.638E-03	83
DESULFOASV1_1484_hypothetical_protein	3ezr-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3ezr-assembly1.cif.gz_A CDK-2 with indazole inhibitor 17 bound at its active site	0.108	338	227	20	357	3	258	3.286E-03	83
DESULFOASV1_1484_hypothetical_protein	5a14-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5a14-assembly1.cif.gz_A Human CDK2 with type II inhibitor	0.115	336	237	22	357	3	271	3.286E-03	83
DESULFOASV1_1484_hypothetical_protein	7v3s-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7v3s-assembly1.cif.gz_A Crystal structure of CMET in complex with a novel inhibitor	0.102	340	246	4	343	1	275	4.628E-03	83
DESULFOASV1_1484_hypothetical_protein	4obp-assembly3.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4obp-assembly3.cif.gz_B MAP4K4 in complex with inhibitor (compound 29), 6-(2-FLUOROPYRIDIN-4-YL)PYRIDO[3,2-D]PYRIMIDIN-4-AMINE	0.106	312	235	47	358	18	281	1.502E-03	83
DESULFOASV1_1484_hypothetical_protein	5osm-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5osm-assembly1.cif.gz_A Cdk2(F80C, C177A) with covalent adduct at C80	0.106	337	242	20	356	7	278	2.450E-03	83
DESULFOASV1_1484_hypothetical_protein	1g3n-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1g3n-assembly1.cif.gz_A STRUCTURE OF A P18(INK4C)-CDK6-K-CYCLIN TERNARY COMPLEX	0.103	340	259	20	359	4	293	2.222E-03	83
DESULFOASV1_1484_hypothetical_protein	3q6w-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3q6w-assembly1.cif.gz_A Structure of dually-phosphorylated MET receptor kinase in complex with an MK-2461 analog with specificity for the activated receptor	0.110	340	249	4	343	4	284	9.674E-04	83
DESULFOASV1_1484_hypothetical_protein	5f95-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5f95-assembly2.cif.gz_B Crystal structure of GSK3b in complex with Compound 18: 2-[(cyclopropylcarbonyl)amino]-N-(4-phenylpyridin-3-yl)pyridine-4-carboxamide	0.094	336	246	23	358	21	293	8.354E-04	83
DESULFOASV1_1484_hypothetical_protein	3oz6-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3oz6-assembly1.cif.gz_A Crystal structure of MapK from Cryptosporidium Parvum, cgd2_1960	0.106	313	223	47	359	15	264	2.342E-04	83
DESULFOASV1_1484_hypothetical_protein	3cok-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3cok-assembly2.cif.gz_B Crystal structure of PLK4 kinase	0.111	305	196	20	324	12	233	7.187E-03	82
DESULFOASV1_1484_hypothetical_protein	3is5-assembly1.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	3is5-assembly1.cif.gz_D Crystal structure of CDPK kinase domain from toxoplasma Gondii, TGME49_018720	0.127	340	196	20	359	11	236	1.497E-02	82
DESULFOASV1_1484_hypothetical_protein	5csw-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5csw-assembly2.cif.gz_B B-RAF in complex with Dabrafenib	0.115	340	209	19	358	9	245	1.919E-03	82
DESULFOASV1_1484_hypothetical_protein	6di9-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6di9-assembly1.cif.gz_A CRYSTAL STRUCTURE OF BTK IN COMPLEX WITH COVALENT INHIBITOR	0.126	312	197	47	358	19	244	1.016E-03	82
DESULFOASV1_1484_hypothetical_protein	4jvg-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4jvg-assembly1.cif.gz_B B-Raf Kinase in Complex with Birb796	0.115	340	215	19	358	8	251	8.354E-04	82
DESULFOASV1_1484_hypothetical_protein	5m51-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5m51-assembly1.cif.gz_A Nek2 bound to arylaminopurine compound 8	0.109	341	227	20	360	5	260	4.407E-03	82
DESULFOASV1_1484_hypothetical_protein	8s99-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	8s99-assembly3.cif.gz_C Crystal structure of the TYK2 pseudokinase domain in complex with compound 11	0.097	340	225	20	359	11	260	1.172E-02	82
DESULFOASV1_1484_hypothetical_protein	6xjk-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6xjk-assembly1.cif.gz_A JAK2 JH2 in complex with JAK067	0.105	341	232	20	360	6	265	5.628E-03	82
DESULFOASV1_1484_hypothetical_protein	8e4t-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8e4t-assembly1.cif.gz_A Crystal structure of the kinase domain of RTKC8 from the choanoflagellate Monosiga brevicollis	0.101	339	224	20	358	11	260	7.547E-03	82
DESULFOASV1_1484_hypothetical_protein	2qol-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2qol-assembly1.cif.gz_A Human EphA3 kinase and juxtamembrane region, Y596:Y602:S768G triple mutant	0.107	339	211	20	358	15	251	4.628E-03	82
DESULFOASV1_1484_hypothetical_protein	5oo1-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5oo1-assembly1.cif.gz_A Cdk2(F80C, C177A) covalent adduct with C37 at F80C	0.092	336	237	22	357	2	263	5.910E-03	82
DESULFOASV1_1484_hypothetical_protein	5nk3-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5nk3-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 1l	0.113	340	233	20	359	12	275	2.116E-03	82
DESULFOASV1_1484_hypothetical_protein	7nj0-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	7nj0-assembly1.cif.gz_B CryoEM structure of the human Separase-Cdk1-cyclin B1-Cks1 complex	0.106	233	132	22	254	3	151	1.357E-02	82
DESULFOASV1_1484_hypothetical_protein	7ukv-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7ukv-assembly1.cif.gz_A Wild type EGFR in complex with Lazertinib (YH25448)	0.114	339	216	20	358	16	260	2.222E-03	82
DESULFOASV1_1484_hypothetical_protein	3kex-assembly2.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3kex-assembly2.cif.gz_A Crystal structure of the catalytically inactive kinase domain of the human epidermal growth factor receptor 3 (HER3)	0.113	324	232	22	345	11	272	1.120E-03	82
DESULFOASV1_1484_hypothetical_protein	4zk5-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4zk5-assembly1.cif.gz_B MAP4K4 in complex with inhibitor GNE-495	0.120	312	231	47	358	22	285	1.297E-03	82
DESULFOASV1_1484_hypothetical_protein	4afj-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4afj-assembly1.cif.gz_A 5-aryl-4-carboxamide-1,3-oxazoles: potent and selective GSK-3 inhibitors	0.091	338	255	21	358	19	300	3.451E-03	82
DESULFOASV1_1484_hypothetical_protein	5xyz-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5xyz-assembly1.cif.gz_B The structure of human BTK kinase domain in complex with a covalent inhibitor	0.119	358	201	1	358	1	229	9.213E-04	81
DESULFOASV1_1484_hypothetical_protein	3miy-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3miy-assembly2.cif.gz_B X-ray crystal structure of ITK complexed with sunitinib	0.126	337	197	22	358	8	233	2.333E-03	81
DESULFOASV1_1484_hypothetical_protein	4knb-assembly4.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	4knb-assembly4.cif.gz_D C-Met in complex with OSI ligand	0.098	324	204	20	343	12	238	2.838E-03	81
DESULFOASV1_1484_hypothetical_protein	5c9c-assembly3.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5c9c-assembly3.cif.gz_A CRYSTAL STRUCTURE OF BRAF(V600E) IN COMPLEX WITH LY3009120 COMPND	0.131	340	209	19	358	7	248	1.120E-03	81
DESULFOASV1_1484_hypothetical_protein	5m53-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5m53-assembly1.cif.gz_A Nek2 bound to arylaminopurine inhibitor 11	0.114	340	220	21	360	2	250	8.740E-03	81
DESULFOASV1_1484_hypothetical_protein	3ii5-assembly3.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3ii5-assembly3.cif.gz_B The Complex of wild-type B-RAF with Pyrazolo pyrimidine inhibitor	0.116	340	215	19	358	7	250	2.980E-03	81
DESULFOASV1_1484_hypothetical_protein	3fzt-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3fzt-assembly1.cif.gz_A Crystal structure of PYK2 complexed with PF-4618433	0.121	339	214	20	358	5	248	4.407E-03	81
DESULFOASV1_1484_hypothetical_protein	2etm-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2etm-assembly1.cif.gz_A Crystal Structure of Focal Adhesion Kinase Domain Complexed with 7H-Pyrrolo [2,3-d] pyrimidine Derivative	0.114	327	226	20	346	7	262	1.231E-02	81
DESULFOASV1_1484_hypothetical_protein	6u2g-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6u2g-assembly1.cif.gz_B BRAF-MEK complex with AMP-PCP bound to BRAF	0.116	340	222	19	358	5	256	4.628E-03	81
DESULFOASV1_1484_hypothetical_protein	5tf9-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5tf9-assembly2.cif.gz_B Crystal structure of WNK1 in complex with Mn2+AMPPNP and WNK476	0.104	332	220	28	359	21	266	3.996E-03	81
DESULFOASV1_1484_hypothetical_protein	8bom-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8bom-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 14	0.088	339	213	20	358	8	242	5.910E-03	81
DESULFOASV1_1484_hypothetical_protein	6fnf-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6fnf-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with NVP-BHG712	0.104	331	228	20	350	7	261	5.910E-03	81
DESULFOASV1_1484_hypothetical_protein	5l6o-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5l6o-assembly1.cif.gz_A EphB3 kinase domain covalently bound to an irreversible inhibitor (compound 3)	0.112	338	224	21	358	2	254	2.838E-03	81
DESULFOASV1_1484_hypothetical_protein	6ziw-assembly1.cif.gz_I	DESULFOASV1_1484_hypothetical_protein	6ziw-assembly1.cif.gz_I The IRAK3 Pseudokinase Domain Bound To ATPgammaS	0.081	312	215	47	358	25	259	3.805E-03	81
DESULFOASV1_1484_hypothetical_protein	1zyc-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	1zyc-assembly2.cif.gz_C Crystal Structure of eIF2alpha Protein Kinase GCN2: Wild-Type in Apo Form.	0.112	335	211	18	352	5	243	1.172E-02	81
DESULFOASV1_1484_hypothetical_protein	8qqy-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8qqy-assembly1.cif.gz_A Crystal structure of human Ephrin type-A receptor 2 (EPHA2) Kinase domain in complex with JG165	0.110	300	204	46	345	19	248	7.926E-03	81
DESULFOASV1_1484_hypothetical_protein	5lvp-assembly4.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	5lvp-assembly4.cif.gz_D Human PDK1 Kinase Domain in Complex with an HM-Peptide Bound to the PIF-Pocket	0.113	325	201	20	344	8	235	6.517E-03	81
DESULFOASV1_1484_hypothetical_protein	3kex-assembly2.cif.gz_B-2	DESULFOASV1_1484_hypothetical_protein	3kex-assembly2.cif.gz_B-2 Crystal structure of the catalytically inactive kinase domain of the human epidermal growth factor receptor 3 (HER3)	0.103	324	232	22	345	11	270	1.235E-03	81
DESULFOASV1_1484_hypothetical_protein	7apf-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	7apf-assembly2.cif.gz_B Crystal structure of JAK3 in complex with FM601 (compound 10a)	0.116	339	238	20	358	8	277	6.206E-03	81
DESULFOASV1_1484_hypothetical_protein	4czt-assembly1.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	4czt-assembly1.cif.gz_C Crystal structure of the kinase domain of CIPK23	0.114	341	229	19	359	2	260	2.702E-03	81
DESULFOASV1_1484_hypothetical_protein	5jq5-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5jq5-assembly1.cif.gz_A Crystal structure of CDK2 in complex with inhibitor ICEC0942	0.115	335	239	22	356	1	271	3.805E-03	81
DESULFOASV1_1484_hypothetical_protein	7b7s-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	7b7s-assembly2.cif.gz_C CDK2/cyclin A2 in complex with 3H-pyrazolo[4,3-f]quinoline-based derivative HSD1368	0.107	339	250	22	360	3	283	1.235E-03	81
DESULFOASV1_1484_hypothetical_protein	2c6o-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2c6o-assembly1.cif.gz_A Crystal structure of the human CDK2 complexed with the triazolopyrimidine inhibitor	0.100	337	246	20	356	3	276	3.805E-03	81
DESULFOASV1_1484_hypothetical_protein	3tnw-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	3tnw-assembly2.cif.gz_C Structure of CDK2/cyclin A in complex with CAN508	0.103	335	247	20	354	3	278	5.910E-03	81
DESULFOASV1_1484_hypothetical_protein	3dkf-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3dkf-assembly1.cif.gz_A Structure of MET receptor tyrosine kinase in complex with inhibitor SGX-523	0.109	340	237	4	343	4	270	3.141E-04	81
DESULFOASV1_1484_hypothetical_protein	4eor-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4eor-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 WT - human cyclin A3 complex with the inhibitor NU6102	0.102	340	251	20	359	4	284	4.197E-03	81
DESULFOASV1_1484_hypothetical_protein	4eoo-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4eoo-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 Q131E - human cyclin A3 complex with ATP	0.102	340	251	20	359	5	285	4.407E-03	81
DESULFOASV1_1484_hypothetical_protein	4eom-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4eom-assembly1.cif.gz_A Thr 160 phosphorylated CDK2 H84S, Q85M, Q131E - human cyclin A3 complex with ATP	0.097	339	249	20	358	5	281	4.407E-03	81
DESULFOASV1_1484_hypothetical_protein	4eon-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	4eon-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 H84S, Q85M, Q131E - human cyclin A3 complex with the inhibitor RO3306	0.105	339	249	20	358	5	283	3.805E-03	81
DESULFOASV1_1484_hypothetical_protein	5a4e-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5a4e-assembly2.cif.gz_B DYRK1A in complex with methoxy benzothiazole fragment	0.096	335	256	21	355	27	310	2.450E-03	81
DESULFOASV1_1484_hypothetical_protein	7nxj-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7nxj-assembly1.cif.gz_A Crystal structure of human Cdk13/Cyclin K in complex with the inhibitor THZ531	0.104	335	254	20	354	10	294	7.187E-03	81
DESULFOASV1_1484_hypothetical_protein	6ln1-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6ln1-assembly2.cif.gz_B A natural inhibitor of DYRK1A for treatment of diabetes mellitus	0.086	269	175	20	288	19	211	5.103E-03	81
DESULFOASV1_1484_hypothetical_protein	5oy4-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5oy4-assembly2.cif.gz_B GSK3beta complex with N-(6-(3,4-dihydroxyphenyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)acetamide	0.105	338	255	21	358	25	310	5.628E-03	81
DESULFOASV1_1484_hypothetical_protein	5tkd-assembly3.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5tkd-assembly3.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH 6-[(3,5-DIMETHYLPHE NYL)AMINO]-8- (METHYLAMINO)IMIDAZO[1,2-B]PYRIDAZINE-3-CARBO XAMIDE	0.094	338	217	22	359	8	247	1.425E-02	80
DESULFOASV1_1484_hypothetical_protein	3v5q-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3v5q-assembly1.cif.gz_A Discovery of a selective TRK Inhibitor with efficacy in rodent cancer tumor models	0.110	314	209	45	358	20	255	2.980E-03	80
DESULFOASV1_1484_hypothetical_protein	5ia0-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5ia0-assembly2.cif.gz_B Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with alisertib (MLN8237)	0.132	326	211	20	345	13	256	2.980E-03	80
DESULFOASV1_1484_hypothetical_protein	5i9z-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5i9z-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with danusertib (PHA739358)	0.114	331	224	20	350	9	262	3.129E-03	80
DESULFOASV1_1484_hypothetical_protein	3zc6-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3zc6-assembly2.cif.gz_B Crystal structure of JAK3 kinase domain in complex with an indazole substituted pyrrolopyrazine inhibitor	0.115	339	234	20	358	9	273	9.638E-03	80
DESULFOASV1_1484_hypothetical_protein	2f2c-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	2f2c-assembly1.cif.gz_B X-ray structure of human CDK6-Vcyclinwith the inhibitor aminopurvalanol	0.108	285	233	47	331	14	275	3.451E-03	80
DESULFOASV1_1484_hypothetical_protein	5tq3-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5tq3-assembly1.cif.gz_A Design and Synthesis of a pan-JAK kinase inhibitor clinical candidate (PF-06263276) suitable for the treatment of inflammatory diseases of the lungs and skin	0.089	339	245	20	358	6	275	6.844E-03	80
DESULFOASV1_1484_hypothetical_protein	7lgs-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	7lgs-assembly2.cif.gz_B Structure of EGFR_D770_N771insNPG/V948R in complex with covalent inhibitor Osimertinib.	0.111	330	240	20	349	10	280	5.628E-03	80
DESULFOASV1_1484_hypothetical_protein	7xqk-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7xqk-assembly1.cif.gz_A The Crystal Structure of CDK3 and CyclinE1 Complex from Biortus.	0.092	333	253	28	360	7	286	5.649E-04	80
DESULFOASV1_1484_hypothetical_protein	5i9y-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5i9y-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with dasatinib	0.107	331	235	20	350	13	276	1.919E-03	80
DESULFOASV1_1484_hypothetical_protein	5nkf-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5nkf-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 3b	0.111	331	242	20	350	8	280	6.206E-03	80
DESULFOASV1_1484_hypothetical_protein	4czt-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4czt-assembly1.cif.gz_A Crystal structure of the kinase domain of CIPK23	0.113	341	229	19	359	10	268	4.407E-03	80
DESULFOASV1_1484_hypothetical_protein	7ctv-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7ctv-assembly1.cif.gz_A Crystal structure of Arabidopsis thaliana SOBIR1 kinase domain D489A mutant in complex with AMP-PNP and magnesium	0.130	334	257	25	358	1	296	1.297E-03	80
DESULFOASV1_1484_hypothetical_protein	5li1-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5li1-assembly1.cif.gz_A Structure of a Par3-inhibitory peptide bound to PKCiota core kinase domain	0.128	341	262	20	360	8	308	2.573E-03	80
DESULFOASV1_1484_hypothetical_protein	6a1g-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6a1g-assembly1.cif.gz_A Crystal structure of human DYRK1A in complex with compound 32	0.095	338	276	21	358	26	331	1.919E-03	80
DESULFOASV1_1484_hypothetical_protein	6ytw-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6ytw-assembly2.cif.gz_B CLK3 bound with benzothiazole Tg003 (Cpd 2)	0.115	336	270	22	357	22	327	4.628E-03	80
DESULFOASV1_1484_hypothetical_protein	7kja-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	7kja-assembly2.cif.gz_B Crystal structure of the EphA2 intracellular KD-SAM domains	0.107	326	213	20	345	23	261	1.657E-03	80
DESULFOASV1_1484_hypothetical_protein	3tku-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3tku-assembly1.cif.gz_B MRCK beta in complex with fasudil	0.122	341	236	20	360	74	343	1.827E-03	80
DESULFOASV1_1484_hypothetical_protein	6sgk-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6sgk-assembly1.cif.gz_A Nek2 kinase bound to inhibitor 102	0.116	335	202	20	354	5	233	1.357E-02	79
DESULFOASV1_1484_hypothetical_protein	4afe-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4afe-assembly1.cif.gz_A Nek2 bound to hybrid compound 21	0.114	335	207	20	354	5	239	7.187E-03	79
DESULFOASV1_1484_hypothetical_protein	2xnp-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2xnp-assembly1.cif.gz_A Structure of Nek2 bound to CCT244858	0.127	335	204	20	354	5	239	1.293E-02	79
DESULFOASV1_1484_hypothetical_protein	6uuo-assembly2.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6uuo-assembly2.cif.gz_A Crystal structure of BRAF kinase domain bound to the PROTAC P4B	0.107	317	206	42	358	15	246	1.497E-02	79
DESULFOASV1_1484_hypothetical_protein	8tb5-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8tb5-assembly1.cif.gz_A TYK2 JH2 bound to Compound7	0.087	333	224	26	358	10	255	1.116E-02	79
DESULFOASV1_1484_hypothetical_protein	6nzq-assembly3.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6nzq-assembly3.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_29 AKA 6-[(5-FLUORO-4-METH YLPYRIDIN-2-YL)AMINO]-4-({2-METHOXY-3-[(PYRIDIN-2-YLMETHYL )CARBAMOYL]PHENYL}AMINO)-N-METHYLPYRIDINE-3-CARBOXAMIDE	0.088	339	225	20	358	9	256	1.572E-02	79
DESULFOASV1_1484_hypothetical_protein	8bin-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8bin-assembly1.cif.gz_A Crystal structure of human Ephrin type-A receptor 2 (EPHA2) Kinase domain in complex with MR21	0.111	300	205	46	345	18	249	8.740E-03	79
DESULFOASV1_1484_hypothetical_protein	1g5s-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1g5s-assembly1.cif.gz_A CRYSTAL STRUCTURE OF HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) IN COMPLEX WITH THE INHIBITOR H717	0.109	338	229	20	357	3	260	4.860E-03	79
DESULFOASV1_1484_hypothetical_protein	3ig7-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3ig7-assembly1.cif.gz_A Novel CDK-5 inhibitors - crystal structure of inhibitor EFP with CDK-2	0.112	337	230	20	356	3	262	5.628E-03	79
DESULFOASV1_1484_hypothetical_protein	4nj3-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4nj3-assembly1.cif.gz_A Modulating the interaction between CDK2 and Cyclin A with a Quinoline-based inhibitor	0.112	337	230	20	356	3	262	2.015E-03	79
DESULFOASV1_1484_hypothetical_protein	3zc6-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3zc6-assembly1.cif.gz_A Crystal structure of JAK3 kinase domain in complex with an indazole substituted pyrrolopyrazine inhibitor	0.125	339	233	20	358	8	274	6.844E-03	79
DESULFOASV1_1484_hypothetical_protein	8ovz-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8ovz-assembly1.cif.gz_A Crystal structure of D1228V c-MET bound by compound 16	0.103	339	235	20	358	15	277	9.638E-03	79
DESULFOASV1_1484_hypothetical_protein	3pp0-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3pp0-assembly1.cif.gz_A Crystal Structure of the Kinase domain of Human HER2 (erbB2).	0.115	339	226	20	358	14	269	4.628E-03	79
DESULFOASV1_1484_hypothetical_protein	3f66-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3f66-assembly1.cif.gz_A Human c-Met Kinase in complex with quinoxaline inhibitor	0.094	355	248	4	358	2	276	3.451E-03	79
DESULFOASV1_1484_hypothetical_protein	1h0v-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1h0v-assembly1.cif.gz_A Human cyclin dependent protein kinase 2 in complex with the inhibitor 2-Amino-6-[(R)-pyrrolidino-5'-yl]methoxypurine	0.113	337	239	20	356	3	272	2.116E-03	79
DESULFOASV1_1484_hypothetical_protein	6q3c-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6q3c-assembly1.cif.gz_A CDK2 in complex with FragLite1	0.104	316	234	41	356	12	273	2.838E-03	79
DESULFOASV1_1484_hypothetical_protein	2clx-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2clx-assembly1.cif.gz_A 4-Arylazo-3,5-diamino-1H-pyrazole CDK Inhibitors: SAR Study, Crystal Structure in Complex with CDK2, Selectivity, and Cellular Effects	0.105	337	245	20	356	3	277	5.359E-03	79
DESULFOASV1_1484_hypothetical_protein	4eol-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	4eol-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 H84S, Q85M, K89D - human cyclin A3 complex with the inhibitor RO3306	0.104	331	249	26	356	7	285	1.297E-03	79
DESULFOASV1_1484_hypothetical_protein	1zrz-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1zrz-assembly1.cif.gz_A Crystal Structure of the Catalytic Domain of Atypical Protein Kinase C-iota	0.120	310	227	20	329	5	263	3.996E-03	79
DESULFOASV1_1484_hypothetical_protein	5li9-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5li9-assembly1.cif.gz_A Structure of a nucleotide-bound form of PKCiota core kinase domain	0.110	333	211	20	352	7	244	4.197E-03	79
DESULFOASV1_1484_hypothetical_protein	7a52-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	7a52-assembly2.cif.gz_B Structure of DYRK1A in complex with compound 6	0.078	338	285	21	358	18	327	2.450E-03	79
DESULFOASV1_1484_hypothetical_protein	3gb2-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3gb2-assembly1.cif.gz_A GSK3beta inhibitor complex	0.077	338	257	21	358	20	298	9.638E-03	79
DESULFOASV1_1484_hypothetical_protein	4nm5-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4nm5-assembly1.cif.gz_A Crystal structure of GSK-3/Axin complex bound to phosphorylated Wnt receptor LRP6 c-motif	0.105	338	256	21	358	31	317	7.926E-03	79
DESULFOASV1_1484_hypothetical_protein	7ejv-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	7ejv-assembly1.cif.gz_B The co-crystal structure of DYRK2 with YK-2-69	0.102	249	164	21	269	70	253	5.910E-03	79
DESULFOASV1_1484_hypothetical_protein	4y93-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4y93-assembly1.cif.gz_A Crystal structure of the PH-TH-kinase construct of Bruton's tyrosine kinase (Btk)	0.140	357	220	2	358	166	422	9.213E-04	79
DESULFOASV1_1484_hypothetical_protein	5fd2-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5fd2-assembly1.cif.gz_B B-Raf wild-type kinase domain in complex with a purinylpyridinylamino-based inhibitor	0.107	312	192	47	358	13	228	1.012E-02	78
DESULFOASV1_1484_hypothetical_protein	7p3v-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7p3v-assembly1.cif.gz_A B-Raf V600E structure bound to a new inhibitor	0.121	340	213	19	358	9	251	6.206E-03	78
DESULFOASV1_1484_hypothetical_protein	6nzr-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6nzr-assembly1.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_12 AKA 4-[(2-methanesulfonylphenyl)amino]-N-(H3)methyl-6-[(pyridin-2- yl)amino]pyridazine-3-carboxamide	0.087	333	226	26	358	10	257	1.820E-02	78
DESULFOASV1_1484_hypothetical_protein	4xli-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4xli-assembly2.cif.gz_B Crystal structure of Abl2/Arg kinase in complex with dasatinib	0.092	312	215	47	358	20	257	5.628E-03	78
DESULFOASV1_1484_hypothetical_protein	3v5q-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3v5q-assembly2.cif.gz_B Discovery of a selective TRK Inhibitor with efficacy in rodent cancer tumor models	0.111	339	219	20	358	11	257	3.996E-03	78
DESULFOASV1_1484_hypothetical_protein	2iw8-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	2iw8-assembly2.cif.gz_C STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR	0.103	339	222	20	358	4	251	3.451E-03	78
DESULFOASV1_1484_hypothetical_protein	3dko-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3dko-assembly1.cif.gz_A Complex between the kinase domain of human ephrin type-a receptor 7 (epha7) and inhibitor alw-ii-49-7	0.123	318	209	42	359	37	275	3.996E-03	78
DESULFOASV1_1484_hypothetical_protein	5i4n-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5i4n-assembly1.cif.gz_A Crystal Structure of the E596A V617F Mutant JAK2 Pseudokinase Domain Bound to Mg-ATP	0.106	339	233	20	358	8	269	6.206E-03	78
DESULFOASV1_1484_hypothetical_protein	2xck-assembly1.cif.gz_A-2	DESULFOASV1_1484_hypothetical_protein	2xck-assembly1.cif.gz_A-2 Crystal structure of PDK1 in complex with a pyrazoloquinazoline inhibitor	0.106	325	204	20	344	6	234	1.172E-02	78
DESULFOASV1_1484_hypothetical_protein	7s84-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7s84-assembly1.cif.gz_A Crystal structure of CDK2 liganded with compound TW8972	0.102	338	237	20	357	3	267	5.628E-03	78
DESULFOASV1_1484_hypothetical_protein	7lgs-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	7lgs-assembly3.cif.gz_C Structure of EGFR_D770_N771insNPG/V948R in complex with covalent inhibitor Osimertinib.	0.101	333	229	26	358	12	267	2.838E-03	78
DESULFOASV1_1484_hypothetical_protein	5nk5-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5nk5-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 1m	0.089	319	226	40	358	15	263	6.517E-03	78
DESULFOASV1_1484_hypothetical_protein	5tq3-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5tq3-assembly2.cif.gz_B Design and Synthesis of a pan-JAK kinase inhibitor clinical candidate (PF-06263276) suitable for the treatment of inflammatory diseases of the lungs and skin	0.089	339	248	20	358	6	278	8.740E-03	78
DESULFOASV1_1484_hypothetical_protein	6vnk-assembly4.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6vnk-assembly4.cif.gz_A JAK2 JH1 in complex with PN4-073	0.095	339	248	20	358	14	288	7.187E-03	78
DESULFOASV1_1484_hypothetical_protein	3ocb-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3ocb-assembly1.cif.gz_A Akt1 kinase domain with pyrrolopyrimidine inhibitor	0.111	341	266	20	360	6	305	4.407E-03	78
DESULFOASV1_1484_hypothetical_protein	3oht-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3oht-assembly1.cif.gz_B Crystal Structure of Salmo Salar p38alpha	0.111	338	239	22	359	20	289	5.649E-04	78
DESULFOASV1_1484_hypothetical_protein	4nct-assembly5.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4nct-assembly5.cif.gz_B Human DYRK1A in complex with PKC412	0.094	338	273	21	358	27	328	2.838E-03	78
DESULFOASV1_1484_hypothetical_protein	4ppc-assembly3.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4ppc-assembly3.cif.gz_B ITK kinase domain with compound 27 (N-{1-[(1R)-3-(DIMETHYLAMINO)-1-PHENYLPROPYL]-1H-PYRAZOL-4-YL}-6-(1H-PYRAZOL-4-YL)-1H-INDAZOLE-3-CARBOXAMIDE)	0.129	337	189	22	358	7	224	7.547E-03	77
DESULFOASV1_1484_hypothetical_protein	6sgh-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6sgh-assembly1.cif.gz_A Nek2 kinase covalently bound to 2-arylamino-6-ethynylpurine inhibitor 66	0.100	335	197	20	354	5	224	1.063E-02	77
DESULFOASV1_1484_hypothetical_protein	4kio-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4kio-assembly1.cif.gz_A Kinase domain mutant of human Itk in complex with a covalently-binding inhibitor	0.110	337	200	22	358	8	233	5.103E-03	77
DESULFOASV1_1484_hypothetical_protein	5tkd-assembly3.cif.gz_A-2	DESULFOASV1_1484_hypothetical_protein	5tkd-assembly3.cif.gz_A-2 CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH 6-[(3,5-DIMETHYLPHE NYL)AMINO]-8- (METHYLAMINO)IMIDAZO[1,2-B]PYRIDAZINE-3-CARBO XAMIDE	0.090	333	211	26	358	9	241	1.820E-02	77
DESULFOASV1_1484_hypothetical_protein	4r5y-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4r5y-assembly1.cif.gz_A The complex structure of Braf V600E kinase domain with a novel Braf inhibitor	0.111	340	213	19	358	7	247	4.197E-03	77
DESULFOASV1_1484_hypothetical_protein	6nzp-assembly3.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6nzp-assembly3.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH COMPOUND-11 AKA 6-CYCLOPROPANEAMIDO-4-{[2-METHOXY-3-(1-METHYL-1H-1,2,4-TRI AZOL-3-YL)PHENYL]AMINO}-N-(?H?)METHYLPYRIDAZINE-3-CARBOXAMIDE	0.087	333	226	26	358	10	258	1.912E-02	77
DESULFOASV1_1484_hypothetical_protein	8s9a-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	8s9a-assembly3.cif.gz_C Crystal structure of the TYK2 pseudokinase domain in complex with TAK-279	0.109	338	223	22	359	11	261	1.357E-02	77
DESULFOASV1_1484_hypothetical_protein	5d1j-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5d1j-assembly1.cif.gz_A CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 (CDK2-WT) COMPLEX WITH N-[5-[[[5-(1,1-DIMETHYLETHYL)-2-OXAZOLYL] METHYL]THIO]-2-THIAZOLYL]-4-PIPERIDINECARBOXAMIDE (BMS-387032)	0.101	329	218	26	354	4	247	3.624E-03	77
DESULFOASV1_1484_hypothetical_protein	2w5h-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2w5h-assembly1.cif.gz_A Human Nek2 kinase Apo	0.117	335	217	20	354	5	251	5.103E-03	77
DESULFOASV1_1484_hypothetical_protein	6aak-assembly2.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	6aak-assembly2.cif.gz_D Crystal structure of JAK3 in complex with peficitinib	0.114	339	228	20	358	8	265	1.357E-02	77
DESULFOASV1_1484_hypothetical_protein	6n0p-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6n0p-assembly1.cif.gz_A BRAF in complex with N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide (LXH254)	0.113	340	225	19	358	7	261	1.297E-03	77
DESULFOASV1_1484_hypothetical_protein	8a2b-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8a2b-assembly1.cif.gz_A EGFR kinase domain (L858R/V948R) in complex with 2-(6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-1-yl)-2-[6-[2-[4-[[4-(hydroxymethyl)-1-piperidyl]methyl]phenyl]ethynyl]-1-oxo-4-(trifluoromethyl)isoindolin-2-yl]-N-thiazol-2-yl-acetamide	0.131	328	215	20	347	10	257	1.172E-02	77
DESULFOASV1_1484_hypothetical_protein	8c09-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8c09-assembly1.cif.gz_A Crystal structure of JAK2 JH2-I559F	0.105	339	234	20	358	7	268	5.910E-03	77
DESULFOASV1_1484_hypothetical_protein	8b8n-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8b8n-assembly1.cif.gz_A Crystal structure of JAK2 JH2-V617F in complex with Cdk2 inhibitor IV	0.088	339	238	20	358	9	270	3.996E-03	77
DESULFOASV1_1484_hypothetical_protein	8cur-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8cur-assembly1.cif.gz_A Crystal structure of Cdk2 in complex with Cyclin A inhibitor 6-[(E)-2-(4-chlorophenyl)ethenyl]-2-{[(2R)-3-(4-hydroxyphenyl)-1-methoxy-1-oxopropan-2-yl]carbamoyl}quinoline-4-carboxylic acid	0.114	337	228	20	356	3	260	6.844E-03	77
DESULFOASV1_1484_hypothetical_protein	2j9m-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2j9m-assembly1.cif.gz_A Crystal Structure of CDK2 in complex with Macrocyclic Aminopyrimidine	0.105	337	229	20	356	3	259	7.547E-03	77
DESULFOASV1_1484_hypothetical_protein	7juw-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	7juw-assembly1.cif.gz_B Crystal Structure of KSR1:MEK1 in complex with AMP-PNP	0.123	338	228	21	358	13	273	1.827E-03	77
DESULFOASV1_1484_hypothetical_protein	4gg7-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4gg7-assembly1.cif.gz_A Crystal structure of cMET in complex with novel inhibitor	0.111	339	230	20	358	12	271	1.827E-03	77
DESULFOASV1_1484_hypothetical_protein	1r1w-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1r1w-assembly1.cif.gz_A CRYSTAL STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HEPATOCYTE GROWTH FACTOR RECEPTOR C-MET	0.108	355	232	4	358	4	264	4.011E-04	77
DESULFOASV1_1484_hypothetical_protein	6gub-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	6gub-assembly2.cif.gz_C CDK2/CyclinA in complex with Flavopiridol	0.101	340	251	20	359	4	283	7.547E-03	77
DESULFOASV1_1484_hypothetical_protein	6gue-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6gue-assembly1.cif.gz_A CDK2/CyclinA in complex with AZD5438	0.098	339	246	20	358	4	277	2.222E-03	77
DESULFOASV1_1484_hypothetical_protein	2cci-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	2cci-assembly2.cif.gz_C Crystal structure of phospho-CDK2 Cyclin A in complex with a peptide containing both the substrate and recruitment sites of CDC6	0.099	339	255	20	358	4	287	3.451E-03	77
DESULFOASV1_1484_hypothetical_protein	6jz0-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6jz0-assembly1.cif.gz_A Crystal structure of EGFR kinase domain in complex with compound 78	0.128	330	232	20	349	16	282	3.805E-03	77
DESULFOASV1_1484_hypothetical_protein	7z5n-assembly5.cif.gz_E	DESULFOASV1_1484_hypothetical_protein	7z5n-assembly5.cif.gz_E Crystal structure of DYRK1A in complex with CX-4945	0.083	338	283	21	358	25	334	3.129E-03	77
DESULFOASV1_1484_hypothetical_protein	6s1i-assembly4.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	6s1i-assembly4.cif.gz_D Crystal Structure of DYRK1A with small molecule inhibitor	0.087	338	287	21	358	25	339	4.197E-03	77
DESULFOASV1_1484_hypothetical_protein	6nsl-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6nsl-assembly1.cif.gz_A CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound-6c AKA 6-((1-(4-CYANOPHENY L)-2-OXO-1,2-DIHYDRO-3-PYRIDINYL)AMINO)-N-CYCLOPROPYL-8-(M ETHYLAMINO)IMIDAZO[1,2-B]PYRIDAZINE-3-CARBOXAMIDE	0.080	333	220	26	358	9	248	8.740E-03	76
DESULFOASV1_1484_hypothetical_protein	8tb6-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	8tb6-assembly2.cif.gz_B TYK2 JH2 bound to Compound14	0.100	340	221	20	359	9	254	1.012E-02	76
DESULFOASV1_1484_hypothetical_protein	6nzp-assembly2.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6nzp-assembly2.cif.gz_A CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH COMPOUND-11 AKA 6-CYCLOPROPANEAMIDO-4-{[2-METHOXY-3-(1-METHYL-1H-1,2,4-TRI AZOL-3-YL)PHENYL]AMINO}-N-(?H?)METHYLPYRIDAZINE-3-CARBOXAMIDE	0.090	333	224	26	358	10	256	2.108E-02	76
DESULFOASV1_1484_hypothetical_protein	7mgk-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7mgk-assembly1.cif.gz_A TNNI3K complexed with 1-(3,5-dichloro-4-((6-(methylamino)pyrimidin-4-yl)oxy)phenyl)-3-(3-(trifluoromethyl)phenyl)urea	0.123	339	207	20	358	19	255	7.926E-03	76
DESULFOASV1_1484_hypothetical_protein	2a1a-assembly1.cif.gz_B-2	DESULFOASV1_1484_hypothetical_protein	2a1a-assembly1.cif.gz_B-2 PKR kinase domain-eIF2alpha Complex	0.118	337	223	22	358	12	265	2.325E-02	76
DESULFOASV1_1484_hypothetical_protein	8b9e-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8b9e-assembly1.cif.gz_A Crystal structure of JAK2 JH2-V617F in complex with Z902-A3	0.097	339	236	20	358	9	270	1.172E-02	76
DESULFOASV1_1484_hypothetical_protein	6hes-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6hes-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative AT050	0.113	331	222	20	350	14	264	5.628E-03	76
DESULFOASV1_1484_hypothetical_protein	6hey-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6hey-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATNK002	0.111	331	225	20	350	13	266	2.214E-02	76
DESULFOASV1_1484_hypothetical_protein	2phk-assembly1.cif.gz_A-2	DESULFOASV1_1484_hypothetical_protein	2phk-assembly1.cif.gz_A-2 THE CRYSTAL STRUCTURE OF A PHOSPHORYLASE KINASE PEPTIDE SUBSTRATE COMPLEX: KINASE SUBSTRATE RECOGNITION	0.090	341	247	20	360	5	276	5.628E-03	76
DESULFOASV1_1484_hypothetical_protein	1h25-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	1h25-assembly2.cif.gz_C CDK2/Cyclin A in complex with an 11-residue recruitment peptide from retinoblastoma-associated protein	0.100	338	239	20	357	4	269	5.359E-03	76
DESULFOASV1_1484_hypothetical_protein	6q7b-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6q7b-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATDL09	0.097	339	217	20	358	14	254	1.357E-02	76
DESULFOASV1_1484_hypothetical_protein	2b52-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2b52-assembly1.cif.gz_A Human cyclin dependent kinase 2 (CDK2) complexed with DPH-042562	0.101	317	228	41	357	14	268	3.996E-03	76
DESULFOASV1_1484_hypothetical_protein	5mrd-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5mrd-assembly1.cif.gz_A Human PDK1-PKCiota Kinase Chimera in Complex with Allosteric Compound PS267 Bound to the PIF-Pocket	0.101	325	212	20	344	6	242	9.178E-03	76
DESULFOASV1_1484_hypothetical_protein	7v3r-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7v3r-assembly1.cif.gz_A Crystal structure of CMET in complex with a novel inhibitor	0.101	340	247	4	343	1	276	6.844E-03	76
DESULFOASV1_1484_hypothetical_protein	4u3z-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4u3z-assembly2.cif.gz_B APO MAP4K4 T181E Phosphomimetic Mutant	0.117	322	243	37	358	14	289	4.860E-03	76
DESULFOASV1_1484_hypothetical_protein	4u45-assembly3.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4u45-assembly3.cif.gz_B MAP4K4 in complex with inhibitor (compound 25)	0.121	314	222	47	360	23	275	2.450E-03	76
DESULFOASV1_1484_hypothetical_protein	3unk-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3unk-assembly1.cif.gz_A CDK2 in complex with inhibitor YL5-083	0.109	336	247	22	357	3	280	6.206E-03	76
DESULFOASV1_1484_hypothetical_protein	7nxj-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	7nxj-assembly2.cif.gz_C Crystal structure of human Cdk13/Cyclin K in complex with the inhibitor THZ531	0.115	335	255	20	354	10	298	4.860E-03	76
DESULFOASV1_1484_hypothetical_protein	7a5n-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	7a5n-assembly2.cif.gz_B Structure of DYRK1A in complex with compound 34	0.094	337	274	22	358	21	323	2.222E-03	76
DESULFOASV1_1484_hypothetical_protein	5a3x-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	5a3x-assembly3.cif.gz_C DYRK1A in complex with hydroxy benzothiazole fragment	0.086	340	282	21	360	26	334	3.624E-03	76
DESULFOASV1_1484_hypothetical_protein	5he2-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5he2-assembly1.cif.gz_A Bovine GRK2 in complex with Gbetagamma subunits and CCG224406	0.120	314	239	20	333	161	433	5.359E-03	76
DESULFOASV1_1484_hypothetical_protein	2xkc-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2xkc-assembly1.cif.gz_A Structure of Nek2 bound to aminopyrazine compound 14	0.117	335	199	20	354	5	230	1.733E-02	75
DESULFOASV1_1484_hypothetical_protein	3zfx-assembly5.cif.gz_E	DESULFOASV1_1484_hypothetical_protein	3zfx-assembly5.cif.gz_E Crystal structure of EphB1	0.116	330	223	20	349	8	260	1.357E-02	75
DESULFOASV1_1484_hypothetical_protein	3lmg-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3lmg-assembly2.cif.gz_B Crystal structure of the ERBB3 kinase domain in complex with AMP-PNP	0.113	324	224	20	343	10	262	5.910E-03	75
DESULFOASV1_1484_hypothetical_protein	1dm2-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1dm2-assembly1.cif.gz_A HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR HYMENIALDISINE	0.110	335	227	22	356	3	258	1.172E-02	75
DESULFOASV1_1484_hypothetical_protein	6q7c-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6q7c-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative ATDL11	0.102	339	214	20	358	14	252	1.820E-02	75
DESULFOASV1_1484_hypothetical_protein	2rei-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2rei-assembly1.cif.gz_A Kinase domain of human ephrin type-A receptor 7 (Epha7)	0.138	339	206	20	358	26	265	4.197E-03	75
DESULFOASV1_1484_hypothetical_protein	1f5q-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	1f5q-assembly2.cif.gz_C CRYSTAL STRUCTURE OF MURINE GAMMA HERPESVIRUS CYCLIN COMPLEXED TO HUMAN CYCLIN DEPENDENT KINASE 2	0.100	322	238	37	358	8	272	4.860E-03	75
DESULFOASV1_1484_hypothetical_protein	6ej4-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	6ej4-assembly3.cif.gz_C DYRK1A in complex with XMD7-112	0.089	338	274	21	358	25	326	3.996E-03	75
DESULFOASV1_1484_hypothetical_protein	7a53-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	7a53-assembly2.cif.gz_B Structure of DYRK1A in complex with compound 7	0.079	338	285	21	358	18	327	4.407E-03	75
DESULFOASV1_1484_hypothetical_protein	2xno-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2xno-assembly1.cif.gz_A Structure of Nek2 bound to CCT243779	0.117	335	205	20	354	5	237	1.572E-02	74
DESULFOASV1_1484_hypothetical_protein	8s98-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8s98-assembly1.cif.gz_A Crystal structure of the TYK2 pseudokinase domain in complex with compound 8	0.093	338	222	22	359	11	256	1.572E-02	74
DESULFOASV1_1484_hypothetical_protein	7mgk-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	7mgk-assembly2.cif.gz_B TNNI3K complexed with 1-(3,5-dichloro-4-((6-(methylamino)pyrimidin-4-yl)oxy)phenyl)-3-(3-(trifluoromethyl)phenyl)urea	0.133	339	203	20	358	19	253	1.651E-02	74
DESULFOASV1_1484_hypothetical_protein	8s99-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8s99-assembly1.cif.gz_A Crystal structure of the TYK2 pseudokinase domain in complex with compound 11	0.091	339	225	20	358	11	259	2.108E-02	74
DESULFOASV1_1484_hypothetical_protein	8s9a-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	8s9a-assembly2.cif.gz_B Crystal structure of the TYK2 pseudokinase domain in complex with TAK-279	0.089	334	229	26	359	12	263	2.108E-02	74
DESULFOASV1_1484_hypothetical_protein	5ia0-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	5ia0-assembly3.cif.gz_C Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with alisertib (MLN8237)	0.120	341	219	20	360	13	262	3.996E-03	74
DESULFOASV1_1484_hypothetical_protein	6cn9-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6cn9-assembly1.cif.gz_A Crystal structure of the Kinase domain of WNK1	0.127	342	230	18	359	8	271	7.547E-03	74
DESULFOASV1_1484_hypothetical_protein	5nka-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5nka-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2g	0.113	331	226	20	350	8	263	2.450E-03	74
DESULFOASV1_1484_hypothetical_protein	1p2a-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1p2a-assembly1.cif.gz_A The structure of cyclin dependent kinase 2 (CKD2) with a trisubstituted naphthostyril inhibitor	0.093	338	233	22	359	3	260	4.197E-03	74
DESULFOASV1_1484_hypothetical_protein	8c0a-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	8c0a-assembly2.cif.gz_B Crystal structure of JAK2 JH2-R683S	0.097	339	236	20	358	9	270	1.912E-02	74
DESULFOASV1_1484_hypothetical_protein	6hev-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6hev-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with the NVP-BHG712 derivative AT061	0.114	331	222	20	350	13	264	1.651E-02	74
DESULFOASV1_1484_hypothetical_protein	6fnh-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6fnh-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with a pyrazolo[3,4-d]pyrimidine fragment of NVP-BHG712	0.115	341	230	20	360	11	271	8.740E-03	74
DESULFOASV1_1484_hypothetical_protein	5hg7-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5hg7-assembly1.cif.gz_A EGFR (L858R, T790M, V948R) in complex with 1-{(3R,4R)-3-[5-Chloro-2-(1-methyl-1H-pyrazol-4-ylamino)-7H-pyrrolo[2,3-d]pyrimidin-4-yloxymethyl]-4-methoxy-pyrrolidin-1-yl}propenone (PF-06459988)	0.124	339	223	20	358	10	264	4.407E-03	74
DESULFOASV1_1484_hypothetical_protein	3bu5-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3bu5-assembly1.cif.gz_A Crystal structure of the insulin receptor kinase in complex with IRS2 KRLB peptide and ATP	0.095	339	240	20	358	9	274	4.197E-03	74
DESULFOASV1_1484_hypothetical_protein	4u44-assembly3.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4u44-assembly3.cif.gz_B MAP4K4 in complex with inhibitor (compound 16)	0.128	340	230	21	360	12	276	2.450E-03	74
DESULFOASV1_1484_hypothetical_protein	3zh8-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	3zh8-assembly3.cif.gz_C A novel small molecule aPKC inhibitor	0.133	357	242	3	359	1	280	2.702E-03	74
DESULFOASV1_1484_hypothetical_protein	8p04-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8p04-assembly1.cif.gz_A Crystal structure of human CLK1 in complex with Leucettinib-92	0.113	332	272	22	353	14	321	9.178E-03	74
DESULFOASV1_1484_hypothetical_protein	4j1r-assembly5.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4j1r-assembly5.cif.gz_B Crystal Structure of GSK3b in complex with inhibitor 15R	0.086	336	258	23	358	21	303	4.860E-03	74
DESULFOASV1_1484_hypothetical_protein	2vd5-assembly2.cif.gz_B-3	DESULFOASV1_1484_hypothetical_protein	2vd5-assembly2.cif.gz_B-3 Structure of Human Myotonic Dystrophy Protein Kinase in Complex with the Bisindoylmaleide inhibitor BIM VIII	0.127	327	237	22	348	60	331	6.844E-03	74
DESULFOASV1_1484_hypothetical_protein	2j0k-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	2j0k-assembly2.cif.gz_B Crystal structure of a fragment of focal adhesion kinase containing the FERM and kinase domains.	0.118	339	213	20	358	361	602	1.657E-03	74
DESULFOASV1_1484_hypothetical_protein	7k7l-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7k7l-assembly1.cif.gz_A Structure of a hit for G Protein Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure	0.114	341	235	20	360	161	426	1.431E-03	74
DESULFOASV1_1484_hypothetical_protein	5nk8-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5nk8-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 2f	0.108	307	216	44	350	18	260	8.740E-03	73
DESULFOASV1_1484_hypothetical_protein	4cfm-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	4cfm-assembly2.cif.gz_C Structure-based design of C8-substituted O6-cyclohexylmethoxyguanine CDK1 and 2 inhibitors.	0.097	340	229	20	359	4	258	8.740E-03	73
DESULFOASV1_1484_hypothetical_protein	4riw-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4riw-assembly1.cif.gz_A Crystal structure of an EGFR/HER3 kinase domain heterodimer	0.120	324	222	20	343	10	262	3.129E-03	73
DESULFOASV1_1484_hypothetical_protein	6bss-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6bss-assembly1.cif.gz_A JAK2 JH2 in complex with NU6102	0.106	339	232	20	358	8	268	7.547E-03	73
DESULFOASV1_1484_hypothetical_protein	4l01-assembly3.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4l01-assembly3.cif.gz_B Crystal structure of the V658F apo Jak1 pseudokinase domain	0.086	339	230	20	358	18	270	2.325E-02	73
DESULFOASV1_1484_hypothetical_protein	4riy-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	4riy-assembly2.cif.gz_C Crystal structure of an EGFR/HER3 kinase domain heterodimer containing the cancer-associated HER3-E909G mutation	0.108	322	230	22	343	10	268	2.015E-03	73
DESULFOASV1_1484_hypothetical_protein	2vu3-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2vu3-assembly1.cif.gz_A Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design.	0.092	340	246	20	359	3	274	1.116E-02	73
DESULFOASV1_1484_hypothetical_protein	6yl1-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6yl1-assembly1.cif.gz_A Cdk2(F80C) with Covalent Adduct TK37 at F80C	0.103	338	237	20	357	8	272	5.359E-03	73
DESULFOASV1_1484_hypothetical_protein	5nkg-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5nkg-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with Compound 3d	0.119	331	243	20	350	8	284	4.407E-03	73
DESULFOASV1_1484_hypothetical_protein	4riy-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4riy-assembly1.cif.gz_B Crystal structure of an EGFR/HER3 kinase domain heterodimer containing the cancer-associated HER3-E909G mutation	0.114	339	224	20	358	24	277	7.926E-03	73
DESULFOASV1_1484_hypothetical_protein	5cnn-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5cnn-assembly2.cif.gz_B Crystal structure of the EGFR kinase domain mutant I682Q	0.117	339	217	20	358	12	258	4.197E-03	73
DESULFOASV1_1484_hypothetical_protein	7ak2-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	7ak2-assembly2.cif.gz_B Structure of DYRK1A in complex with compound 53	0.106	249	165	21	269	18	203	1.912E-02	73
DESULFOASV1_1484_hypothetical_protein	3anq-assembly4.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	3anq-assembly4.cif.gz_D human DYRK1A/inhibitor complex	0.092	338	278	21	358	24	330	4.860E-03	73
DESULFOASV1_1484_hypothetical_protein	3anr-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	3anr-assembly3.cif.gz_C human DYRK1A/harmine complex	0.094	338	276	21	358	26	331	6.844E-03	73
DESULFOASV1_1484_hypothetical_protein	6zr5-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6zr5-assembly1.cif.gz_A Crystal structure of JNK1 in complex with ATF2(19-58)	0.089	336	258	22	357	23	306	1.740E-03	73
DESULFOASV1_1484_hypothetical_protein	1zth-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	1zth-assembly2.cif.gz_B Crystal Structure of A.fulgidus Rio1 serine protein kinase bound to ADP and Manganese ion	0.118	290	186	4	293	29	240	3.981E-02	72
DESULFOASV1_1484_hypothetical_protein	6sgd-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6sgd-assembly1.cif.gz_A Nek2 kinase covalently bound to 2-arylamino-6-ethynylpurine inhibitor 24	0.123	335	201	20	354	5	234	8.323E-03	72
DESULFOASV1_1484_hypothetical_protein	6sgi-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6sgi-assembly1.cif.gz_A Nek2 kinase bound to inhibitor 96	0.123	335	204	20	354	5	238	2.692E-02	72
DESULFOASV1_1484_hypothetical_protein	8s99-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	8s99-assembly2.cif.gz_B Crystal structure of the TYK2 pseudokinase domain in complex with compound 11	0.092	334	227	26	359	11	261	1.651E-02	72
DESULFOASV1_1484_hypothetical_protein	8tb6-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8tb6-assembly1.cif.gz_A TYK2 JH2 bound to Compound14	0.096	333	221	26	358	16	260	5.910E-03	72
DESULFOASV1_1484_hypothetical_protein	2wmb-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	2wmb-assembly2.cif.gz_C Structural and thermodynamic consequences of cyclization of peptide ligands for the recruitment site of cyclin A	0.106	334	226	26	359	5	258	9.638E-03	72
DESULFOASV1_1484_hypothetical_protein	6occ-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6occ-assembly1.cif.gz_A JAK2 JH2 in complex with JAK190	0.104	339	230	20	358	8	265	2.007E-02	72
DESULFOASV1_1484_hypothetical_protein	4riy-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4riy-assembly1.cif.gz_A Crystal structure of an EGFR/HER3 kinase domain heterodimer containing the cancer-associated HER3-E909G mutation	0.118	324	222	20	343	10	262	2.015E-03	72
DESULFOASV1_1484_hypothetical_protein	2bts-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2bts-assembly1.cif.gz_A STRUCTURE OF CDK2 COMPLEXED WITH PNU-230032	0.098	340	235	20	359	3	263	1.820E-02	72
DESULFOASV1_1484_hypothetical_protein	5lvp-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5lvp-assembly2.cif.gz_B Human PDK1 Kinase Domain in Complex with an HM-Peptide Bound to the PIF-Pocket	0.114	332	237	20	351	8	276	2.007E-02	72
DESULFOASV1_1484_hypothetical_protein	5i9x-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5i9x-assembly1.cif.gz_A Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with bosutinib (SKI-606)	0.105	331	236	20	350	9	273	3.624E-03	72
DESULFOASV1_1484_hypothetical_protein	1y91-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1y91-assembly1.cif.gz_A Crystal structure of human CDK2 complexed with a pyrazolo[1,5-a]pyrimidine inhibitor	0.104	331	238	26	356	4	270	1.231E-02	72
DESULFOASV1_1484_hypothetical_protein	2vz6-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	2vz6-assembly2.cif.gz_B Structure of human calcium calmodulin dependent protein kinase type II alpha (CAMK2A) in complex with Indirubin E804	0.117	319	247	21	339	7	287	5.628E-03	72
DESULFOASV1_1484_hypothetical_protein	5ig1-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5ig1-assembly1.cif.gz_A Crystal structure of S. rosetta CaMKII kinase domain	0.097	333	253	26	358	11	291	1.572E-02	72
DESULFOASV1_1484_hypothetical_protein	5a54-assembly4.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	5a54-assembly4.cif.gz_D DYRK1A IN COMPLEX WITH NITRO BENZOTHIAZOLE FRAGMENT	0.089	338	277	21	358	26	330	8.323E-03	72
DESULFOASV1_1484_hypothetical_protein	7a4w-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7a4w-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 3	0.093	338	280	21	358	24	333	7.187E-03	72
DESULFOASV1_1484_hypothetical_protein	3anq-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3anq-assembly1.cif.gz_A human DYRK1A/inhibitor complex	0.093	339	282	20	358	25	336	6.517E-03	72
DESULFOASV1_1484_hypothetical_protein	2jd5-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2jd5-assembly1.cif.gz_A Sky1p bound to Npl3p-derived substrate peptide	0.109	342	276	18	359	12	322	1.012E-02	72
DESULFOASV1_1484_hypothetical_protein	7ejv-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7ejv-assembly1.cif.gz_A The co-crystal structure of DYRK2 with YK-2-69	0.098	340	282	21	360	72	385	5.359E-03	72
DESULFOASV1_1484_hypothetical_protein	4lue-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4lue-assembly2.cif.gz_B Crystal Structure of HCK in complex with 7-[trans-4-(4-methylpiperazin-1-yl)cyclohexyl]-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (resulting from displacement of SKF86002)	0.101	339	203	20	358	178	404	4.407E-03	72
DESULFOASV1_1484_hypothetical_protein	6nzh-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6nzh-assembly1.cif.gz_A CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_40 AKA 6-cyclopropaneamido-4-[(2-methanesulfonylphenyl)amino]-N-methylpyridine-3-carboxamide	0.087	333	216	26	358	9	246	1.820E-02	71
DESULFOASV1_1484_hypothetical_protein	6qav-assembly2.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	6qav-assembly2.cif.gz_D Crystal structure of ULK2 in complexed with MRT68921	0.117	341	220	19	359	5	254	1.497E-02	71
DESULFOASV1_1484_hypothetical_protein	4h1m-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4h1m-assembly1.cif.gz_A Crystal structure of PYK2 with the indole 10c	0.129	339	209	20	358	5	245	1.231E-02	71
DESULFOASV1_1484_hypothetical_protein	5c03-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5c03-assembly1.cif.gz_A Crystal Structure of kinase	0.082	333	226	26	358	11	257	2.007E-02	71
DESULFOASV1_1484_hypothetical_protein	4cfv-assembly1.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	4cfv-assembly1.cif.gz_C Structure-based design of C8-substituted O6-cyclohexylmethoxyguanine CDK1 and 2 inhibitors.	0.102	340	226	20	359	4	256	6.206E-03	71
DESULFOASV1_1484_hypothetical_protein	8bio-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8bio-assembly1.cif.gz_A Crystal structure of human Ephrin type-A receptor 2 (EPHA2) Kinase domain in complex with MRAL5	0.091	313	211	46	358	18	250	1.497E-02	71
DESULFOASV1_1484_hypothetical_protein	4l01-assembly3.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4l01-assembly3.cif.gz_A Crystal structure of the V658F apo Jak1 pseudokinase domain	0.095	339	224	20	358	18	266	3.438E-02	71
DESULFOASV1_1484_hypothetical_protein	5fp6-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5fp6-assembly1.cif.gz_A Structure of cyclin-dependent kinase 2 with small-molecule ligand 3-(4,7-dichloro-1H-indol-3-yl)prop-2-yn-1-ol (AT17833) in an alternate binding site.	0.097	337	237	20	356	3	266	1.820E-02	71
DESULFOASV1_1484_hypothetical_protein	4obq-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4obq-assembly1.cif.gz_B MAP4K4 in complex with inhibitor (compound 31), N-[3-(4-AMINOQUINAZOLIN-6-YL)-5-FLUOROPHENYL]-2-(PYRROLIDIN-1-YL)ACETAMIDE	0.110	312	238	47	358	21	288	5.628E-03	71
DESULFOASV1_1484_hypothetical_protein	2xmy-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2xmy-assembly1.cif.gz_A Discovery and Characterisation of 2-Anilino-4-(thiazol-5-yl) pyrimidine Transcriptional CDK Inhibitors as Anticancer Agents	0.111	339	244	20	358	3	278	4.628E-03	71
DESULFOASV1_1484_hypothetical_protein	2iw6-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	2iw6-assembly2.cif.gz_C STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR	0.102	340	255	20	359	4	288	1.820E-02	71
DESULFOASV1_1484_hypothetical_protein	7z5n-assembly8.cif.gz_H	DESULFOASV1_1484_hypothetical_protein	7z5n-assembly8.cif.gz_H Crystal structure of DYRK1A in complex with CX-4945	0.097	339	250	21	359	25	302	9.178E-03	71
DESULFOASV1_1484_hypothetical_protein	3rtp-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3rtp-assembly1.cif.gz_A Design and synthesis of brain penetrant selective JNK inhibitors with improved pharmacokinetic properties for the prevention of neurodegeneration	0.109	337	227	22	358	18	273	1.657E-03	71
DESULFOASV1_1484_hypothetical_protein	6z2v-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6z2v-assembly1.cif.gz_A CLK3 A319V mutant bound with beta-carboline KH-CARB13 (Cpd 3)	0.095	319	279	22	340	22	330	8.740E-03	71
DESULFOASV1_1484_hypothetical_protein	5kpl-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5kpl-assembly1.cif.gz_A Glycogen Synthase Kinase 3 beta Complexed with BRD0705	0.114	336	244	23	358	21	296	3.451E-03	71
DESULFOASV1_1484_hypothetical_protein	4afj-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4afj-assembly2.cif.gz_B 5-aryl-4-carboxamide-1,3-oxazoles: potent and selective GSK-3 inhibitors	0.125	338	247	21	358	21	303	3.805E-03	71
DESULFOASV1_1484_hypothetical_protein	6ytw-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6ytw-assembly1.cif.gz_A CLK3 bound with benzothiazole Tg003 (Cpd 2)	0.093	294	266	47	340	46	339	3.996E-03	71
DESULFOASV1_1484_hypothetical_protein	6xr4-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6xr4-assembly1.cif.gz_B Integrative in situ structure of Parkinsons disease-linked human LRRK2	0.092	345	250	13	357	447	722	1.572E-02	71
DESULFOASV1_1484_hypothetical_protein	4mf0-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4mf0-assembly1.cif.gz_A ITK kinase domain in complex with benzothiazole inhibitor compound 12a (1S,2S)-2-{4-[(DIMETHYLAMINO)METHYL]PHENYL}-N-[6-(PYRIDIN-3-YL)-1,3-BENZOTHIAZOL-2-YL]CYCLOPROPANECARBOXAMIDE (12a)	0.106	339	203	20	358	6	233	4.628E-03	70
DESULFOASV1_1484_hypothetical_protein	4g9c-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4g9c-assembly1.cif.gz_A Human B-Raf Kinase Domain bound to a Type II Pyrazolopyridine Inhibitor	0.109	340	221	19	358	8	256	4.390E-02	70
DESULFOASV1_1484_hypothetical_protein	6vvg-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6vvg-assembly1.cif.gz_A Structure of the Cydia pomonella Granulovirus kinase, PK-1	0.096	356	240	5	360	1	267	2.969E-02	70
DESULFOASV1_1484_hypothetical_protein	2w5b-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2w5b-assembly1.cif.gz_A Human Nek2 kinase ATPgammaS-bound	0.120	335	222	20	354	5	257	1.116E-02	70
DESULFOASV1_1484_hypothetical_protein	2duv-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2duv-assembly1.cif.gz_A Structure of CDK2 with a 3-hydroxychromones	0.093	338	230	20	357	3	257	1.733E-02	70
DESULFOASV1_1484_hypothetical_protein	2rfe-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2rfe-assembly1.cif.gz_A Crystal structure of the complex between the EGFR kinase domain and a Mig6 peptide	0.108	339	222	20	358	11	260	7.926E-03	70
DESULFOASV1_1484_hypothetical_protein	7jxp-assembly2.cif.gz_E	DESULFOASV1_1484_hypothetical_protein	7jxp-assembly2.cif.gz_E EGFR kinase (T790M/V948R) in complex with osimertinib and JBJ-04-125-02	0.125	339	211	20	358	12	253	6.844E-03	70
DESULFOASV1_1484_hypothetical_protein	2x4f-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	2x4f-assembly2.cif.gz_B The Crystal Structure of the human myosin light chain kinase LOC340156.	0.094	339	232	21	359	24	280	2.108E-02	70
DESULFOASV1_1484_hypothetical_protein	2iw6-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2iw6-assembly1.cif.gz_A STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR	0.092	340	255	20	359	4	285	6.844E-03	70
DESULFOASV1_1484_hypothetical_protein	5eak-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5eak-assembly2.cif.gz_B Optimization of Microtubule Affinity Regulating Kinase (MARK) Inhibitors with Improved Physical Properties	0.106	332	224	19	350	1	251	2.441E-02	70
DESULFOASV1_1484_hypothetical_protein	4mq1-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	4mq1-assembly3.cif.gz_C The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor	0.097	249	164	21	269	25	207	1.497E-02	70
DESULFOASV1_1484_hypothetical_protein	5aik-assembly4.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	5aik-assembly4.cif.gz_D Human DYRK1A in complex with LDN-211898	0.090	338	283	21	358	26	337	8.740E-03	70
DESULFOASV1_1484_hypothetical_protein	5he0-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5he0-assembly1.cif.gz_A Bovine GRK2 in complex with Gbetagamma subunits and CCG215022	0.112	314	242	20	333	161	433	5.359E-03	70
DESULFOASV1_1484_hypothetical_protein	4mf0-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4mf0-assembly1.cif.gz_B ITK kinase domain in complex with benzothiazole inhibitor compound 12a (1S,2S)-2-{4-[(DIMETHYLAMINO)METHYL]PHENYL}-N-[6-(PYRIDIN-3-YL)-1,3-BENZOTHIAZOL-2-YL]CYCLOPROPANECARBOXAMIDE (12a)	0.133	323	195	23	345	7	232	1.572E-02	69
DESULFOASV1_1484_hypothetical_protein	6nzh-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6nzh-assembly1.cif.gz_B CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_40 AKA 6-cyclopropaneamido-4-[(2-methanesulfonylphenyl)amino]-N-methylpyridine-3-carboxamide	0.095	340	217	20	359	9	249	2.007E-02	69
DESULFOASV1_1484_hypothetical_protein	6nze-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6nze-assembly1.cif.gz_A CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) COMPLEXED WITH Compound_5 AKA 4-[(2-CARBAMOYLPHEN YL)AMINO]-6-[(5-FLUOROPYRIDIN-2-YL)AMINO]-N-METHYLPYRIDINE -3-CARBOXAMIDE	0.097	333	201	26	358	9	232	2.441E-02	69
DESULFOASV1_1484_hypothetical_protein	4c4j-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4c4j-assembly1.cif.gz_A Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1	0.114	339	222	21	359	10	260	1.172E-02	69
DESULFOASV1_1484_hypothetical_protein	6tfu-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6tfu-assembly1.cif.gz_A Crystal Structure of EGFR T790M/V948R in Complex with Covalent Pyrrolopyrimidine 14d	0.114	339	214	20	358	12	253	1.231E-02	69
DESULFOASV1_1484_hypothetical_protein	6qav-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6qav-assembly1.cif.gz_B Crystal structure of ULK2 in complexed with MRT68921	0.119	342	232	19	360	6	269	2.007E-02	69
DESULFOASV1_1484_hypothetical_protein	5uq3-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5uq3-assembly1.cif.gz_A Crystal structure of human Cdk2-Spy1-P27 ternary complex	0.095	311	238	49	359	2	265	2.007E-02	69
DESULFOASV1_1484_hypothetical_protein	4riw-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	4riw-assembly2.cif.gz_C Crystal structure of an EGFR/HER3 kinase domain heterodimer	0.113	318	228	26	343	11	268	3.451E-03	69
DESULFOASV1_1484_hypothetical_protein	4rix-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	4rix-assembly2.cif.gz_C Crystal structure of an EGFR/HER3 kinase domain heterodimer containing the cancer-associated HER3-Q790R mutation	0.110	318	229	26	343	11	268	2.702E-03	69
DESULFOASV1_1484_hypothetical_protein	2iw9-assembly2.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2iw9-assembly2.cif.gz_A STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR	0.104	340	251	20	359	4	284	6.206E-03	69
DESULFOASV1_1484_hypothetical_protein	6ytg-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6ytg-assembly1.cif.gz_A CLK1 bound with beta-carboline KH-CARB13 (Cpd 3)	0.101	309	276	37	345	22	329	4.407E-03	69
DESULFOASV1_1484_hypothetical_protein	5a4q-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5a4q-assembly2.cif.gz_B DYRK1A IN COMPLEX WITH CHLORO BENZOTHIAZOLE FRAGMENT	0.089	339	281	21	359	27	336	9.638E-03	69
DESULFOASV1_1484_hypothetical_protein	2vx3-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	2vx3-assembly3.cif.gz_C Crystal structure of the human dual specificity tyrosine- phosphorylation-regulated kinase 1A	0.083	338	282	21	358	25	332	5.910E-03	69
DESULFOASV1_1484_hypothetical_protein	6s1i-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	6s1i-assembly3.cif.gz_C Crystal Structure of DYRK1A with small molecule inhibitor	0.080	338	288	21	358	25	338	8.323E-03	69
DESULFOASV1_1484_hypothetical_protein	2jld-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	2jld-assembly1.cif.gz_B Extremely Tight Binding of Ruthenium Complex to Glycogen Synthase Kinase 3	0.124	338	250	21	358	20	305	6.206E-03	69
DESULFOASV1_1484_hypothetical_protein	3uzs-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3uzs-assembly1.cif.gz_A Structure of the C13.28 RNA Aptamer Bound to the G Protein-Coupled Receptor Kinase 2-Heterotrimeric G Protein Beta 1 and Gamma 2 Subunit Complex	0.106	340	229	20	359	162	418	4.628E-03	69
DESULFOASV1_1484_hypothetical_protein	4ppc-assembly3.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4ppc-assembly3.cif.gz_A ITK kinase domain with compound 27 (N-{1-[(1R)-3-(DIMETHYLAMINO)-1-PHENYLPROPYL]-1H-PYRAZOL-4-YL}-6-(1H-PYRAZOL-4-YL)-1H-INDAZOLE-3-CARBOXAMIDE)	0.131	337	190	22	358	7	226	2.325E-02	68
DESULFOASV1_1484_hypothetical_protein	1zth-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	1zth-assembly3.cif.gz_C Crystal Structure of A.fulgidus Rio1 serine protein kinase bound to ADP and Manganese ion	0.123	283	178	11	293	37	240	4.181E-02	68
DESULFOASV1_1484_hypothetical_protein	3cr0-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3cr0-assembly1.cif.gz_A Wee1 kinase complex with inhibitor PD259_809	0.108	345	224	14	358	2	253	3.118E-02	68
DESULFOASV1_1484_hypothetical_protein	7ax4-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	7ax4-assembly2.cif.gz_B Human TYK2 pseudokinase domain (575-869) in complex with 5-(4-Fluoro-phenyl)-2-ureido-thiophene-3-carboxylic acid amide.	0.094	333	225	26	358	11	259	3.610E-02	68
DESULFOASV1_1484_hypothetical_protein	2w5a-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2w5a-assembly1.cif.gz_A Human Nek2 kinase ADP-bound	0.118	335	219	20	354	5	253	1.651E-02	68
DESULFOASV1_1484_hypothetical_protein	4eor-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	4eor-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 WT - human cyclin A3 complex with the inhibitor NU6102	0.098	340	235	20	359	4	264	1.497E-02	68
DESULFOASV1_1484_hypothetical_protein	8bem-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8bem-assembly1.cif.gz_A STE20-like serine/threonine-protein kinase (SLK) in complex with Tivozanib	0.126	358	217	3	360	11	259	1.293E-02	68
DESULFOASV1_1484_hypothetical_protein	7t1t-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7t1t-assembly1.cif.gz_A JAK2 JH2 IN COMPLEX WITH JAK292	0.103	339	234	20	358	9	270	1.497E-02	68
DESULFOASV1_1484_hypothetical_protein	8ans-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8ans-assembly1.cif.gz_A Crystal structure of D1228V c-MET bound by compound 1.	0.088	357	241	2	358	4	268	1.116E-02	68
DESULFOASV1_1484_hypothetical_protein	4hjo-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4hjo-assembly1.cif.gz_A Crystal structure of the inactive EGFR tyrosine kinase domain with erlotinib	0.110	333	224	26	358	10	262	1.231E-02	68
DESULFOASV1_1484_hypothetical_protein	6guc-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6guc-assembly1.cif.gz_A CDK2/CyclinA in complex with SU9516	0.095	339	247	20	358	4	277	6.517E-03	68
DESULFOASV1_1484_hypothetical_protein	2iw8-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2iw8-assembly1.cif.gz_A STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR	0.111	340	252	20	359	4	288	4.197E-03	68
DESULFOASV1_1484_hypothetical_protein	6fyo-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6fyo-assembly1.cif.gz_A X-RAY STRUCTURE OF CLK1-KD(148-484)/Cpd-2 AT 2.32A	0.101	335	279	22	356	13	323	1.231E-02	68
DESULFOASV1_1484_hypothetical_protein	6eiq-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	6eiq-assembly3.cif.gz_C DYRK1A in complex with XMD14-124	0.093	338	275	21	358	25	328	1.357E-02	68
DESULFOASV1_1484_hypothetical_protein	7q4a-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7q4a-assembly1.cif.gz_A Toxoplasma gondii PRP4K kinase domain (L715F) bound to altiratinib	0.119	343	278	18	360	18	333	2.980E-03	68
DESULFOASV1_1484_hypothetical_protein	6yty-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6yty-assembly1.cif.gz_A CLK3 A319V mutant bound with benzothiazole Tg003 (Cpd 2)	0.100	319	283	22	340	29	343	9.638E-03	68
DESULFOASV1_1484_hypothetical_protein	1q97-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	1q97-assembly2.cif.gz_B The structure of the Saccharomyces cerevisiae SR protein kinase, Sky1p, with bound ATP	0.102	342	287	18	359	11	331	3.996E-03	68
DESULFOASV1_1484_hypothetical_protein	3lmg-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3lmg-assembly1.cif.gz_A Crystal structure of the ERBB3 kinase domain in complex with AMP-PNP	0.107	326	227	20	345	10	264	7.547E-03	67
DESULFOASV1_1484_hypothetical_protein	8c08-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8c08-assembly1.cif.gz_A Crystal structure of JAK2 JH2-K539L	0.093	339	233	20	358	8	265	2.325E-02	67
DESULFOASV1_1484_hypothetical_protein	4h58-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	4h58-assembly3.cif.gz_C BRAF in complex with compound 3	0.117	340	227	19	358	7	264	6.844E-03	67
DESULFOASV1_1484_hypothetical_protein	7qhl-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	7qhl-assembly2.cif.gz_C Crystal structure of Cyclin-dependent kinase 2/cyclin A in complex with 3,5,7-Substituted pyrazolo[4,3-d]pyrimidine inhibitor 24	0.101	310	235	47	356	14	275	3.129E-03	67
DESULFOASV1_1484_hypothetical_protein	3ctj-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3ctj-assembly1.cif.gz_A Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-met in complex with a aminopyridine based inhibitor	0.110	356	235	3	358	2	266	7.547E-03	67
DESULFOASV1_1484_hypothetical_protein	3gt8-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3gt8-assembly1.cif.gz_B Crystal structure of the inactive EGFR kinase domain in complex with AMP-PNP	0.118	330	222	20	349	11	263	1.231E-02	67
DESULFOASV1_1484_hypothetical_protein	1ogu-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1ogu-assembly1.cif.gz_A STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 2-ARYLAMINO-4-CYCLOHEXYLMETHYL-5-NITROSO-6-AMINOPYRIMIDINE INHIBITOR	0.100	337	248	20	356	6	282	9.178E-03	67
DESULFOASV1_1484_hypothetical_protein	5cnn-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5cnn-assembly1.cif.gz_A Crystal structure of the EGFR kinase domain mutant I682Q	0.121	339	212	20	358	13	254	8.323E-03	67
DESULFOASV1_1484_hypothetical_protein	6khd-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	6khd-assembly3.cif.gz_C Crystal structure of CLK1 in complex with CX-4945	0.121	337	232	22	358	11	275	1.733E-02	67
DESULFOASV1_1484_hypothetical_protein	6k0j-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6k0j-assembly1.cif.gz_A The co-crystal structure of DYRK2 with a small molecule inhibitor	0.100	340	284	21	360	11	326	1.497E-02	67
DESULFOASV1_1484_hypothetical_protein	6qtg-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6qtg-assembly1.cif.gz_A Crystal structure of human CDK8/CYCC in complex with BI-1347	0.097	208	121	42	249	33	167	5.339E-02	67
DESULFOASV1_1484_hypothetical_protein	4mq2-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	4mq2-assembly3.cif.gz_C The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor	0.085	338	282	21	358	25	333	1.231E-02	67
DESULFOASV1_1484_hypothetical_protein	1h8f-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	1h8f-assembly1.cif.gz_B Glycogen Synthase Kinase 3 beta.	0.121	338	251	21	358	20	306	3.129E-03	67
DESULFOASV1_1484_hypothetical_protein	2vd5-assembly1.cif.gz_A-2	DESULFOASV1_1484_hypothetical_protein	2vd5-assembly1.cif.gz_A-2 Structure of Human Myotonic Dystrophy Protein Kinase in Complex with the Bisindoylmaleide inhibitor BIM VIII	0.144	325	209	20	344	60	304	5.910E-03	67
DESULFOASV1_1484_hypothetical_protein	5uuu-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5uuu-assembly1.cif.gz_A Design, Synthesis, and Evaluation of the First Selective and Potent G-protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure	0.124	359	239	2	360	71	344	5.103E-03	67
DESULFOASV1_1484_hypothetical_protein	4oli-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4oli-assembly1.cif.gz_A The pseudokinase/kinase protein from JAK-family member TYK2	0.127	336	225	23	358	273	531	2.108E-02	67
DESULFOASV1_1484_hypothetical_protein	2xk3-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2xk3-assembly1.cif.gz_A Structure of Nek2 bound to Aminopyrazine compound 35	0.127	335	199	20	354	5	233	4.390E-02	66
DESULFOASV1_1484_hypothetical_protein	2xkd-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2xkd-assembly1.cif.gz_A Structure of Nek2 bound to aminopyrazine compound 12	0.118	335	205	20	354	5	237	3.981E-02	66
DESULFOASV1_1484_hypothetical_protein	2xnn-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2xnn-assembly1.cif.gz_A Structure of Nek2 bound to CCT242430	0.127	335	203	20	354	5	237	2.214E-02	66
DESULFOASV1_1484_hypothetical_protein	8c08-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	8c08-assembly1.cif.gz_B Crystal structure of JAK2 JH2-K539L	0.108	339	227	20	358	9	264	2.564E-02	66
DESULFOASV1_1484_hypothetical_protein	1aq1-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1aq1-assembly1.cif.gz_A HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR STAUROSPORINE	0.095	338	234	20	357	3	262	9.638E-03	66
DESULFOASV1_1484_hypothetical_protein	4ct2-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4ct2-assembly1.cif.gz_A Human PDK1-PKCzeta Kinase Chimera	0.107	325	205	20	344	6	236	3.610E-02	66
DESULFOASV1_1484_hypothetical_protein	1h0w-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1h0w-assembly1.cif.gz_A Human cyclin dependent protein kinase 2 in complex with the inhibitor 2-Amino-6-[cyclohex-3-enyl]methoxypurine	0.107	332	236	26	357	4	268	1.012E-02	66
DESULFOASV1_1484_hypothetical_protein	5uq1-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5uq1-assembly1.cif.gz_A Crystal structure of human Cdk2-Spy1 complex	0.112	336	242	22	357	3	275	1.497E-02	66
DESULFOASV1_1484_hypothetical_protein	2g15-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2g15-assembly1.cif.gz_A Structural Characterization of autoinhibited c-Met kinase	0.090	357	260	2	358	6	292	5.103E-03	66
DESULFOASV1_1484_hypothetical_protein	6i5h-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6i5h-assembly1.cif.gz_A Crystal structure of CLK1 in complex with furanopyrimidin VN412	0.102	314	260	43	356	28	317	9.638E-03	66
DESULFOASV1_1484_hypothetical_protein	7aj8-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7aj8-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 25	0.081	338	286	21	358	12	323	1.293E-02	66
DESULFOASV1_1484_hypothetical_protein	6emh-assembly4.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	6emh-assembly4.cif.gz_D Crystal structure of JNK3 in complex with a pyridinylimidazole inhibitor	0.102	311	242	47	357	28	297	2.333E-03	66
DESULFOASV1_1484_hypothetical_protein	6s1b-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6s1b-assembly1.cif.gz_A Crystal Structure of DYRK1A with small molecule inhibitor	0.079	338	282	21	358	25	331	5.628E-03	66
DESULFOASV1_1484_hypothetical_protein	6eiv-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6eiv-assembly2.cif.gz_B DYRK1A in complex with JWD-065	0.087	338	279	21	358	27	333	1.293E-02	66
DESULFOASV1_1484_hypothetical_protein	8x5m-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8x5m-assembly1.cif.gz_A The Crystal Structure of JNK1 from Biortus.	0.108	337	250	22	358	19	299	7.187E-03	66
DESULFOASV1_1484_hypothetical_protein	6ln1-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6ln1-assembly1.cif.gz_A A natural inhibitor of DYRK1A for treatment of diabetes mellitus	0.083	338	284	21	358	25	335	7.926E-03	66
DESULFOASV1_1484_hypothetical_protein	3anr-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3anr-assembly2.cif.gz_B human DYRK1A/harmine complex	0.087	340	289	21	360	27	343	1.497E-02	66
DESULFOASV1_1484_hypothetical_protein	7z5n-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	7z5n-assembly2.cif.gz_B Crystal structure of DYRK1A in complex with CX-4945	0.090	338	284	21	358	25	337	1.651E-02	66
DESULFOASV1_1484_hypothetical_protein	7z1f-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7z1f-assembly1.cif.gz_A Crystal structure of GSK3b in complex with CX-4945	0.101	337	244	21	357	27	298	1.497E-02	66
DESULFOASV1_1484_hypothetical_protein	5ckw-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5ckw-assembly1.cif.gz_A Crystal structure of LegK4_AMPPNP Kinase	0.100	336	221	23	358	42	287	2.450E-03	66
DESULFOASV1_1484_hypothetical_protein	4qd6-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4qd6-assembly2.cif.gz_B ITK kinase domain in complex with inhibitor compound	0.122	326	202	20	345	8	238	8.323E-03	65
DESULFOASV1_1484_hypothetical_protein	2xk6-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2xk6-assembly1.cif.gz_A Structure of Nek2 bound to aminopyrazine compound 36	0.114	308	190	47	354	14	229	3.981E-02	65
DESULFOASV1_1484_hypothetical_protein	4yzm-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4yzm-assembly2.cif.gz_B Humanized Roco4 bound to LRRK2-In1	0.123	339	219	20	358	9	259	1.352E-01	65
DESULFOASV1_1484_hypothetical_protein	1jpa-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1jpa-assembly1.cif.gz_A Crystal Structure of unphosphorylated EphB2 receptor tyrosine kinase and juxtamembrane region	0.125	342	229	5	346	11	273	1.912E-02	65
DESULFOASV1_1484_hypothetical_protein	6op9-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6op9-assembly1.cif.gz_A HER3 pseudokinase domain bound to bosutinib	0.124	339	221	20	358	10	262	1.172E-02	65
DESULFOASV1_1484_hypothetical_protein	7b43-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7b43-assembly1.cif.gz_A Crystal structure of c-MET bound by compound 9	0.110	358	239	1	358	1	270	1.425E-02	65
DESULFOASV1_1484_hypothetical_protein	5gnk-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5gnk-assembly1.cif.gz_A Crystal structure of EGFR 696-988 T790M in complex with LXX-6-34	0.119	339	216	20	358	15	260	1.012E-02	65
DESULFOASV1_1484_hypothetical_protein	4eoj-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	4eoj-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 H84S, Q85M, K89D - human cyclin A3 complex with ATP	0.102	337	235	20	356	7	269	1.172E-02	65
DESULFOASV1_1484_hypothetical_protein	3uyt-assembly6.cif.gz_B-3	DESULFOASV1_1484_hypothetical_protein	3uyt-assembly6.cif.gz_B-3 crystal structure of ck1d with PF670462 from P1 crystal form	0.104	339	235	20	358	4	266	1.820E-02	65
DESULFOASV1_1484_hypothetical_protein	3zh8-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3zh8-assembly2.cif.gz_B A novel small molecule aPKC inhibitor	0.141	341	221	20	360	6	263	7.187E-03	65
DESULFOASV1_1484_hypothetical_protein	4mq2-assembly4.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	4mq2-assembly4.cif.gz_D The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor	0.093	335	265	21	355	25	317	2.214E-02	65
DESULFOASV1_1484_hypothetical_protein	6s11-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6s11-assembly2.cif.gz_B Crystal Structure of DYRK1A with small molecule inhibitor	0.089	338	272	21	358	24	323	1.116E-02	65
DESULFOASV1_1484_hypothetical_protein	6eir-assembly4.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	6eir-assembly4.cif.gz_D DYRK1A in complex with XMD15-27-2	0.088	329	265	27	355	30	321	1.497E-02	65
DESULFOASV1_1484_hypothetical_protein	6eir-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6eir-assembly2.cif.gz_B DYRK1A in complex with XMD15-27-2	0.096	339	274	21	359	27	330	1.912E-02	65
DESULFOASV1_1484_hypothetical_protein	6s11-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6s11-assembly1.cif.gz_A Crystal Structure of DYRK1A with small molecule inhibitor	0.085	340	292	20	359	25	344	1.293E-02	65
DESULFOASV1_1484_hypothetical_protein	5awm-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5awm-assembly1.cif.gz_A The Crystal Structure of JNK from Drosophila melanogaster Reveals an Evolutionarily Conserved Topology with that of Mammalian JNK Proteins.	0.106	303	199	47	349	28	251	4.407E-03	65
DESULFOASV1_1484_hypothetical_protein	3zrm-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3zrm-assembly1.cif.gz_A Identification of 2-(4-pyridyl)thienopyridinones as GSK-3beta inhibitors	0.100	338	256	21	358	19	303	2.980E-03	65
DESULFOASV1_1484_hypothetical_protein	7kjb-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7kjb-assembly1.cif.gz_A Crystal structure of the EphA2 S897E/S901E mutant intracellular KD-SAM domains	0.116	333	239	13	345	7	277	7.547E-03	65
DESULFOASV1_1484_hypothetical_protein	5uvc-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5uvc-assembly1.cif.gz_A Design, Synthesis, and Evaluation of the First Selective and Potent G-protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor for the Potential Treatment of Heart Failure	0.100	358	256	2	359	126	410	1.293E-02	65
DESULFOASV1_1484_hypothetical_protein	4yuq-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4yuq-assembly1.cif.gz_A CDPK1 from Eimeria tenella in complex with inhibitor UW1354	0.122	340	220	21	360	21	272	2.838E-03	65
DESULFOASV1_1484_hypothetical_protein	2xkf-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2xkf-assembly1.cif.gz_A Structure of Nek2 bound to aminopyrazine compound 2	0.120	335	203	20	354	5	236	3.438E-02	64
DESULFOASV1_1484_hypothetical_protein	4tth-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4tth-assembly1.cif.gz_B Crystal structure of a CDK6/Vcyclin complex with inhibitor bound	0.092	331	217	26	356	9	248	3.610E-02	64
DESULFOASV1_1484_hypothetical_protein	1bi8-assembly1.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	1bi8-assembly1.cif.gz_C MECHANISM OF G1 CYCLIN DEPENDENT KINASE INHIBITION FROM THE STRUCTURES CDK6-P19INK4D INHIBITOR COMPLEX	0.126	340	229	20	359	2	264	2.214E-02	64
DESULFOASV1_1484_hypothetical_protein	1h26-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	1h26-assembly2.cif.gz_C CDK2/CyclinA in complex with an 11-residue recruitment peptide from p53	0.110	335	221	20	354	4	252	1.912E-02	64
DESULFOASV1_1484_hypothetical_protein	2gs7-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2gs7-assembly1.cif.gz_A Crystal Structure of the inactive EGFR kinase domain in complex with AMP-PNP	0.109	328	232	20	347	9	269	2.108E-02	64
DESULFOASV1_1484_hypothetical_protein	5x1s-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5x1s-assembly1.cif.gz_A PpkA-294 with Amppcp	0.102	341	242	19	359	11	281	1.912E-02	64
DESULFOASV1_1484_hypothetical_protein	7qhl-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7qhl-assembly1.cif.gz_A Crystal structure of Cyclin-dependent kinase 2/cyclin A in complex with 3,5,7-Substituted pyrazolo[4,3-d]pyrimidine inhibitor 24	0.103	335	242	22	356	3	273	9.638E-03	64
DESULFOASV1_1484_hypothetical_protein	6p8q-assembly2.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	6p8q-assembly2.cif.gz_D EGFR in complex with a dihydrodibenzodiazepinone allosteric inhibitor.	0.101	326	228	20	345	12	266	1.572E-02	64
DESULFOASV1_1484_hypothetical_protein	4eoi-assembly2.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	4eoi-assembly2.cif.gz_C Thr 160 phosphorylated CDK2 K89D, Q131E - human cyclin A3 complex with the inhibitor RO3306	0.112	337	248	20	356	4	283	6.517E-03	64
DESULFOASV1_1484_hypothetical_protein	6eis-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	6eis-assembly3.cif.gz_C DYRK1A in complex with JWC-055	0.088	337	279	22	358	29	335	9.638E-03	64
DESULFOASV1_1484_hypothetical_protein	7sxh-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7sxh-assembly1.cif.gz_A BIO-8546 bound GSK3beta-axin complex	0.089	338	255	21	358	18	298	3.274E-02	64
DESULFOASV1_1484_hypothetical_protein	1how-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1how-assembly1.cif.gz_A THE X-RAY CRYSTAL STRUCTURE OF SKY1P, AN SR PROTEIN KINASE IN YEAST	0.119	341	267	19	359	13	316	6.844E-03	64
DESULFOASV1_1484_hypothetical_protein	1q99-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1q99-assembly1.cif.gz_A Crystal structure of the Saccharomyces cerevisiae SR protein kinsae, Sky1p, complexed with the non-hydrolyzable ATP analogue, AMP-PNP	0.113	320	266	40	359	24	324	3.624E-03	64
DESULFOASV1_1484_hypothetical_protein	4l00-assembly3.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4l00-assembly3.cif.gz_A Crystal structure of the apo Jak1 pseudokinase domain	0.101	339	227	20	358	19	272	8.292E-02	63
DESULFOASV1_1484_hypothetical_protein	5j1w-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	5j1w-assembly3.cif.gz_C Crystal structure of human CLK1 in complex with pyrido[3,4-g]quinazoline derivative ZW31 (compound 14)	0.105	338	260	22	359	15	306	2.827E-02	63
DESULFOASV1_1484_hypothetical_protein	6i5i-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6i5i-assembly1.cif.gz_A Crystal structure of CLK1 in complexed with furo[3,2-b]pyridine compound 12h	0.087	313	282	37	346	22	334	9.638E-03	63
DESULFOASV1_1484_hypothetical_protein	1wbp-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1wbp-assembly1.cif.gz_A SRPK1 bound to 9mer docking motif peptide	0.098	339	304	22	360	13	350	7.547E-03	63
DESULFOASV1_1484_hypothetical_protein	6z55-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6z55-assembly2.cif.gz_B Crystal structure of CLK3 in complex with macrocycle ODS2004070	0.110	336	279	22	357	28	342	1.231E-02	63
DESULFOASV1_1484_hypothetical_protein	5ukm-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5ukm-assembly1.cif.gz_A bovine GRK2 in complex with human Gbetagamma subunits and CCG258208 (14as)	0.102	340	248	20	359	160	436	1.172E-02	63
DESULFOASV1_1484_hypothetical_protein	2xk8-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2xk8-assembly1.cif.gz_A Structure of Nek2 bound to aminopyrazine compound 15	0.112	308	192	47	354	16	232	4.390E-02	62
DESULFOASV1_1484_hypothetical_protein	4hok-assembly10.cif.gz_S	DESULFOASV1_1484_hypothetical_protein	4hok-assembly10.cif.gz_S crystal structure of apo ck1e	0.101	339	234	20	358	5	265	1.912E-02	62
DESULFOASV1_1484_hypothetical_protein	2x4f-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2x4f-assembly1.cif.gz_A The Crystal Structure of the human myosin light chain kinase LOC340156.	0.092	313	220	47	359	36	278	3.610E-02	62
DESULFOASV1_1484_hypothetical_protein	4c0t-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4c0t-assembly1.cif.gz_A Candida albicans PKh Kinase Domain	0.089	355	243	5	359	4	271	1.425E-02	62
DESULFOASV1_1484_hypothetical_protein	5gty-assembly2.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	5gty-assembly2.cif.gz_D Crystal structure of EGFR 696-1022 T790M in complex with LXX-6-26	0.117	324	215	20	343	11	255	1.651E-02	62
DESULFOASV1_1484_hypothetical_protein	2jit-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	2jit-assembly2.cif.gz_B Crystal structure of EGFR kinase domain T790M mutation	0.114	328	234	20	347	15	279	2.214E-02	62
DESULFOASV1_1484_hypothetical_protein	5j1v-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	5j1v-assembly3.cif.gz_C Crystal structure of human CLK1 in complex with pyrido[3,4-g]quinazoline derivative ZW29 (compound 13)	0.097	318	251	41	358	25	303	1.063E-02	62
DESULFOASV1_1484_hypothetical_protein	7akb-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7akb-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 56	0.079	318	274	41	358	28	326	1.172E-02	62
DESULFOASV1_1484_hypothetical_protein	6q8p-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	6q8p-assembly3.cif.gz_C Structure of CLK1 with bound N-methyl-10-nitropyrido[3,4-g]quinazolin-2-amine	0.106	338	277	22	359	14	324	4.181E-02	62
DESULFOASV1_1484_hypothetical_protein	6z4z-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6z4z-assembly2.cif.gz_B Crystal structure of CLK1 in complex with macrocycle ODS2004070	0.096	325	291	22	346	15	337	1.357E-02	62
DESULFOASV1_1484_hypothetical_protein	4nm0-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4nm0-assembly1.cif.gz_A Crystal structure of peptide inhibitor-free GSK-3/Axin complex	0.094	338	259	21	358	26	312	7.547E-03	62
DESULFOASV1_1484_hypothetical_protein	3v5w-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3v5w-assembly1.cif.gz_A Human G Protein-Coupled Receptor Kinase 2 in Complex with Soluble Gbetagamma Subunits and Paroxetine	0.117	339	232	20	358	161	424	7.926E-03	62
DESULFOASV1_1484_hypothetical_protein	2xnm-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2xnm-assembly1.cif.gz_A Structure of NEK2 bound to CCT	0.120	335	210	20	354	5	244	3.791E-02	61
DESULFOASV1_1484_hypothetical_protein	6vc0-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6vc0-assembly1.cif.gz_A Crystal structure of the horse MLKL pseudokinase domain	0.102	313	219	45	357	24	268	9.638E-03	61
DESULFOASV1_1484_hypothetical_protein	7jus-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	7jus-assembly1.cif.gz_B Crystal Structure of KSR2:MEK1 in complex with AMP-PNP, and allosteric MEK inhibitor Cobimetinib	0.125	338	225	21	358	15	272	1.172E-02	61
DESULFOASV1_1484_hypothetical_protein	8a2d-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	8a2d-assembly1.cif.gz_A EGFR kinase domain (L858R/V948R) in complex with 2-[4-(difluoromethyl)-6-[2-[4-[[4-(hydroxymethyl)-1-piperidyl]methyl]phenyl]ethynyl]-7-methyl-indazol-2-yl]-2-spiro[6,7-dihydropyrrolo[1,2-c]imidazole-5,1'-cyclopropane]-1-yl-N-thiazol-2-yl-acetamide	0.116	337	218	22	358	11	258	4.181E-02	61
DESULFOASV1_1484_hypothetical_protein	6eif-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	6eif-assembly3.cif.gz_C DYRK1A in complex with XMD7-117	0.089	333	259	27	359	29	313	2.692E-02	61
DESULFOASV1_1484_hypothetical_protein	1uv5-assembly1.cif.gz_A-2	DESULFOASV1_1484_hypothetical_protein	1uv5-assembly1.cif.gz_A-2 GLYCOGEN SYNTHASE KINASE 3 BETA COMPLEXED WITH 6-BROMOINDIRUBIN-3'-OXIME	0.110	338	255	21	358	20	306	9.638E-03	61
DESULFOASV1_1484_hypothetical_protein	7dd1-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7dd1-assembly1.cif.gz_A Crystal structure of SRPK1 in complex with a peptide inhibitor	0.094	339	306	22	360	13	351	1.012E-02	61
DESULFOASV1_1484_hypothetical_protein	5air-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5air-assembly1.cif.gz_B Structural analysis of mouse GSK3beta fused with LRP6 peptide.	0.088	338	259	21	358	33	317	3.118E-02	61
DESULFOASV1_1484_hypothetical_protein	4ysj-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4ysj-assembly2.cif.gz_B Calcium-Dependent Protein Kinase from Eimeria tenella in complex with ADP	0.115	339	221	22	360	20	270	2.827E-02	61
DESULFOASV1_1484_hypothetical_protein	5wg5-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5wg5-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG224061	0.096	340	247	20	359	157	430	9.178E-03	61
DESULFOASV1_1484_hypothetical_protein	8an8-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	8an8-assembly2.cif.gz_B Crystal structure of wild-type c-MET bound by compound 7.	0.093	324	215	20	343	18	255	2.564E-02	60
DESULFOASV1_1484_hypothetical_protein	2rf9-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2rf9-assembly1.cif.gz_A Crystal structure of the complex between the EGFR kinase domain and a Mig6 peptide	0.112	324	231	24	347	12	272	3.274E-02	60
DESULFOASV1_1484_hypothetical_protein	6fyv-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6fyv-assembly1.cif.gz_A X-RAY STRUCTURE OF CLK4-KD(146-480)/CX-4945 AT 2.46A	0.098	337	279	22	358	11	320	3.791E-02	60
DESULFOASV1_1484_hypothetical_protein	6ej4-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6ej4-assembly2.cif.gz_B DYRK1A in complex with XMD7-112	0.086	339	284	21	359	27	338	2.441E-02	60
DESULFOASV1_1484_hypothetical_protein	6yu1-assembly1.cif.gz_a	DESULFOASV1_1484_hypothetical_protein	6yu1-assembly1.cif.gz_a CLK3 bound with beta-carboline KH-CARB13 (Cpd 3)	0.093	292	263	47	337	36	327	1.116E-02	60
DESULFOASV1_1484_hypothetical_protein	7o7k-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7o7k-assembly1.cif.gz_A Crystal structure of the human DYRK1A kinase domain bound to abemaciclib	0.091	338	285	21	358	26	339	2.969E-02	60
DESULFOASV1_1484_hypothetical_protein	6yu1-assembly2.cif.gz_c	DESULFOASV1_1484_hypothetical_protein	6yu1-assembly2.cif.gz_c CLK3 bound with beta-carboline KH-CARB13 (Cpd 3)	0.100	295	264	47	340	46	340	1.063E-02	60
DESULFOASV1_1484_hypothetical_protein	7pqs-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	7pqs-assembly2.cif.gz_B SRPK1 in complex with MSC2711186	0.100	339	303	22	360	14	351	1.497E-02	60
DESULFOASV1_1484_hypothetical_protein	7t4m-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7t4m-assembly1.cif.gz_A Structure of dodecameric unphosphorylated Pediculus humanus (Ph) PINK1 D357A mutant	0.094	337	271	20	356	34	333	1.651E-02	60
DESULFOASV1_1484_hypothetical_protein	5he1-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5he1-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG224062	0.094	340	250	20	359	162	438	1.572E-02	60
DESULFOASV1_1484_hypothetical_protein	5gty-assembly1.cif.gz_H	DESULFOASV1_1484_hypothetical_protein	5gty-assembly1.cif.gz_H Crystal structure of EGFR 696-1022 T790M in complex with LXX-6-26	0.125	341	229	20	360	12	274	2.214E-02	59
DESULFOASV1_1484_hypothetical_protein	3rgf-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3rgf-assembly1.cif.gz_A Crystal Structure of human CDK8/CycC	0.105	355	269	3	357	2	302	1.357E-02	59
DESULFOASV1_1484_hypothetical_protein	6khf-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6khf-assembly1.cif.gz_A Crystal structure of CLK3 in complex with CX-4945	0.094	312	257	47	358	29	313	3.118E-02	59
DESULFOASV1_1484_hypothetical_protein	6q8p-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6q8p-assembly2.cif.gz_B Structure of CLK1 with bound N-methyl-10-nitropyrido[3,4-g]quinazolin-2-amine	0.111	321	203	22	342	15	243	7.519E-02	59
DESULFOASV1_1484_hypothetical_protein	6qty-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6qty-assembly1.cif.gz_A Non-phosphorylated human CLK1 in complex with an indole inhibitor to 1.65 Ang	0.101	323	288	22	344	12	332	2.692E-02	59
DESULFOASV1_1484_hypothetical_protein	4mq2-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4mq2-assembly2.cif.gz_B The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor	0.082	314	276	46	359	38	339	2.827E-02	59
DESULFOASV1_1484_hypothetical_protein	7q4a-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	7q4a-assembly1.cif.gz_B Toxoplasma gondii PRP4K kinase domain (L715F) bound to altiratinib	0.140	276	175	45	320	35	238	1.063E-02	59
DESULFOASV1_1484_hypothetical_protein	1q97-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1q97-assembly1.cif.gz_A The structure of the Saccharomyces cerevisiae SR protein kinase, Sky1p, with bound ATP	0.113	320	264	40	359	23	321	8.323E-03	59
DESULFOASV1_1484_hypothetical_protein	1q8y-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	1q8y-assembly2.cif.gz_B The structure of the yeast SR protein kinase, Sky1p, with bound ADP	0.103	320	276	40	359	19	327	1.425E-02	59
DESULFOASV1_1484_hypothetical_protein	5wg4-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5wg4-assembly1.cif.gz_A Human GRK2 in complex with Gbetagamma subunits and CCG257284	0.107	341	235	20	360	160	423	2.969E-02	59
DESULFOASV1_1484_hypothetical_protein	2xk7-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2xk7-assembly1.cif.gz_A Structure of Nek2 bound to aminopyrazine compound 23	0.113	335	201	20	354	5	232	7.160E-02	58
DESULFOASV1_1484_hypothetical_protein	3nr9-assembly1.cif.gz_A-2	DESULFOASV1_1484_hypothetical_protein	3nr9-assembly1.cif.gz_A-2 Structure of human CDC2-like kinase 2 (CLK2)	0.093	302	272	46	346	40	341	2.692E-02	58
DESULFOASV1_1484_hypothetical_protein	6fad-assembly4.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	6fad-assembly4.cif.gz_D SR protein kinase 1 (SRPK1) in complex with the RGG-box of HSV1 ICP27	0.094	339	300	22	360	25	356	1.733E-02	58
DESULFOASV1_1484_hypothetical_protein	7o7i-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7o7i-assembly1.cif.gz_A Crystal structure of the human HIPK3 kinase domain	0.103	353	305	19	359	15	367	8.740E-03	58
DESULFOASV1_1484_hypothetical_protein	6s75-assembly4.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	6s75-assembly4.cif.gz_D Crystal structure of Nek7 bound to compound 51	0.122	318	202	41	358	17	247	6.819E-02	57
DESULFOASV1_1484_hypothetical_protein	2vag-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2vag-assembly1.cif.gz_A Crystal structure of di-phosphorylated human CLK1 in complex with a novel substituted indole inhibitor	0.107	332	284	22	353	14	332	3.610E-02	57
DESULFOASV1_1484_hypothetical_protein	2x7g-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2x7g-assembly1.cif.gz_A Structure of human serine-arginine-rich protein-specific kinase 2 (SRPK2) bound to purvalanol B	0.084	339	305	22	360	11	344	2.827E-02	57
DESULFOASV1_1484_hypothetical_protein	5myv-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	5myv-assembly3.cif.gz_C Crystal structure of SRPK2 in complex with compound 1	0.082	339	308	22	360	13	348	2.692E-02	57
DESULFOASV1_1484_hypothetical_protein	7zks-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7zks-assembly1.cif.gz_A SRPK1 IN COMPLEX WITH INHIBITOR	0.096	339	303	22	360	13	348	2.108E-02	57
DESULFOASV1_1484_hypothetical_protein	3fbv-assembly1.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	3fbv-assembly1.cif.gz_D Crystal structure of the oligomer formed by the kinase-ribonuclease domain of Ire1	0.098	331	235	22	352	16	276	1.733E-02	57
DESULFOASV1_1484_hypothetical_protein	4yzb-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4yzb-assembly2.cif.gz_B CDPK1 from Eimeria tenella in complex with inhibitor UW1521	0.106	340	229	21	360	21	277	2.969E-02	57
DESULFOASV1_1484_hypothetical_protein	5m55-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5m55-assembly1.cif.gz_A Nek2 bound to arylaminopurine 71	0.107	308	188	47	354	16	226	6.493E-02	56
DESULFOASV1_1484_hypothetical_protein	6khd-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6khd-assembly2.cif.gz_B Crystal structure of CLK1 in complex with CX-4945	0.104	308	271	43	346	25	332	3.118E-02	56
DESULFOASV1_1484_hypothetical_protein	7ajy-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7ajy-assembly1.cif.gz_A Structure of DYRK1A in complex with compound 51	0.075	339	290	22	360	21	335	2.007E-02	56
DESULFOASV1_1484_hypothetical_protein	6fyk-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6fyk-assembly2.cif.gz_B X-Ray structure of CLK2-KD(136-496)/Indazole1 at 2.39A	0.096	316	283	22	337	26	339	4.842E-02	56
DESULFOASV1_1484_hypothetical_protein	5myv-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	5myv-assembly2.cif.gz_B Crystal structure of SRPK2 in complex with compound 1	0.082	339	308	22	360	13	349	3.274E-02	56
DESULFOASV1_1484_hypothetical_protein	5xv7-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5xv7-assembly1.cif.gz_A SRPK1 in complex with Alectinib	0.103	339	302	22	360	13	350	2.007E-02	56
DESULFOASV1_1484_hypothetical_protein	4f0g-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4f0g-assembly1.cif.gz_A Crystal Structure of the Roco4 Kinase Domain from D. discoideum	0.126	339	219	20	358	10	260	1.352E-01	55
DESULFOASV1_1484_hypothetical_protein	5hvy-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5hvy-assembly1.cif.gz_A CDK8/CYCC IN COMPLEX WITH COMPOUND 20	0.099	204	120	46	249	32	165	1.491E-01	55
DESULFOASV1_1484_hypothetical_protein	3llt-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3llt-assembly1.cif.gz_A Crystal structure of PF14_0431, kinase domain.	0.110	338	288	22	359	17	341	5.339E-02	55
DESULFOASV1_1484_hypothetical_protein	3q60-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3q60-assembly1.cif.gz_A Crystal structure of virulent allele ROP5B pseudokinase domain bound to ATP	0.115	248	178	7	254	23	224	1.059E-01	55
DESULFOASV1_1484_hypothetical_protein	2wqo-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2wqo-assembly1.cif.gz_A STRUCTURE OF NEK2 BOUND TO THE AMINOPYRIDINE CCT241950	0.099	335	201	20	354	5	228	1.008E-01	54
DESULFOASV1_1484_hypothetical_protein	4crl-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4crl-assembly1.cif.gz_A Crystal structure of human CDK8-Cyclin C in complex with cortistatin A	0.092	209	123	42	250	35	171	1.566E-01	54
DESULFOASV1_1484_hypothetical_protein	6w3c-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	6w3c-assembly2.cif.gz_B Structure of phosphorylated apo IRE1	0.105	337	244	24	360	2	275	8.740E-03	54
DESULFOASV1_1484_hypothetical_protein	4m69-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4m69-assembly1.cif.gz_B Crystal structure of the mouse RIP3-MLKL complex	0.109	310	207	45	354	23	255	6.183E-02	53
DESULFOASV1_1484_hypothetical_protein	4wua-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4wua-assembly1.cif.gz_A Crystal structure of human SRPK1 complexed to an inhibitor SRPIN340	0.101	339	299	22	360	11	344	3.610E-02	53
DESULFOASV1_1484_hypothetical_protein	6fad-assembly3.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	6fad-assembly3.cif.gz_C SR protein kinase 1 (SRPK1) in complex with the RGG-box of HSV1 ICP27	0.097	339	302	22	360	25	359	3.981E-02	53
DESULFOASV1_1484_hypothetical_protein	4yzb-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4yzb-assembly1.cif.gz_A CDPK1 from Eimeria tenella in complex with inhibitor UW1521	0.097	340	231	21	360	21	277	5.084E-02	53
DESULFOASV1_1484_hypothetical_protein	5fgk-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5fgk-assembly1.cif.gz_A CDK8-CYCC IN COMPLEX WITH 8-[3-(3-Amino-1H-indazol-6-yl)-5-chloro- pyridine-4-yl]-2,8-diaza-spiro[4.5]decan-1-one	0.099	316	244	42	357	32	303	5.339E-02	52
DESULFOASV1_1484_hypothetical_protein	3lj0-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3lj0-assembly1.cif.gz_A IRE1 complexed with ADP and Quercetin	0.096	307	240	20	326	8	274	2.000E-01	52
DESULFOASV1_1484_hypothetical_protein	1ztf-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1ztf-assembly1.cif.gz_A Crystal Structure of A.fulgidus Rio1 serine protein kinase	0.109	282	195	11	292	33	252	1.814E-01	51
DESULFOASV1_1484_hypothetical_protein	6yti-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6yti-assembly1.cif.gz_A CLK1 bound with ETH1610 (Cpd 17)	0.107	310	263	47	356	25	320	2.441E-02	51
DESULFOASV1_1484_hypothetical_protein	6qtj-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6qtj-assembly1.cif.gz_A Crystal structure of human CDK8/CYCC in complex with BI 919811	0.088	310	256	42	351	33	314	6.819E-02	51
DESULFOASV1_1484_hypothetical_protein	5myv-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5myv-assembly1.cif.gz_A Crystal structure of SRPK2 in complex with compound 1	0.073	340	313	22	360	13	352	2.692E-02	51
DESULFOASV1_1484_hypothetical_protein	5mxx-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5mxx-assembly1.cif.gz_A Crystal structure of human SR protein kinase 1 (SRPK1) in complex with compound 1	0.105	339	302	22	360	24	361	4.842E-02	51
DESULFOASV1_1484_hypothetical_protein	3qc4-assembly2.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	3qc4-assembly2.cif.gz_B PDK1 in complex with DFG-OUT inhibitor xxx	0.103	339	221	20	358	16	262	2.432E-01	50
DESULFOASV1_1484_hypothetical_protein	4f7l-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4f7l-assembly1.cif.gz_A Crystal structure of human CDK8/CYCC in complex with compound 2 (tert-butyl [3-({[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]carbamoyl}amino)propyl]carbamate)	0.105	355	269	3	357	2	303	7.896E-02	50
DESULFOASV1_1484_hypothetical_protein	6sk9-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6sk9-assembly1.cif.gz_A Nek2 bound to purine compound 51	0.122	308	185	47	354	15	226	1.168E-01	49
DESULFOASV1_1484_hypothetical_protein	7zkx-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	7zkx-assembly1.cif.gz_A SRPK2 IN COMPLEX WITH INHIBITOR	0.088	338	299	22	359	11	339	1.112E-01	48
DESULFOASV1_1484_hypothetical_protein	5icp-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5icp-assembly1.cif.gz_A CDK8-CYCC IN COMPLEX WITH [(S)-2-(4-Chloro-phenyl)-pyrrolidin-1-yl]-(5-methyl-imidazo[5,1-b][1,3,4]thiadiazol-2-yl)-methanone	0.078	317	263	41	357	30	315	1.008E-01	48
DESULFOASV1_1484_hypothetical_protein	4bwp-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	4bwp-assembly1.cif.gz_B Structure of Drosophila Melanogaster PAN3 pseudokinase	0.070	337	227	22	358	6	250	8.292E-02	48
DESULFOASV1_1484_hypothetical_protein	4z7h-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4z7h-assembly1.cif.gz_A Crystal structure of human IRE1 cytoplasmic kinase-RNase region - complex with imidazopyridine compound 3	0.103	342	231	19	360	6	263	2.969E-02	48
DESULFOASV1_1484_hypothetical_protein	6ath-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6ath-assembly1.cif.gz_A Cdk2/cyclin A/p27-KID-deltaC	0.101	311	236	49	359	4	267	3.791E-02	47
DESULFOASV1_1484_hypothetical_protein	4f70-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4f70-assembly1.cif.gz_A Crystal structure of human CDK8/CYCC in complex with compound 4 (1-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-3-[2-(morpholin-4-yl)ethyl]urea)	0.085	317	248	41	357	31	302	1.112E-01	47
DESULFOASV1_1484_hypothetical_protein	5myv-assembly4.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	5myv-assembly4.cif.gz_D Crystal structure of SRPK2 in complex with compound 1	0.078	337	286	22	358	13	323	5.339E-02	47
DESULFOASV1_1484_hypothetical_protein	4f7s-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4f7s-assembly1.cif.gz_A Crystal structure of human CDK8/CYCC in the DMG-in conformation	0.101	337	264	21	357	20	314	2.100E-01	46
DESULFOASV1_1484_hypothetical_protein	2rio-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2rio-assembly1.cif.gz_A Structure of the dual enzyme Ire1 reveals the basis for catalysis and regulation of non-conventional splicing	0.094	341	236	20	360	8	268	7.896E-02	45
DESULFOASV1_1484_hypothetical_protein	3sdj-assembly1.cif.gz_D	DESULFOASV1_1484_hypothetical_protein	3sdj-assembly1.cif.gz_D Structure of RNase-inactive point mutant of oligomeric kinase/RNase Ire1	0.100	318	240	37	354	17	284	4.181E-02	45
DESULFOASV1_1484_hypothetical_protein	6sg4-assembly1.cif.gz_C	DESULFOASV1_1484_hypothetical_protein	6sg4-assembly1.cif.gz_C Structure of CDK2/cyclin A M246Q, S247EN	0.121	303	220	57	359	3	253	9.603E-02	44
DESULFOASV1_1484_hypothetical_protein	4f7n-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	4f7n-assembly1.cif.gz_A Crystal structure of human CDK8/CYCC in complex with compound 11 (1-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-3-(5-hydroxypentyl)urea)	0.093	271	164	28	298	27	208	5.586E-01	44
DESULFOASV1_1484_hypothetical_protein	6w3k-assembly1.cif.gz_A-2	DESULFOASV1_1484_hypothetical_protein	6w3k-assembly1.cif.gz_A-2 Structure of unphosphorylated human IRE1 bound to G-9807	0.107	336	228	19	354	6	261	4.842E-02	44
DESULFOASV1_1484_hypothetical_protein	2rio-assembly1.cif.gz_B	DESULFOASV1_1484_hypothetical_protein	2rio-assembly1.cif.gz_B Structure of the dual enzyme Ire1 reveals the basis for catalysis and regulation of non-conventional splicing	0.105	335	229	23	357	6	262	1.352E-01	39
DESULFOASV1_1484_hypothetical_protein	4k15-assembly1.cif.gz_B-2	DESULFOASV1_1484_hypothetical_protein	4k15-assembly1.cif.gz_B-2 2.75 Angstrom Crystal Structure of Hypothetical Protein lmo2686 from Listeria monocytogenes EGD-e	0.088	45	34	20	64	82	119	4.576E+00	36
DESULFOASV1_1484_hypothetical_protein	3beg-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	3beg-assembly1.cif.gz_A Crystal structure of SR protein kinase 1 complexed to its substrate ASF/SF2	0.103	332	290	37	360	17	348	4.593E-01	36
DESULFOASV1_1484_hypothetical_protein	4k15-assembly1.cif.gz_A-2	DESULFOASV1_1484_hypothetical_protein	4k15-assembly1.cif.gz_A-2 2.75 Angstrom Crystal Structure of Hypothetical Protein lmo2686 from Listeria monocytogenes EGD-e	0.088	45	34	20	64	90	127	6.137E+00	34
DESULFOASV1_1484_hypothetical_protein	4k15-assembly1.cif.gz_C-2	DESULFOASV1_1484_hypothetical_protein	4k15-assembly1.cif.gz_C-2 2.75 Angstrom Crystal Structure of Hypothetical Protein lmo2686 from Listeria monocytogenes EGD-e	0.088	45	34	20	64	82	119	6.768E+00	33
DESULFOASV1_1484_hypothetical_protein	6stj-assembly1.cif.gz_H	DESULFOASV1_1484_hypothetical_protein	6stj-assembly1.cif.gz_H Selective Affimers Recognize BCL-2 Family Proteins Through Non-Canonical Structural Motifs	0.166	62	46	9	64	7	68	8.230E+00	26
DESULFOASV1_1484_hypothetical_protein	2x6h-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	2x6h-assembly1.cif.gz_A THE CRYSTAL STRUCTURE OF THE DROSOPHILA CLASS III PI3-KINASE VPS34	0.106	317	220	40	356	269	515	1.486E+00	25
DESULFOASV1_1484_hypothetical_protein	5elu-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	5elu-assembly1.cif.gz_A Isoform-specific inhibition of SUMO-dependent protein-protein interactions	0.109	66	53	6	65	7	72	7.107E+00	23
DESULFOASV1_1484_hypothetical_protein	1mwq-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	1mwq-assembly1.cif.gz_A Structure of HI0828, a Hypothetical Protein from Haemophilus influenzae with a Putative Active-Site Phosphohistidine	0.084	72	62	55	126	1	69	9.531E+00	21
DESULFOASV1_1484_hypothetical_protein	6ax0-assembly1.cif.gz_A	DESULFOASV1_1484_hypothetical_protein	6ax0-assembly1.cif.gz_A Structure of PR-10 Allergen Ara h 8.01 in complex with epicatechin	0.084	136	107	6	141	22	139	7.463E+00	19
